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Abstract
More than twenty years ago the first genome sequencing of an organism
was seen as a revolution in the world of biological sciences. After a few
years, Carl Woese suggested that in the long run, the real justification of
genomics would have been genomic of prokaryotic microorganisms, due
to the important implication for the study of biological evolution and the
many biotechnological applications (spanning from medical, to agricultural,
environmental and industrial). However, the challenge was then the possibil-
ity to computationally infer the biological properties of an organism on the
simple basis of its genome sequence. Such challenge, still ongoing, relies on
the possibility: i) to reconstruct the genome sequences of organisms from
the (relatively short) sequence reads obtained on the various sequencing
platforms; ii) to identify genes inside DNA sequences and assign functions;
iii) to predict organisms’ phenotypes. It is possible to imagine such challenges
as a 1-D, 2-D and 3-D “-omics” reconstruction. In this thesis, the aim was to
explore, by using specific case studies, such 1-D, 2-D and 3-D computational
biology inference on prokaryotic genome sequences. Each chapter of the
results section will provide data on bacterial genomes of relevant strains
for various biotechnological applications. The overall results are presented
according to the depth of functional (phenotypical) inference, from genome
assembly and simple functional annotation to the powerful genome-scale
metabolic models. The main focus will be centered to emphasize the high
predictive value of genome-scale metabolic modeling for complex pheno-
types and in silico prediction of gene essentiality. The main conclusion is
concerned with an integrated use of the computational tools to assist systems
biology-based computational inferences, to help whole predictive biological
(genomic) sciences.
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Sommario
Più di vent’anni fa il primo sequenziamento genico automatizzato di un
organismo costituì una rivoluzione nel mondo delle scienze biologiche. Dopo
qualche anno Carl Woese suggerì che, alla lunga, la reale giustificazione della
genomica sarebbe stata la genomica dei microrganismi procarioti, a causa
delle importanti implicazioni per lo studio dell’evoluzione biologica e le tante
applicazioni biotecnologiche (da quelle mediche a quelle industriali, ambien-
tali e agricole). Ad ogni modo, la sfida divenne poi la possibilità di inferire
computazionalmente le proprietà biologiche di un organismo sulla sola base
della sua sequenza genica. Tale sfida, ancora in corso, risiede nella possibilità
i) di ricostruire le sequenze genomiche di un organismo a partire dalle (rela-
tivamente corte) reads ottentute da diverse piattaforme di sequenziamento;
ii) di identificare geni all’interno delle sequenze di DNA e assegnare loro fun-
zioni; iii) di predire i fenotipi degli organismi. E’ possibile immaginare queste
sfide come ricostruzioni -omiche 1-D, 2-D e 3-D. In questa tesi lo scopo era di
esplorare, usando specifici casi studio, tali inferenze biologiche computazion-
ali 1-D, 2-D e 3-D sulle sequenze genomiche procariotiche. Ciascun capitolo
della sezione risultati presenterà dati su genomi batterici di ceppi importanti
per svariate applicazioni biotecnologiche. I risultati complessivi sono presen-
tati a seconda del grado di profondità dell’inferenza funzionale (fenotipica),
dall’assemblaggio e semplice annotazione funzionale di un genoma fino ai
potenti modelli metabolici genome-scale. Il focus principale sarà incentrato
sull’enfatizzazione del valore predittivo del metabolic modeling su scala ge-
nomica per fenotipi complessi e predizione di geni essenziali in silico. La
conclusione principale riguarda l’uso integrato dei tool computazionali per
assistere le inferenze di systems biology, per aiutare tutte le scienze biologiche
(genomiche) predittive.
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Part I
INTRODUCTION

Preface
„The whole is greater than the sum of its
parts.
— Aristotele
The past twenty years of biological studies have been defined as the genomic
era. Enormous progress in the experimental and computational techniques
used to sequence genomes allowed an unprecedent level of knowledge. How-
ever, many questions are still uncovered. The main reason of these gaps is
probably connected to a “reductionist” approach to the study of organisms,
which historically privileged the “fraction” over the “system”. This basically
means that complex biological mechanisms have been studied under the
lens of molecular biology, which focuses on searching below the large-scale
manifestations of a system. However, to reach a deep understanding of such
complex processes, it is necessary to examine the structure and dynamics of
the cellular and organism functions, rather than the characteristics of their
isolated parts. This is the leading idea of systems biology. Luckily, these
two views are not intended to be set apart for ever: computational systems
biology is emerging as the natural meeting point of both.
Molecular aspects can now be seen in a functional perspective thanks to the
use of tools like genome-scale metabolic models. These implementations
synthesize the bottom-up (data-driven) and the top-down (model-driven)
scientific approaches, connecting these two in a loop of wet- and dry- ex-
perimental steps in which both result fundamental. The overall goal of this
dissertation is to show how genomics easily flow in GEMs framework, thus
enabling for functional estimations of organisms’ properties, instead of purely
descriptive ones. The works herein contained can be conceptually distinct in
three main sections:
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• genome sequencing, assembly and annotation;
• comparative and evolutionary biology;
• metabolic modeling.
However, this subdivision has the only scope to drive the logical progression
of the studies, rather than actually separate them. On the contrary, the under-
laying intent is to show their common scope, the possible interconnections
and, hopefully, to sketch the auspicable path of future research field.
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1The genomic era
1.1 The first glimpse
The first DNA sequencing methods can be tracked back to 70s and 80s
(Maxam-Gilbert sequencing and Sanger sequencing [1, 2]); however, it was
only in 1995 that the first completely automated genome sequencing of an
organism took place [3]. The chance to know the exact DNA sequence of
an organism kick-started for deep-impact genomic studies and a new era in
biological science begun.
At the early stages, the major implications of this innovation were in the
field of bacteriology (see Figure 1.1), where it immediately revealed unex-
pected insights and transformed the way to discern bacteria evolution and
functions. Since they were relatively small and easy to handle, sequencing
technology boosted the study of microbial genomes. Initially, the priority
was to sequence as many different organisms as possible, with great concern
about the genome composition and organization. Publicly available databases
and repositories collecting the sequenced data, like GenBank, were created.
Moreover, software tools, as BLAST [4], made it easy to infer the function of
novel, unknown sequences, based on comparison with those already stored
into existing databases. Soon, thanks to the increasing number of available
genomes, comparative and phylogenetic approaches revealed how deep the
impact of horizontal gene transfer (HGT) was and how it shaped the evolu-
tion of Bacteria and Archea.
In April 2003, another milestone in human history and scientific discovery
was reached when the Human Genome Project (HGP) [5] was completed.
The ambitious, thirteen years long and three-billion-dollar project, raised the
expectation of many to reveal the “secret of life” (and of disease?). However,
information is only as good as the ability to use it, and indeed, on one side it
enabled to answer to many questions, and on the other side, it also brought
to light new challenges for researchers and scientists: how to read and inter-
pret the contents written into the genome? The following years witnessed
enthusiastic explorations and disappointing difficulties.
In 2004, a pioneering shotgun metagenomics sequencing project reported
thousands of new genes [6]. Uncultivable species whose presence had always
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been postulated were now finally detected. It would have impacted the whole
field, spanning from ecological to evolutionary, from clinical to agricultural
microbiology.
    1977
Invention of dideoxy chain terminator 
sequencing by Fred Sanger
1981
First human mitochondrial genome 
sequence
1996
Mycoplasma becomes first bacterial genus 
that has completely sequenced genomes 
from two different species (M. genitalium and 
M. pneumoniae)
1998
First genome sequence from M. tuberculosis
Genome sequence from R. prowazekii reveals 
reductive evolution
1995
First complete genome sequences 
obtained of free-living bacteria: H. 
influenzae and M. genitalium
1997
First genome sequences from E. coli 
and B. subtilis.
    1999
H. pylori becomes the first species with 
sequenced genomes from two isolates
Evidence for lateral gene transfer between 
Archaea and bacteria from genome 
sequence of T. maritima
2001
E. coli genome sequences reveal extensive 
horizontal gene transfer
Genome sequences of two strains from one 
species (S. aureus) in a single publication
Genome sequence of M. leprae documents 
bacterial pseudogenes and reductive evolution
2000
Meningococcal genome sequence kick-starts 
reverse vaccinology
2002
Genome sequencing of multiple strains of B. 
anthracis to provide markers for forensic 
epidemiology
2004 Genome sequencing of uncultivable T. whipplei leads to design of axenic growth medium
2003
Genome sequence of mimivirus blurs 
distinctions between bacteria and viruses
Bacterial metagenomics survey of Sargasso 
sea yields >1 million new genes
2007
Release of the Illumina Genetic Analyzer 
Single-cell genomics of TM7 microorganisms 
from the human mouth
2009
Transposon-sequencing identifies essential 
genes in Salmonella
Whole-genome sequencing identifies 
target of new drug against M. tuberculosis
First next-generation sequencer: the 454 
GS20
2008
First genomics super-project; 
sequencing of 100 strains of S. Typhi
2010
    2005
Rise of bacterial genomic epidemiology to 
track hospital pathogens
A human gut microbial gene catalogue 
established by metagenomic sequencing
2011
Open-source genomics of an E. coli outbreak in 
Germany
Genome sequencing shows role for UN 
peacekeepers in Haiti cholera outbreak
Genome sequence of Y. pestis from the Black 
Death
2013
Metagenomics used to analyse E. coli 
outbreak
2015
2014
Oxford Nanopore launch MinION Access 
Programme
Dense sequencing of >3,000 S. pneumoniae 
isolates shows bacterial populations shaped by 
human interventions
CRISPR–Cas adopted for programmable 
genome editing
    2012
Genome sequencing adopted for routine 
surveillance of salmonellosis and tuberculosis
Genomics of candidate phyla radiation reveals 
novel unusual biology
Fig. 1.1: Milestones in bacterial genome sequencing. Figure edited from [7]
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1.2 The next-generation sequencing
technology
A decade after the H. influenzae genome sequencing [3], society was ready
for the first high-throughput sequencing technology. The new platforms
replaced the onerous, expensive, biologically-based method with a new
chemistry-based one. As a matter of fact, the new in-vitro method, allowed
fast, high-throughput and relatively low-cost results. On the contrary, the
first genome shotgun technology required the in-vivo generation of templates
which was slow and less effective since it demanded for colonies selection
and plasmids preparation. The switch to the new technology had two big
consequences: it delivered the ability to perform genome-sequencing inside
universities and small research centers and it also affected the quality of
the whole system by producing shorter and less-refined reads (i.e. short
copies of DNA fragments). This basically meant that scientific community
witnessed a shift from complete genomes to draft genomes. In fact, the
new technology made extremely easy to sequence a genome but in turn it
required a big effort to assemble and annotate it. Moreover, the shorter
reads affected the resolution of repeated regions. Paired-end (PE) sequencing
[8, 9] was hence introduced in order to solve the problem. Sequencing
both ends of the DNA fragments and aligning the forward and reverse reads
as read-pairs enabled a regain in accuracy. However, it also doubled the
amount of reads, which entailed demanding computational support. Thus,
the methodological development was accompanied by bioinformatic advance.
At that point indeed, given the small experimental effort needed, the fastness
of the method and the low-cost of the sequencing, massive quantity of data
started to be delivered, and the proportion of the phenomena was so huge (
Fig.1.2 and Fig. 1.3) that the new bottleneck became how to analyze the raw
data rather than how to generate them.
1.3 Bioinformatic blooming and the third
generation of NGS
In such a context, bioinformatics became both the answer and the challenge
to face-off. The mere availability of powerful sequencing platform would
1.2 The next-generation sequencing technology 7
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are collected from the NHGRI website. Original source PhD dissertation
http://hdl.handle.net/2158/986409
have been ineffective without raw-data processing. Similarly, the knowledge
of an exact genome sequence alone would have been useless in absence
of algorithms to analyze its content. Simple local alignment that could be
performed by hand were already used for sometime. Nevertheless, as a
larger amount of sequences could now be compared, it became necessary to
8 Chapter 1 The genomic era
move to new, specific algorithms and parallel, mathematical computing to
address the issue. BLAST was one of the first similarity search, heuristic-based
methods to be developed and constituted the foundation of the successive
algorithms designed for genome assembly (that in the meantime became
very critical). New and powerful tools were released both for assembly, such
as ABySS [10], SOAPdenovo [11] and Velvet [12], and for gene calling and
annotation, like Phred, Phrap [13], Glimmer [14] and Artemis [15]. However,
the biggest return of all these innovations was, probably, the adoption of
a new mindset in the scientific community with an increasing interest in
evolutionary turn-out and phenotype inferences. The joint development
of wet-lab techniques and computational methods fostered the start and
dissemination of new comparative genomics studies. The high-throughput
screening of gene function now rapidly allows the investigation of basic
biological similarities/differences and the estimation of the gene repertoire of
various taxonomic group. Structural and genetic landmarks and evolutionary
relationships between organisms can be targeted, sometimes influencing the
concept of species as we knew it.
Today we are assisting in the third revolution in the genome sequencing
practice. Different machineries, relying on different methodologies, have
been commercially released. These provide a new opportunity to study
genetic variation on an unprecedented scale by producing longer reads, like
the first generation of sequencing machines, but with the high throughput
introduced by the second one. The new platforms (e.g. long-read, single-
molecule sequencing technology (SMRT) [16] and Nanopore sequencing
[17]) restored the ability to produce complete genomes, a practice that was
largely dismissed with the advent of the first NGS technologies. This enables
high accuracy of the analysis, especially of repeat-rich areas of the genome,
revealing large genomic complexity and, at the same time, reducing the
annotation effort/cost.
Before moving to practical implications that all these technical improvements
brought, the following chapters will cover some bioinformatics aspects about
genome sequencing.
1.3 Bioinformatic blooming and the third generation of NGS 9
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2From raw data to complete
genome
Rapid progress in high-throughput sequencing technology would have been
useless without the intense bioinformatic labour that accompanied its onset.
The new sequencing method in fact, presented two major critical concerns:
how to place back together the enormous amount of raw data produced
(reads) to make up the original genome, and how to deal with repetitive
sequences. However, the de novo assembly is a mathematically difficult prob-
lem, regardless of the sequencing technology used, for which no efficient
solution is known, falling in the class of the computational NP-hard prob-
lems (nondetermistic polynomial-time hard problem) [1]. This chapter will
cover the basic downstream data processing pipeline used to approach these
issues.
2.1 A preliminary phase: raw data check
The first action required to reconstruct long stretches of DNA sequence (up to
genome length) from the reads library is to check their quality. Sequencing
in fact, is an error prone process during which different anomalies may occur
(e.g. PCR duplications, poor base calling toward the 3’ (terminal) ends of
reads, inaccurate determination of simple sequence repeats, etcetera). To
avoid misleading results, reads are pre-processed and the PHRED score (Q)
[2, 3] associated to each nucleotide is estimated (it stands for the degree
of confidence of the identification of the nucleobases and corresponds to
the ASCII-encoded quality number). Other parameters like the GC content,
repeats abundance and/or the proportion of duplicated reads are then taken
into account to estimate the overall features makeup and individuate possible
artifacts. To achieve this scope several tools may be adopted. One of the
most famous is the user-friendly FASTQC software [4] that yields graphical
visualization of basic statistical parameters. Based on the results of this
preliminary analysis, reads can be trimmed. Trimming is a non-trivial process
which aims at removing low quality portions while preserving the longest
high quality part of a NGS read. During such a phase duplicates, contaminant
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sequences, adapters and low quality reads are eventually filtered out. Here,
the principal effort is to pick the optimal trimming cut-off in order to not
reduce the coverage and to speed-up the following assembly process.
2.2 The assembly problem
Determining the correct order of reads seeks computational approach. An
assembly is a hierarchical data structure that maps the sequence data to
a putative reconstruction of the target. The sequencing depth influence
the correct achievement of that task. Perfect duplicated repeats located in
different regions of the genome may result indistinguishable, especially if
the repeats are longer than the reads. Over-sampling the target DNA is
thus the first requirement to satisfy minimum detectable overlap criteria
(but may not be sufficient in case of short reads). However, high coverage
increases complexity and intensifies computational issues. Estimation of
the correct assembly is demanded to different algorithms, some of them
aim to minimize mis-assemblies while others mainly focus on improving the
contiguity. Beyond the possible strategies, they are all based on graph theory
and they can be classified accordingly. Moreover, all assembly softwares rely
on the notion of a K-mer (figure 2.1). This is a sequence of a number K calls
of nucleic base, where K is any positive integer. The detection of shared
K-mer in the reads reduces the computational cost of assembly. Overlap
discovery is sensitive to settings of K-mer size, minimum overlap length, and
minimum percent identity required for an overlap. These three parameters
affect robustness. A brief description of the joining problem and the basic
work flow of the algorithms is provided below.
2.2.1 Structuring the assembly as a graph
As mentioned, computational solutions represent the sequence of the reads
in an assembly graph where the labels along a path of the graph encode
a sequence. A graph is an abstraction widely used in computer science. It
is a set of nodes connected by a set of edges. Nodes and edges may also
be called vertices and arcs, respectively. If the edges are traversed in one
direction, the graph is known as a directed graph, otherwise it is undirected.
Importantly, each directed edge represents a connection from one source
node to one sink node. Collections of edges form paths that visit nodes in
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some order, such that the sink node of one edge forms the source node for
any subsequent nodes. In modeling the assembly as a graph reads are nodes
and the overlaps connect the nodes with edges. For the assembly problem
the principal algorithms used are three:
• the Overlap/Layout/Consensus (OLC)
• the de Bruijn graph (DBG)
• the Greedy graph
The factors that influence the choice of algorithms include the quantity of
data (as read length and coverage), quality of data and genome structure
(e.g., GC content and the number and size of repeated regions).
2.2.2 The Overlap/Layout/Consensus algorithm
Overlap/Layout/Consensus (OLC) method rely on an overlap graph and it
is manly used for long reads. In an overlap graph assembling the reads into
the genome is equivalent to finding a Hamiltonian path, which is a path
that visits every node of the graph exactly once. Overlap discovery involves
all-against-all, pairwise read comparison. The seed and extend heuristic
algorithm is used for efficiency. The software precomputes K-mer content
across all reads, selects overlap candidates that share K-mers, and computes
alignments using the K-mers as alignment seeds. The second (layout) step is
the construction of the graph, such that two vertices are connected with an
edge if the corresponding reads overlap. However, due to this heuristics, the
set of sequences obtained (contigs) may be biased and fragmented because
of complex patterns in the graph that are generated by sequencing errors,
genomic variants and repeats. Construction and manipulation of an overlap
graph leads to an approximate read layout. The overlap graph need not
include the sequence base calls, so large-genome graphs may fit into practical
amounts of computer memory. Paths in overlap graphs converge at repeats
longer than a read. Many widely used assembly programs adopted OLC, such
as Phrap [5], Newbler [6], Arachne [7], etc.
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2.2.3 The De Bruijn Graph algorithm
The De Bruijn graph (DBG) was generated for the “string reconstruction
problem” i.e. finding the shortest superstring that contains as substrings
all possible reads of a given length k over an arbitrary alphabet. Today it
is now largely applied in genome assembly, manly in case of short reads
produced by the second generation of sequencing technologies. The De
Bruijn graph has the form of a K-mer graph for the search of a Eulerian
path (see Figure 2.1). The nodes represent all possible fixed-length strings.
The edges represent suffix-to-prefix perfect overlaps and its nodes all the
fixed-length subsequences drawn from a larger sequence. that contains every
edge exactly once is called an Eulerian path. K-mer graphs are more sensitive
to repeats and sequencing errors and paths converge at perfect repeats of
length K or more. Several tools have been developed based on DBG, such as
Euler-USR [8], Velvet [[9], ABySS [10], AllPath-LG [11] and SOAPdenovo
[12].
accagttg
accagt
cagttg
acca ccag cagt agtt gttg
1)
2)
3)
Fig. 2.1: K-mer graph based on pair-wise overlap. (1) Two reads have an error-free
overlap of 4 bases. (2) One K-mer graph, with K=4, represents both
reads.(3) Consensus sequence is easily reconstructed from the path.
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2.2.4 The greedy graph algorithm
The greedy algorithms apply one basic operation: given any reads or contigs
merge the two with the maximum overlap score at the time. The basic
operation is performed at both the 3’ and the 5’ end of the read until no
further extensions are possible until no more reads are left. Even in this
case the problem is the search of an Hamiltonian path. Greedy approach
drastically simplify the graph by considering only the high-scoring edges.
Indeed, issues may arise since a local maxima may occur when the current
contig is merged with reads that would help further contigs to grow even
larger. As an optimization, they may actually instantiate just one overlap
for each read end they examine, hence this strategy besides being very easy
to implement, but it does not necessarily result in the optimal solution.
Moreover, tools which rely on greedy approach have relatively long running
times. Examples of softwares are SSAKE [13], SHARCGS [14] and VCAKE
[15].
2.3 Growing in size: the scaffolding
process
After reads are grouped in contigs (long stretches of DNA) they are merged to
form scaffolds. Scaffolding is the process that links together a non-contiguous
set of sequences establishing their order and orientation with a high confi-
dence level. Analysing gene order and synteny, carrying out comparative
or functional genomics or investigating patterns of recombination all rely
heavily on obtaining an assembly with good continuity. However, the number
of contigs depends on a combination of assembly tool used, sequence cover-
age, sequencing methodology and genome complexity. The more fragmented
the assembly is, the harder the downstream analysis becomes. Algorithms
used by assembly software are very diverse, however, even in this case, the
problem can be formalised using graph theory, with contigs corresponding
to nodes of the graph, and linking read pairs corresponding to edges. Gaps
occur where reads from the two sequenced ends of at least one fragment
overlap with other reads in two different contigs (as long as the arrange-
ment is otherwise consistent with the contigs being adjacent). They may
be of undefined or defined length (even if an estimation could always be
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done), such length often has no relation to the true gap size. In several
genomes, gaps are arbitrarily set to certain fixed lengths, most of the cases
a series of 100 Ns connects two contigs or supercontigs. The reason for
gaps in scaffolded assemblies is the presence of large, repetitive elements
which short-read sequencing methods struggle to bridge. Thus, duplicated
genes, pseudogenes, short tandem repeats, and many other structural ge-
nomic features are often unresolved in scaffolds. The uncertainties of gap
sizes also result in an inability to understand the true spatial relationships of
functional elements in genomes and is an underestimate of the actual extent
of missing information. Paired-end information can be used to fill these gaps
joining contigs into scaffolds. Most of the software based on such approach
have several preparatory steps in which read and contig libraries are first
converted to a specific format, then mapped against each other by means of
an external aligner (e.g. BWA, [16] or BOWTIE, [17]). Currently available
methods/software based on that pipeline include SOPRA [18], SCARPA [19],
Opera [20], GRASS [21] and SSPACE [22]. An alternative and efficient
approach to partially overcome gap issues may be that based on the use of
one or more completes (closed) reference genomes to guide the ordering and
the orientating of the contigs. Many software relying on that system exist:
CONTIGuator [23], progressiveMauve [24], Projector2 [25], Ragout [26],
MeDuSa [27].
2.4 Closing the genome
Gaps remaining after scaffolding can be closed only through supplementary
refinement steps which are crucial, time-consuming and expensive but which
in return result in complete genomes. Usually such refinements consist
of amplifying the region corresponding to gaps followed by sequencing;
alternatively, for more complex assemblies with a high number of gaps, a run
with long reads, single-molecule sequencing platform is strongly suggested.
After, the mapping approach can be adopted using the principal assembly as
a backbone.
18 Chapter 2 From raw data to complete genome
2.5 Genome annotation
The final operation of the modern genome sequencing work flow is the one
that enables to find the location of each gene in the raw DNA sequence
and labeling all the relevant features, i.e. the genome annotation process.
This is properly the phase which actually treasures all the upstream effort
and makes it possible to analyze genome contents. The information used
to annotate genomes comes from three types of analysis: (i) ab initio gene
finding programs, which are run on the DNA sequence to predict protein-
coding genes; (ii) alignments of cDNAs and expressed sequence tags (ESTs), if
available, from the same or related species; and (iii) translated alignments of
the DNA sequence to known proteins. These types of evidence are abundant
in various amounts depending on the organism; for less well-studied species,
cDNA and EST evidence is often lacking, and annotators depend much more
heavily on ab initio prediction programs, i.e. based only on the statistical
parameters in the sequence. Many tools have been developed for such a
scope, but generally proteins coding genes are annotated in two stages. First
the coordinates of candidate genes are identified, then the putative gene
product is described. The traditional way to predict what a gene codes for is
to compare it with a large database of known sequences, usually at a protein
sequence level, and transfer the annotation of the best significant match.
Annotation can be performed through various online annotation servers (such
as the NCBI Prokaryotic Genomes Automatic Annotation Pipeline service or
RAST web server [28] for annotating bacterial and archaeal genomes, the
fisrt has a turn-around time measured in days while the second provides
annotation results in under a day) or through softwares which may be
run locally (Prokka [29]). Importantly, identification of different genomic
features may be demanded to different methods which are called by the
software while running, for example Prokka uses Prodigal [30] to recognize
Coding sequence (CDS), RNAmmer [31] for Ribosomal RNA genes (rRNA),
Aragorn [32] for Transfer RNA genes, SignalP [33] for Signal leader peptides
and Infernal [34] for Non-coding RNA.
2.5 Genome annotation 19
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3The comparative approach
Although comparative genomics lays its root in the early 1980s with the
comparison of viral genomes [1], it reached its top only later thanks to in-
silico applications [2–4]. Indeed, during the first years of shot-gun genome
sequencing there was a great concern about genome structures and major
landmarks such as genome size, number of genes, and chromosome/replicons
number became an entry point into comparative genomic analysis at different
taxonomic levels (see Table 3.1). These focus rapidly led to one of the most
striking findings of that time i.e. that genome size does not correlate with
evolutionary status, nor is the number of genes proportionate to genome
size. However, it was just the kick-off. From the middle 90s onwards, the in-
creasing reservoir of available genomics data, did tickle the use of comparing
basic biological similarities and differences, as well as evolutionary relation-
ships between organisms, at a finer-resolution, i.e. by mean of sequences
comparison. Such a chance results from the equation that if a function is
evolutionarily conserved among different organisms then the DNA encoding
for it should be conserved too. Likewise, different functions between species
should be ascribed to divergent genetic material. Therefore, gene functions
can be inferred by analyzing sequences.
Organisms Size (bp) Chromosomes Genes
Human (Homo sapiens) 3 billion 46 25000
Mouse (Mus musculus) 2.9 billion 40 25000
Fruit fly (Drosophila melanogaster) 165 million 8 13000
Plant (Arabidopsis thaliana) 157 million 10 25000
Roundworm (Caenorhabditis elegans) 97 million 12 19000
Yeast (Saccharomyces cerevisiae) 12 million 32 6000
Bacteria (Escherichia coli) 4.6 million 1 3200
Tab. 3.1: Genomic features of different organisms
This approach, coupled with genome structure analysis, mobile elements
clues and many other genomic observations, pushed the research-field at un-
precedented levels by comparing fruit fly or yeast genomes to that of humans
or plants and pinpointing less straightforward correlations like genes that are
essential to life and genomic signals that control gene functions across many
species.
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Beside these informations may be used for very diverse applications, the
first and probably the naturally closest one, was in evolutionary biology.
Fresh-new challenges gave a brand new impetus to scientists which started
combining molecular fingerprints with the more classic physical and phys-
iological methods to understand how the biology of living organisms has
changed over time.
3.1 From molecular evolution to clinical
applications
Mathematical computing not only assisted the transition to new frontiers of
study but actually it has been the device that made it possible. Indeed, se-
quences comparison was computational expensive, involving multi-alignment
of DNA or protein sequences, score-matrix generation, phylogeny trees con-
struction etc. By implementing new algorithms and softwares enabling to
estimate the evolutionary distance between species, bioinformaticians de-
livered the capability to analyze entire genomes and to track the simplest
genetic events, like point mutations, as very complex evolutionary marks,
like, for instance, gene duplication, deletion or insertion and horizontal gene
transfer (HGT). Moreover, the magnitude of the analysis was enormous,
involving not only closely related organism but also very phylogenetically
distant taxonomic species. Models and algorithms to infer such events, range
from exact, heuristics, fixed parameter and approximation algorithms (for
problems based on parsimony models) to Markov Chain Monte Carlo algo-
rithms (for Bayesian analysis of problems based on probabilistic models).
3.1.1 In-silico taxonomy inference
Despite large experimental techniques availability (DNA-DNA hybridization
for instance), today molecular phylogeny became almost a requirement to
infer taxonomy. Bacterial phylogenies, for example, are inferred based on
the molecular analysis of 16S RNA. The secondary structure of the small
ribosomal subunit is the most conserved genomic region known across all
the prokaryotic species and its degree of conservation varies widely only be-
tween hypervariable regions, which makes it perfect for taxonomic gathering
purpose. High-conserved regions in fact, correlate to higher-level taxonomy
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while less conserved regions correlate to lower levels, such as genus and
species. It is also possible to deduce the phylogeny of a specific function
based on homologous sequences set-up of many other genes or proteins.
This often benefits of the comparison with the reference species phylogeny
to estimate the frequency and the points of the HGT events. Recently, the
horizontal transfer of 16S RNA has been argued [5] and, although this may
be infrequent, the validity of 16S rRNA-based typing could be reevaluated.
Indeed, the concept of species itself has been challenged in the genomic era.
By providing evidence of extensive HGT, comparative genomics has in fact
shown that the strains belonging to the same prokaryotic species may share
a fraction only of their genome, thus, the concept of pan-genome analysis [6,
7] has been developed to accommodate such peculiar feature of prokaryotic
genomes. Several definitions of prokaryotic species have been proposed
(e.g. ecological, [8]); however, an operative definition for defining species
affiliation of strains is based on the percentage of nucleotide identity within
the shared (core) genome fraction, known as Average Nucleotide Identity
(ANI, [9]).
3.1.2 The pangenome perspective
A pangenome [6, 7] is defined as the full complement of genes in a taxonomic
group and is a tool to study the unique and cohesive genomic features of that
class. In other words, it provides the ability to perform in depth analysis of
intra-species diversity by taking advantage of an incredible accurate, though
comprehensive, view. It consists of the determination of (see Figure 3.1):
• the “core” genome, i.e. those genes shared by all the strains of the
studied group;
• the “dispensable” genome, i.e. those genes present in only two or more
strains;
• and, finally, the “unique” genome, i.e. that repertoire of genes belonging
to exclusively one strain of the examined group.
The size of each category (and pangenome itself) can result as a function of
the number of genomes embedded into the analysis. As mentioned, different
strains have different capacity to acquire exogenous DNA (due to different
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Fig. 3.1: Pangenome representation. The uninion of three different genomes results
in core genome C, dispensable D and unique U.
HGT mechanisms and their occurrence); this influences the amount of the
unique pangenome’s segment. Because of that, it can be classified as “open”
if its size increase as increasing the number of genomes analyzed. Conversely,
if the size of the three categories is not influenced by the number of included
genomes, then the pangenome is named “closed”. Such definition stands for
the ability of the species to maintain a certain set of genes, a property that
is strictly related with the ecological niche occupied by the species. Closed
pangenome in fact, are proper of those species that live in a narrow eco-
logical niche where there is no real reason for a different adaptation and
diversification of the strains, that would result in an open pangenome instead
[10, 11].
Consequently, some considerations arise: genes belonging to core genomes
usually encode for housekeeping functions of the species, therefore it can
be used to identify those traits that are vertically inherited, while the other
two identify lifestyle-related functions and strains’ peculiarities, which are
often horizontally acquired. Though evolutionary aspects are very important,
far-reaching applications raise from the observations of genetic traits embed-
ded in core, accessory and unique genomes. Reverse vaccinology [12], for
example, is an emergent field that benefits from core features species insights
to develop vaccine and pan-vaccine. Observations of dispensable or unique
characters instead, cover great relevance in eco-evo studies and in antibiotic
production or resistance mechanisms targeting.
NGS technology catalyzed the development of a plethora of comparative
genomics methods. In addition to pangenome analysis in fact, several tech-
niques are now used to characterize a species, or strains within species, at
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various level: pulsed field gel electrophoresis [13], multilocus sequence typ-
ing (MLST) [14], multispacer sequence typing [15–17] or single nucleotide
polymorphisms (SNPs) [18] represent a small subset used for various ap-
plications. The last, for instance, is a technique that finds a huge number
of applications. It is used in forensic studies to match DNA samples and
to infer phenotypic traits, in medicine to underline differences in human
susceptibility to disease, in microbiology as one of the election methods to
geo-typify relevant pathogens (covering great value in diagnostic and in
outbreaks surveillance).
However, new perspective and applications of comparative genomics are
awaited as whole genome shot-gun sequencing is likely to reach the main-
stream settings, such as hospitals, where it promises to became the designated
device even for routinely tasks.
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The described genome sequencing flow, combined with increasingly efficient
annotation methods, set the stage for the systematic identification of most
enzymes encoded in the genomes. Moreover, thanks to NGS technologies a
huge variety of high-throughput experimental methodologies (the so-called
-OMICS) rapidly emerged. These now routinely provide large-scale functional
clues and snapshots of the physiological dynamics under specified conditions
(and their underlying molecules). In a certain sense, the goal of the tra-
ditional studies of biological systems to isolate and measure their single
involved components, reached the highest point. The technology enabled to
successfully identify most of the cellular components and to describe their
mechanisms at the molecular level. Unfortunately, despite this astonishing
possibility, scientists often fail to capture multiple relevant biological features
at the same time. The reason is that this is a reductionist approach which
strives to describe the whole as the sum of its parts. The result is a lack of
comprehensive, multi-layer knowledge whereas it is necessary to depict the
long-range and complex interactions that are essential for the functionality.
Since a cellular system is not just an ensemble of genes and proteins, its
properties cannot be fully described by the merely depictions of isolated parts.
To make a parallelism, identifying all the genes and proteins in an organism
is like listing all the parts of an airplane. While such a list provides a catalog
of the individual components, it is not sufficient to understand the complexity
underlying the engineered object. It is necessary to know how these parts
are assembled to form the structure of the airplane. Similarly, it is possible
to draw diagrams of the principal molecular interconnections in a cell, but,
although such diagrams represent an important first step, they are analogous
to static road-maps, whereas what really matters are the traffic patterns, why
such traffic patterns emerge, and how to control them (see Figure 4.1). Thus,
despite an understanding of basic mechanism and molecular components
continues to be important, the comprehension of system’s structure and
dynamics now moved on top of the scientific agenda. Here is where systems
biology comes into play. Its final goal is to integrate biological and analytical
systems to generate large-scale data about dynamic cellular processes. The
election method used for that is to create a predictive, computational model.
In-silico prediction approaches have received little attention in the past, but
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Fig. 4.1: A: Major metabolic pathways in metro-style map. Single lines: pathways
common to most lifeforms. Double lines: pathways not in humans (occurs
in e.g. plants, fungi, prokaryotes). Metabolic metro. Orange nodes: car-
bohydrate metabolism. Violet nodes: photosynthesis. Red nodes: cellular
respiration. Pink nodes: cell signaling. Blue nodes: amino acid metabolism.
Grey nodes: vitamin and cofactor metabolism. Brown nodes: nucleotide
and protein metabolism. Green nodes: lipid metabolism. Original source:
Wikipedia
it is now changing and great expectations are refueling the field. Substantial
advances in software and computational power, in fact, have enabled the
creation and analysis of reliable, yet intricate, biological models. These aim
to predict the dynamics of systems so that the validity of certain assumptions
can be tested. Detailed behaviors in computer-executable frames can be
compared to experimental observations. Inconsistency at this stage stands
for erroneous or incomplete assumptions. Conversely, models that survive
the initial validation can then be used to make predictions and to design
experiments, as well as to explore questions that are not amenable to ex-
perimental inquiry (carefully considering the purpose of models themselves,
i.e. the scope and abstraction level of the models should always be defined
before performing any analysis).
The choice of the used analytical methods often depends on the availability
of biological knowledge to incorporate into the model. For instance, genome-
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scale metabolic models (GEMs) [1–4] represent a type of systems modeling
framework which (at a first stage) is based “only” on the genome annotation
of the organism to be modeled. They are a consistent framework on which
a mechanistic basis for the metabolic genotype-phenotype relationship can
be formulated. In other words, GEMs are a bottom-up reconstructions of
structured knowledge-bases that abstract pertinent information on the bio-
chemical transformations taking place within specific target organisms. The
conversion of such models into a mathematical format facilitates computa-
tional biological studies including evaluation of network content, hypothesis
testing and generation, analysis of phenotypic characteristics, and metabolic
engineering. For example, steady-state analysis can be performed on GEMs
by just using the network structure (i.e. without any knowledge of the rate
constants for a particular reaction). After a basic reconstruction, several high-
throughput molecular data can be integrated. These lead to a very broad
spectra of applications with high-confidence degree. A deeper description of
such models will be now afforded.
4.1 Genome-scale metabolic models
GEMs represent very valuable resources but their applications have been lim-
ited due to the large manual effort required to develop them. The metabolic
reconstruction, in fact, is a bottom-up operation based on genomic and bib-
liomic data, usually very labor and time intensive, depending on the targeted
organism and the knowledge of its biology. The process is often iterative,
consisting of multiple checks and, although a bunch of automated reconstruc-
tion methods exist, their output always require manual effort (see Figure
4.2 for an overlook of the reconstructions steps). The first stage consists of
the generation of a draft network reconstruction only based on the genome
annotation of the target organism. Software tools such as KBase [5], Seed
[6], RAVEN [7] can be used to automatically generate it.
At this stage the network will represent a collection of genome encoded
metabolic functions, some of which may be falsely included while other ones
may be missing. Main issues are constituted by low-confidence annotations
which can fail to correctly represent all the metabolic features of an organ-
ism. This results in lack of network connections and/or dead-end pathways.
Thus, the quality and reliability of the genome annotation is crucial to the
reconstruction quality. With the assistance of semi-automated algorithms
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Fig. 4.2: Overview of the procedure to iteratively reconstruct metabolic models.
The main steps are recovered from [8].
36 Chapter 4 A system-wide view
(tINIT, Task-driven Integrative Network Inference for Tissues algorithm in
RAVEN [9], for example) these knowledge gaps can be filled-in by modifying
the network to include additional biochemical reactions or by removing func-
tions that were improperly added by previous annotators. However, manual
inspection is mandatory. It mainly consists in verifying the connectivity of
the network, identifying erroneous gene incorporation or possible gaps and,
above all, retrieving experimental evidence for the presence of a gene product
and its metabolic function. The step has a double relevance since it represents
both a refinement and a validation process. Organism-specific literature must
be collected and evaluated against model’s behavior. If this lacks, it is possible
to use phylogenetically close organisms to acquire the needed informations.
For example, by finding ORFs encoding for enzymes orthologous to those
that catalyze the same functions in other organisms, it is possible to create a
higher quality metabolic model. Reference of publicly available databases like
KEGG [10] and Brenda [11], is highly recommended. Data about biomass
composition (that details all precursors and their fractional contributions to
a cell’s macromolecular composition), maintenance parameters, and growth
conditions must be assessed during this phase too, since they deeply affect
model’s prediction credits. A final check of metabolite charge and reaction
balance, as well as evaluation of reaction directionality and gene protein
reaction rule (GPR) close the circle.
The standardized format used for models is the Systems Biology Markup
Language (SBML). SBML file describing the model has to include at least
the following information: stoichiometry, upper/lower bounds and objective
function coefficients for each reaction. However, inclusion of further infor-
mations is strongly suggested in order to facilitate large reuse of models:
reference of genes, metabolites and reactions should be added to be easily
mapped to the majors existing catalogs (i.e. gene ontology (G.O.), KEGG,
Seed, BiGG (Biochemical, Genetic and Genomic) [12], Chebi [13], Metanetx
[14, 15]) and provide unique, unambiguous, standard-compliant and resolv-
able identifiers. At the end of the refinement, the model can be converted
into a mathematical object to proceed with the simulation stage. COBRA [16,
17] and RAVEN toolboxes perform that conversion and come along with a
suite of ad hoc useful functionalities that can be run locally by users in Matlab
or Python environments. Various solver can be used in order to perform in
silico tests, however, linear or quadratic solvers should be correctly chosen
according to the computational problem to address.
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4.2 Flux Balance Analysis
A widely used method (perhaps the most widely used) that exploits the
transformation of genome-scale metabolic network in a mathematical object
is the flux balance analysis (FBA) [18]. FBA calculates the flow of metabolites
through the network structure allowing to make predictions on various
biological aspects. The core features of FBA are:
1. a set of rules for gene-protein-reaction (GPR) relationships;
2. a mathematical representation of the model in the form of a numerical
matrix (S-matrix).
GPR relationships represent conditional statements in Boolean logic between
ORFs and their enzymatic functions while the S-matrix is comprised of
biochemical reactions occurring in an organism: columns represent reactions
and rows metabolites (see Figure 4.3). The coefficients of the substrates
and products of each reaction are entered in the corresponding cell of the
matrix.
A B
Fig. 4.3: A: A small metabolic network; reactions’ flux and boundaries are repre-
sented as vectors. B: Stoichiometric matrix, S, of the network reaction
list. The columns of S correspond to the network reactions, while the
rows represent the network metabolites. The substrates in a reaction are
defined to have a negative coefficient (they are consumed), while products
have a positive value (they are produced). The metabolites participating
in a reaction have non-zero entry in the S-matrix. All steady-states can be
thus described by S•v=0, where v is a vector of reaction fluxes. Edited
from [18]
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The last impose constraints on the flow of metabolites through the network.
Since all proper chemical equations can be described by stoichiometric co-
efficients, and since a set of chemical equations can be described by the
S-matrix, all steady states of a network can be described by a simple linear
equation, S•v=0, where v is a vector of fluxes through chemical reactions.
Thus, the computation of functional states of a network is enabled based on
the known underlying chemistry. In FBA the restrains are represented in two
ways, as equations that balance inputs and outputs and as inequalities that
impose bounds on the system. The ensemble of reactions stoichiometries and
systems boundaries identify condition-specific models defining the space of
allowable flux distributions in a system and the rate at which every metabo-
lite is consumed or produced by each reaction. In that conditions the flux
distribution carries sufficient information to completely describe the state of
the system (see Figure 4.4). Since the goal is to describe the joint operation
of many metabolic reactions, it is convenient to define a flux distribution as a
collection of reaction fluxes covering the entire system.
v2 
v1 
v3 
Allowable 
solution space Optimal solution 
v3 
Constraints 
1) Sv = 0
2) ai < vi < bi
v2 v2 
v1 
v3 
Optimization 
maximize Z
v1
With unconstrained space 
the ux distribution may 
lie at any point in a solu-
tion space
Imposing constraints the 
ux distribution may lie 
everywhere inside the de-
ned solution space
Objective function allows 
FBA to identify a single 
optimal ux distribution 
that lies on the edge of 
the allowable solution 
space
Fig. 4.4: The conceptual basis of constraint-based modeling. Edited from [18]
FBA can be applied in many contexts to analyze the phenotypic capabilities
of organisms, in the background of different environmental and genetic per-
turbations by imposing external and internal pressures. Several and very
different hypotheses can be computationally tested, such as by-product se-
cretion, single and double gene deletion phenotypes, known (in)capabilities,
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comparison of predicted physiological properties to known properties, quanti-
tative evaluation of growth rate and so on. A reliable model could, in theory,
be used in order to reproduce cells behavior during a variety of perturbations.
However, when a cell is placed in a particular environment, it expresses a
subset of its genes in response to environmental cues. The abundance of
cellular components can be profiled using -OMICS methods. Such -OMICS
data like transcriptomics, metabolomic or fluxomic data, can be analyzed
using the model as a scaffold (see Figure 4.5 below) or turning the concept
upside down, in a second modeling phase, -OMICS data can be mapped onto
a network reconstruction to tailor it to the particular condition being consid-
ered. The result is that, when integrated in the computational framework,
experimental outputs actually play as additional constraints that narrow the
space solutions, giving raise to sharper predictions.
The union of the two methodologies (experimental and computational)
creates a golden chance never reached before: to perform analysis at the
genome scale while imposing the desired (real) external stimuli or genetic
circuits with distinct properties. This is the core power of the mechanistic
genotype-phenotype relationship for metabolism, i.e. it yields representation
of specific metabolic conditions and derive non-trivial information about the
underlying mechanism which are usually undetectable with the traditional
approaches (see Figure 4.5).
The natural pipeline of model use should consist of feedback-loops between
in-silico inferences and experimental assays (see Figure 4.6), where at each
turn, better models allow better experiments and better results/hypothesis.
4.3 Metabolic systems biology
perspectives
The ability of GEMs opens up new scientific directions to study fundamental
biological phenomena. They were firstly used to predict the outcome of
bacterial adaptation to new nutritional environments [19], even in the face of
gene deletions [20], thereof the method has been extensively applied. Good
computational models, in fact, accelerate design processes, and minimize
prototyping, testing, and experimentation. Chapter 8, in the second part
of this work, will offer two examples of development and usage of GEMs.
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Metabolome
Proteome
Phenome
Genome
Metabolic Network
Genome
Metabolic Network
A
B
Fig. 4.5: A: The genomic and bibliomic data possessed are transferred in the cor-
responding metabolic network which can be converted in the scaffold
metabolic model. B: Additional -OMICS data map the correct metabolic
patterns and flux rates on the model which results in high confidence
in-silico predictions.
There, thanks to the integrations of large-scale phenotypic data (Phenotype
Microarray) and gene expression, functional clues on pathogenic microbial
strains are made. However, the potential applications are enormous. The
production of valuable metabolites or the degradation of pollutants and the
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ANALYSIS
COMPUTATION
GENOMICS
TECHNOLOGY
SYSTEMS
BIOLOGY
Experimental design
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Predictions
Data analysis
In silico 
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Data-driven
 model
Biological data
Fig. 4.6: A cycle of predictive model development begins with the selection of
biological data which are transformed into a computable set of assumptions
in the form of a model. Through the analysis of “dry” experiments results
assumptions and predictions can be formulated. Based on that computer-
derived hypothesis new experiments can be designed which at their turn
lead to new experimental facts and-or thesis validation.
generation of renewable energy are just few of them [21–24]. About a decade
since its appearance, genome-scale metabolic modeling aims to drive the
use of microbial organisms for industrial purposes. Further applications can
be found on microbial communities [25–27], plants [28, 29] and humans
[1, 30, 31]. These developments currently represent an open avenue for
highly complex systems evaluation. Whole-patient models for specific disease,
such as obesity, diabetes and cancer offer a platform to explore personalized
medicine and/or perform drug discovery [9, 32, 33]. Notably, the techniques
and applications listed promise to have a broad impact on the life sciences in
the next years and, hopefully, they are just at the early stages of their use.
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Part II
RESULTS

5Genome assembly and
annotation
Genome sequencing, assembly and annotation, with their challenges and
their routines, can be considered the entry point of any modern biological
study. These data collection, which is always interesting, may become crucial
when dealing with relatively unknown strains. The set of insights brought to
light by sequencing analysis in fact, often determines further investigation
directions.
The genome projects reported in this chapter belong to strains collected in
poorly characterized niche and in extreme environments. For this reason,
the aim of the works was to reconstruct the DNA sequence of the organ-
isms of interest. In the next chapters examples of usage of these data will
be presented. Here, the assemblies produced allowed the basic annotation
of the genetic features and the detection of potentially relevant metabolic
abilities. The reconstructed sequences represented the input of comparative
studies which provided structural overviews and relevant clues on the biol-
ogy of the targeted organisms. For instance, inferences on resistome and
secondary metabolites production have been derived and set the stage for
future phenotypic characterization.
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INTRODUCTION
One of the most promising, but still overlooked fields of microbiological research is represented
by endophytic microorganisms, i.e., those organisms living in the tissues of host plants and/or in
their rhizosphere (Rosenblueth and Martínez-Romero, 2006; Reinhold-Hurek and Hurek, 2011).
These microbes are emerging as a new potential source of secondary metabolites and products, for
exploitation in medicine, agriculture, and industry.
From a biotechnological perspective, a controlled (engineered) colonization of plant’s tissues
by some bacteria may be desirable because of their ability to produce a variety of plant growth
promoting (PGP) molecules, spanning from siderophores, nitrogenases, hormones, and so on.
In addition, host-microbe interaction confers indirect advantage to the plant, resulting from the
inhibition activity exerted by the associated microbial community toward potential pathogens.
Moreover, in the field of medicine, there are examples of very well-known molecules derived by
endophytes like antibiotics, antimycotics, and anticancer drugs. Also, it is still unknown if plant-
associated bacteria may enhance (or be responsible for) some of the effects exerted by the extracts
of medicinal plants (essential oils) (Kloepper and Ryu, 2006; Hardoim et al., 2008).
In this regard, in October 2012, in Casola Valsenio (Italy), a collection of microorganisms was
isolated from both internal tissues and the rhizospheric soil of the medicinal plant Echinacea
purpurea, as reported in Chiellini et al. (2014). Among others, two strains sampled from the
rhizosphere and belonging to Arthrobacter species were identified, i.e., Arthrobacter sp. EpRS66
and Arthrobacter sp. EpRS71. Based on their antibiotic resistance profile, reported in Mengoni
et al. (2014), and on further tests performed on these two strains, they were selected as good
candidates for genome sequencing analysis. The last, will constitute a resource to deeply investigate
their genomic features and to perform comparative genomics analysis. Moreover, in the aim of new
drugs discovery, the genome sequence will facilitate the identification of putative genes responsible
for the production of bioactive compounds.
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MATERIALS AND METHODS
DNA Extraction and Sequencing
Arthrobacter sp. EpRS66 and Arthrobacter sp. EpRS71 strains
were inoculated overnight on TSB medium at 30◦C. Their
genomic DNA was then extracted using the CTAB method
(Perrin et al., 2015). Furthermore, the authenticity of the genomic
DNA was confirmed by 16S RNA gene sequencing.
MiSeq sequencing system (Illumina Inc., San Diego, CA)
was used to perform the whole genome shot-gun of the two
organisms. The method used a 2 × 300 bp paired-end approach,
which produced a genome coverage of 246.0 x for Arthrobacter
sp. EpRS66 and 91x for Arthrobacter sp. EpRS71.
Genome Assembly and Annotation
The quality of the obtained read pairs was evaluated by
inspecting them with FastQC software package v. 0.52 (Kunde-
Ramamoorthy et al., 2014). Poor quality bases were removed
with StreamingTrim (Bacci et al., 2014). De novo assembly was
performed by using SPAdes 3.5 software (Bankevich et al., 2012)
with a k-mer length of 21, 33, and 55. After, those contigs with
length inferior to 2000 bp were trimmed and the remaining
(6 and 24 for Arthrobacter sp. EPRS66 and Arthrobacter sp.
EPRS71, respectively) were launched in a multi-draft based
analysis through MeDuSa scaffolder (Bosi et al., 2015), by
using as references 5 Arthrobacter genomes retrieved at NCBI
database (Arthrobacter arilaitensis Re117, Arthrobacter FB24,
Arthrobacter Rue61a, Arthrobacter aurescens TC1, Arthrobacter
chlorophenolicus A6).
Automated annotation of the two draft genome sequences
has then been performed with NCBI Prokaryotic Genome
Annotation Pipeline.
RESULTS
The last version of Arthrobacter sp. EpRS66 genome has a total
length of 3,707,708 bp and embeds only 2 scaffolds (L50 equal
to 1), with a mean G+C content of 59.27%. The annotation
analysis identified a total of 3485 genes, of which 3383 have been
annotated as coding DNA sequences (CDS), 29 as pseudogenes,
4 as rRNAs, 68 as tRNAs, and 1 as ncRNA.
The draft genome sequence of Arthrobacter sp. EpRS71 24
is 4,849,450 bp long and its contigs are set-up in 10 scaffolds
(L50 equal to 1). The G+C content is 61.60%, a value slightly
higher than the previous but still perfectly comparable with that
of other Arthrobacter genomes sequenced so far. The annotation
of Arthrobacter sp. EpRS71 genome revealed the presence of
4515 genes. This total amount includes 4379 proteins coding
sequences, 71 pseudogenes, and 62 RNA (6 rRNAs, 55 tRNAs,
1 ncRNA) coding sequences.
Both genome sequences have been deposited at NCBI
database and are available in both fasta and GenBank
format; the GenBank accession number of Arthrobacter
sp. EPRS66 is LNUU00000000 and the version reported
in this work was named LNUU01000000; the GenBank
accession number of Arthrobacter sp. EPRS71 is
LNUV00000000 and the version reported in this work is
LNUV01000000.
AUTHOR CONTRIBUTIONS
This project was planned by RF and AM. The DNA extraction
was performed by IM and EP. The DNA sequencing has
been performed by GR and VD. The data processing has
been performed by LP and MF. CC, VM, PB, and EM
assisted substantially on the technical part of this work.
All author contributed to writing and editing the present
manuscript.
FUNDING
This work was supported financially by Ente Cassa di Risparmio
di Firenze (Project 2013.0657).
REFERENCES
Bacci, G., Bazzicalupo, M., Benedetti, A., and Mengoni, A. (2014). StreamingTrim
1.0: a Java software for dynamic trimming of 16S rRNA sequence data
from metagenetic studies. Mol. Ecol. Resour. 14, 426–434. doi: 10.1111/1755-
0998.12187
Bankevich, A., Nurk, S., Antipov, D., Gurevich, A. A., Dvorkin, M., Kulikov,
A. S., et al. (2012). SPAdes: a new genome assembly algorithm and its
applications to single-cell sequencing. J. Comput. Biol. 19, 455–477. doi:
10.1089/cmb.2012.0021
Bosi, E., Donati, B., Galardini, M., Brunetti, S., Sagot, M.-F., Lió, P., et al. (2015).
MeDuSa: a multi-draft based scaffolder. Bioinformatics 31, 2443–2451. doi:
10.1093/bioinformatics/btv171
Chiellini, C., Maida, I., Emiliani, G., Mengoni, A., Stefano, M., Fabiani, A., et al.
(2014), Endophytic and rhizospheric bacterial communities isolated from the
medicinal plants Echinacea purpurea and Echinacea angustifolia. Int. Microbiol.
17, 165–174. doi: 10.2436/20.1501.01.219
Hardoim, P. R., van Overbeek, L. S., and Elsas van, J. D. (2008). Properties of
bacterial endophytes and their proposed role in plant growth. Trends Microbiol.
16, 463–471. doi: 10.1016/j.tim.2008.07.008
Kloepper, J. W., and Ryu, C.-M. (2006). “Bacterial endophytes as elicitors of
induced systemic resistance,” in Microbial Root Endophytes, eds B. Schulz, C.
Boyle, and T. N. Sieber (Berlin; Heidelberg: Springer), 33–52. doi: 10.1007/3-
540-33526-9_3
Kunde-Ramamoorthy, G., Coarfa, C., Laritsky, E., Kessler, N. J., Harris, R. A.,
Xu, M., et al. (2014). Comparison and quantitative verification of mapping
algorithms for whole-genome bisulfite sequencing. Nucleic Acids Res. 42:e43.
doi: 10.1093/nar/gkt1325
Mengoni, A., Maida, I., Chiellini, C., Emiliani, G., Mocali, S., Fabiani,
A., et al. (2014). Antibiotic resistance differentiates Echinacea
purpurea endophytic bacterial communities with respect to plant
organs. Res. Microbiol. 165, 686–694. doi: 10.1016/j.resmic.2014.
09.008
Perrin, E., Fondi, M., Maida, I., Mengoni, A., Chiellini, C., Mocali, S., et al.
(2015). Genomes analysis and bacteria identification: the use of overlapping
genes as molecular markers. J. Microbiol. Methods 117, 108–112. doi:
10.1016/j.mimet.2015.07.025
Reinhold-Hurek, B., and Hurek, T. (2011). Living inside plants: bacterial
endophytes. Curr. Opin. Plant Biol. 14, 435–443. doi: 10.1016/j.pbi.2011.
04.004
Frontiers in Microbiology | www.frontiersin.org 2 September 2016 | Volume 7 | Article 1417
Presta et al. Arthrobacter sp. EpRS66 and EpRS71
Rosenblueth, M., and Martínez-Romero, E. (2006). Bacterial endophytes and
their interactions with hosts. Mol. Plant. Microbe. Interact. 19, 827–837. doi:
10.1094/MPMI-19-0827
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Presta, Fondi, Perrin, Maida, Miceli, Chiellini, Maggini, Bogani,
Di Pilato, Rossolini, Mengoni and Fani. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 3 September 2016 | Volume 7 | Article 1417
Draft Genome Sequence of Pseudomonas sp. EpS/L25, Isolated from
the Medicinal Plant Echinacea purpurea and Able To Synthesize
Antimicrobial Compounds
Luana Presta,a Emanuele Bosi,a Marco Fondi,a Isabel Maida,a Elena Perrin,a Elisangela Miceli,a Valentina Maggini,a,b Patrizia Bogani,a
Fabio Firenzuoli,b Vincenzo Di Pilato,c Gian Maria Rossolini,d,e,f,g Alessio Mengoni,a Renato Fania
Department of Biology, University of Florence, Florence, Italya; Center for Integrative Medicine, Careggi University Hospital, University of Florence, Florence, Italyb;
Department of Surgery and Translational Medicine, University of Florence, Florence, Italyc; Department of Medical Biotechnologies, University of Siena, Siena, Italyd;
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italye; Clinical Microbiology and Virology Unit, Careggi University Hospital, Florence,
Italyf; Don Carlo Gnocchi Foundation, Florence, Italyg
We announce here the draft genome sequence of Pseudomonas sp. strain EpS/L25, isolated from the stem/leaves of the medicinal
plant Echinacea purpurea. This genome will allow for comparative genomics in order to identify genes associated with the pro-
duction of bioactive compounds and antibiotic resistance.
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The genus Pseudomonas consists of a group of bacteria particu-larly relevant from both medical and biotechnological view-
points (1). Thanks to their metabolic versatility, they successfully
colonized several different niches, including water, soil, plants,
and animals. Here, we present the draft genome sequence of Pseu-
domonas sp. EpS/L25, a strain close to Pseudomonas oleovorans,
isolated from the stem/leaves of Echinacea purpurea, a medicinal
plant whose essential oil possesses antimicrobial activity (2). The
E. purpurea plants were collected in October 2012 (3) at the “Gi-
ardino delle Erbe,” Casola Valsenio. Medicinal plants are known
for their beneficial effects for humans (including their antibacte-
rial activity), but, in spite of their high relevance, endophytic bac-
terial communities inhabiting their rhizosphere or internal tissues
are almost totally unknown. Thus, it is still unknown if they con-
tribute to the antimicrobial activity exerted by E. purpurea ex-
tracts.
Previous characterization of Pseudomonas sp. EpS/L25 re-
vealed the ability of this strain to inhibit the growth of other
E. purpurea-associated bacteria (4) and, more interestingly, some
opportunistic bacterial pathogens belonging to the Burkholderia
cepacia complex. Furthermore, it showed resistance to several an-
tibiotic compounds (5). Due to these properties, it represents a
good candidate for further molecular investigations on the genetic
basis of such features, prompting for sequencing of its genome.
The genome sequence of Pseudomonas sp. EpS/L25 was deter-
mined by a 2  300-bp paired-end approach using the MiSeq
sequencing system (Illumina Inc., San Diego, CA, USA). A total of
3,020,786 paired-end reads were obtained, representing approxi-
mately 158 coverage of the whole genome. Denovo assembly was
performed using SPAdes version 3.5 (6), which generated 300
contigs. Contigs with length less than 2,000 bp were discarded and
the remaining ones used for a multi-draft-based analysis using 16
Pseudomonas genomes retrieved from the NCBI database (Pseu-
domonas ND6, Pseudomonas TKP, Pseudomonas VLB120, P.
aeruginosa B136 33, P. aeruginosa UCBPP PA14, P. brassicacearum
NFM421, P. denitrificans ATCC 13867, P. entomophila L48, P.
fluorescens R124, P. mendocina NK 01, P. poae RE 1 1 14, P. putida
BIRD 1, P. putida KT2440, P. stutzeri CCUG 29243, P. syringae
B728a) through MeDuSa scaffolder (7). The final version of the
genome embeds 18 scaffolds, the longest of which is 1,664,566 bp
long. The draft genome assembly of Pseudomonas sp. EpS/L25 has
a total length of 5,435,234 bp. The GC content is 65.5%, similar
to that of other Pseudomonas genomes. Automated annotation of
the Pseudomonas sp. EpS/L25 draft genome sequence using NCBI
Prokaryotic Genome Annotation Pipeline detected 4,690 protein
coding genes, 76 RNA coding genes (5 complete rRNAs, 57
tRNAs, 14 ncRNAs), and 105 pseudogenes. Three CRISPR arrays
were also identified.
Comparative genomics analysis confirmed the presence of an-
tibiotic efflux pumps, some conferring specific resistance to beta-
lactams (pdc), florfenicol (cfrA), and polymyxins (arnA and
pmrF). Moreover, genes involved in the production of secondary
metabolites with antimicrobial activity have also been detected
(terpene, aryl-polyene, and two nonribosomal peptides).
Nucleotide sequence accessionnumbers.This whole-genome
shotgun project has been deposited at GenBank under the acces-
sion number LNUP00000000. The version described in this paper
is the first version, LNUP01000000.
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Strain EpSL27, Able To Inhibit Human-
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ABSTRACT We announce here the draft genome sequence of Arthrobacter sp.
strain EpSL27, isolated from the stem and leaves of the medicinal plant Echinacea
purpurea and able to inhibit human-pathogenic bacterial strains. The genome se-
quencing of this strain may lead to the identification of genes involved in the pro-
duction of antimicrobial molecules.
Medicinal plants are well known and have been largely explored for centuries fortheir therapeutic properties (1). What is little known is that their therapeutic
potential could be related to endophytic microorganisms inhabiting their tissues (2).
Many bioactive molecules have been already extracted from endophytic bacteria (3).
The promising potential of such organisms has led to the characterization of endo-
phytic bacterial communities from medicinal plants, which are poorly known. Endo-
phytic and rhizospheric bacterial communities from the medicinal plants Echinacea
purpurea and Echinacea angustifolia have been characterized, highlighting the specific
composition of such communities within plants’ compartments (4). Arthrobacter sp.
strain EpSL27, extracted from the stem and leaves of E. purpurea, has been evidenced
as being resistant to a high level of oxidative stress (20 mM H2O2) and is able to
degrade diesel fuel. Among such notable biotechnological potentialities, Arthrobacter
sp. EpSL27 has also been found to show strong inhibition activity toward human-
pathogenic bacteria from the Burkholderia cepacia complex (5), which are multidrug-
resistant organisms able to induce serious infections in immunocompromised patients.
The intriguing information obtained by the above-cited analyses led to whole
sequencing of the strain genome.
Arthrobacter sp. EpSL27 genomic DNA was extracted using the cetyltrimethylam-
monium bromide (CTAB) method (6), and its authenticity has been confirmed by 16S
rRNA gene sequencing. Whole-genome shotgun sequencing was performed with a
2  300-bp paired-end approach using the MiSeq sequencing system (Illumina, Inc.,
San Diego, CA). The FastQC software package version 0.52 (7) was used to evaluate the
quality of the obtained read pairs, and poor-quality bases were removed using Streaming-
Trim (8). Assembly was performed using the SPAdes 3.5 software (9), with k-mer lengths
of 21, 33, and 55, generating 21 contigs. Those having a length shorter than 200
nucleotides were removed and the others launched for scaffolding through Medusa
software (10), using the following genomes as references: Arthrobacter arilaitensis
Re117 (11), Arthrobacter Rue61a (12), Arthrobacter sp. strain FB24 (13), Arthrobacter
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aurescens TC1 (14), and Arthrobacter chlorophenolicus A6. The resulting scaffolds were
then annotated using the NCBI Prokaryotic Genome Annotation Pipeline (PGAAP) (15).
The final version of the Arthrobacter sp. EpSL27 draft genome consists of 8 scaffolds,
and its total length is 4,176,054 bp, with a coverage of 215.0. The GC content is
about 67.8%, which reflects the characteristic high GC content of the genus. The
Arthrobacter sp. EpSL27 genome harbors 3,758 genes, 3,610 of which are protein-
coding genes, 66 are RNA-coding genes (5 5S rRNA, 1 23S rRNA, 1 16S rRNA, 50 tRNAs,
and 9 noncoding RNA [ncRNA]), and 91 are pseudogenes.
The EpSL27 genome was analyzed using CARD (16) for the presence of genes
conferring antibiotic resistance. The analysis has evidenced genes putatively involved
in specific antibiotic resistance to isoniazid (Mycobacterium tuberculosis kasA mutant),
fluoroquinolones (mfd), amynocoumarin (Streptomyces rishiriensis parY mutant), rifamy-
cin (rphB), mupirocin (Bifidobacterium intrinsic ileS), and fosfomycin (Chlamydia trachlo-
matis intrinsic murA). antiSMASH (17) analysis for secondary metabolites with antimi-
crobial activities was also performed, revealing the presence of 5 clusters, with one
cluster encoding nonribosomal peptide synthetase (NRPS), one cluster encoding type
3 polyketide synthase (T3pks), and another three clusters with an unspecified reference.
Accession number(s). The whole-genome shotgun project has been deposited at
NCBI whole-genome sequencing (WGS) database under accession number LNUT00000000,
and the version reported in this work is version LNUT00000000.1.
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We report here the draft genome sequence of the Pseudomonas sp. TAA207 and Pseudomonas sp. TAD18 strains, isolated
from Antarctic sediments during a summer campaign near coastal areas of Terra Nova Bay (Antarctica). Genome sequence
knowledge allowed the identification of genes associated with the production of bioactive compounds and antibiotic resis-
tance. Furthermore, it will be instrumental for comparative genomics and the fulfillment of both basic and application-
oriented investigations.
Received 1 June 2016 Accepted 3 June 2016 Published 28 July 2016
Citation Presta L, Inzucchi I, Bosi E, Fondi M, Perrin E, Maida I, Miceli E, Tutino ML, Lo Giudice A, de Pascale D, Fani R. 2016. Draft genome sequences of the antimicrobial
producers Pseudomonas sp. TAA207 and Pseudomonas sp. TAD18 isolated from Antarctic sediments. Genome Announc 4(4):e00728-16. doi:10.1128/genomeA.00728-16.
Copyright © 2016 Presta et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Address correspondence to Renato Fani, renato.fani@unifi.it.
Antarctica provides one of the largest unexplored sources ofbiodiversity. Here, the continuous environmental challenges
led to extremely adapted living forms that may be sources of po-
tentially novel, untapped gene functions. Particularly, it has been
shown how microorganisms are claimed to be a reservoir of bio-
technologically relevant molecules, such as antibiotics (1–6).
Here, we report the genome sequences of two Pseudomonas sp.
strains, TAA207 and TAD18, isolated from Antarctic sediments
during a summer campaign near the coastal areas of Terra Nova
Bay (Antarctica). These bacteria have been screened for antimi-
crobial activity against human pathogens. The results obtained
show how they totally inhibited 40 strains belonging to the Burk-
holderia cepacia complex (BCC), most of which are affiliated to the
species Burkholderia cenocepacia and Burkholderia multivorans,
two of the most important pathogens in immunocompromised
patients affected by cystic fibrosis disease. Also, they produce an-
tibiofilm molecules acting against Staphylococcus aureus and Pseu-
domonas aeruginosa (7).
Both genome sequences of Pseudomonas sp. TAA207 and Pseu-
domonas sp. TAD18 were determined through a paired-end ap-
proach using the Illumina/Solexa genome analyzer IIx platform at
the Institute of Applied Genomics and IGA Technology Services
Srl (University of Udine, Italy). A total of 11,007,120 and of
12,698,315 reads were obtained for Pseudomonas sp. TAA207 and
Pseudomonas sp. TAD18, respectively. Low-quality sequences
were trimmed with StreamingTrim (8), and the remaining were
assembled with SPAdes genome assembler version 3.6.1 (9). Only
contigs longer than 1,000 bp were embedded in the final version of
the draft genomes, which are 4,900,197-bp long for Pseudomonas
sp. TAA207 (72 contigs, 453 average coverage, 57% GC content)
and 4,917,586-bp long for Pseudomonas sp. TAD18 (82 contigs,
average coverage 521, 57.24% GC content).
Annotation was then performed using Prokka (10), which
identified 4,379 and 4,403 genes for Pseudomonas sp. TAA207 and
Pseudomonas sp. TAD18, respectively. Among these, 4,028 are
protein-encoding genes in the former organism, and 4,220 are in
the latter one.
The genome sequences allowed comparative genomics analysis
to check for the presence of genetic traits involved in secondary
metabolite biosynthesis. The analysis was performed within the
antiSMASH shell (11), revealing that both genomes harbor gene
clusters encoding molecules involved in inhibitory activities. Par-
ticularly, the two strains embed gene clusters similar to those cod-
ing for aryl-polyene, terpene, bacteriocin, and nonribosomal pep-
tide synthase. Additionally, Pseudomonas sp. TAA207 contains a
cluster involved in microcin production.
Further, we investigated the possibility that both strains
possess antibiotic resistance genes in their pool by probing
their sequences in the Comprehensive Antibiotic Resistance
Database (CARD). The outcome yields strong indications that
both genomes have genes coding for general efflux pumps, along-
side several genes conferring resistance to specific classes of
antibiotics, including chloramphenicol, fluoroquinilone, beta-
lactam, trimethoprim, tetracycline, polymyxin, aminoglyco-
side, and rifampin.
Nucleotide sequence accession numbers. The whole-genome
shotgun projects of Pseudomonas sp. TAA207 and Pseudomonas
sp. TAD18 have been deposited at GenBank under the accession
numbers LLWJ00000000 and LLWI00000000, respectively. The
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versions described in this paper are the first versions,
LLWJ01000000 and LLWI01000000.
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We report here the draft genome sequence of the Flavobacterium sp. TAB 87 strain, isolated from Antarctic seawater during a
summer campaign near the French Antarctic station Dumont d’Urville (60°40=S, 40°01=E). It will allow for comparative genom-
ics and the fulfillment of both fundamental and application-oriented investigations. It allowed the recognition of genes associ-
ated with the production of bioactive compounds and antibiotic resistance.
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Antarctic bacteria are cold-adapted microorganisms that haveevolved peculiar features to overcome barriers for growth at
low temperatures. They are driving scientific interest, both in the
field of ecological sciences as they play a key role in maintaining
proper ecosystem functions, and in the clinical setting, since they
are known to producemolecules able to exert antibacterial activity
in order to withstand strongly adapted competitors. Indeed, it was
recently demonstrated that many Antarctic bacteria exhibited the
ability to counteract the growth of other Antarctic strains (1) and,
more intriguingly, of some human pathogens belonging to the
Burkholderia cepacia complex (BCC) (2–5), which represent a se-
rious threat among immunocompromised patients, especially
those affected by cystic fibrosis (CF).
Here, we report the draft genome sequence of Flavobacterium
sp. strain TAB 87, a Gram-negative bacterium belonging to the
family Flavobacteriaceae (6). The strainwas isolated from seawater
during a summer campaign near the French Antarctic stationDu-
mont d’Urville (60°40= S, 40°01= E). The genome analysis of this
Antarctic strain enables both fundamental and application-
oriented investigations. Indeed, this strain completely inhibited
the growth of 40 BCC strains belonging to 18 different bacterial
species, most of which belonged to the species Burkholderia ceno-
cepacia and Burkholderia multivorans, two of the most important
CF pathogens. Moreover, some of the antimicrobial compounds
produced were volatile organic compounds (VOCs), according to
previous observations (3, 4). The draft genome sequence of Fla-
vobacterium sp. TAB 87 was determined by the Institute of Ap-
plied Genomics and IGA Technology Services Srl (University of
Udine, Italy) through a paired-end approach using an Illumina
(Solexa) Genome Analyzer II platform. A total of 19,040,534
paired-end reads (average coverage, 1,004) were initially ob-
tained, those with low quality were trimmed with Streaming Trim
(7), and those remaining were assembled with SPAdes genome
assembler version 3.6.1 (8), which generated a total of 5,056 con-
tigs. Those contigs 1,000 bp were discarded, while the others
were embedded in the final version of the draft genome, which is
3,827,405 bp long and harbors 38 contigs (the longest of which is
1,014,695 bp long). The GC content is 65.5%, similar to that of
other Flavobacterium genomes sequenced so far. Annotation was
performed by using Prokka (9), which, among all the predicted
genes (3,365), identified a total of 3,323 protein-coding genes, 3
rRNA-coding genes, and 39 tRNA-coding genes.
Moreover, we screened the genome sequence for the presence
of genetic traits involved in secondary metabolite biosynthesis.
The analysis was performed within antiSMASH shell (10), reveal-
ing that the Flavobacterium sp. TAB 87 genome harbors four in-
teresting gene clusters: a type I and a type III polyketide synthase
(PKS) and two terpene biosynthetic gene clusters. Additionally,
the genome sequence was analyzed through CARD (11), leading
to the identification of cfrA and Staphylococcus aureus parE, two
genes conferring resistance to florfenicol and fluoroquinolones,
respectively.
Nucleotide sequence accession numbers.Thiswhole-genome
shotgun project has been deposited at GenBank under the acces-
sion no. LLWK00000000. The version described in this paper is
version LLWK01000000.
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ABSTRACT In this announcement, we detail the draft genome sequence of the
Pseudomonas sp. strain Ep R1, isolated from the roots of the medicinal plant Echina-
cea purpurea. The elucidation of this genome sequence may allow the identification
of genes associated with the production of antimicrobial compounds.
Endophytic bacterial communities inhabiting the rhizosphere or internal tissues ofthe medicinal plants (MPs) may contribute to the therapeutic properties of these
plants (1). Here we report on the draft genome sequence of Pseudomonas sp. strain Ep
R1, a strain isolated from the roots of Echinacea purpurea, an MP with immunomodu-
lant, antiviral, and antimicrobial activity (2). The E. purpurea bacterial endophytes were
isolated and molecular and phenotypic characterizations were conducted (3). In par-
ticular, Pseudomonas sp. Ep R1 showed the ability to inhibit the growth of other
E. purpurea endophytes (4) and of cystic fibrosis bacterial pathogens belonging to the
Burkholderia cepacia complex (5). Moreover, it has been demonstrated to be highly
(50 g/ml) resistant to chloramphenicol and streptomycin (6).
The genome sequence of Pseudomonas sp. Ep R1 was determined by a 2- 300-bp
paired-end approach using the MiSeq sequencing system (Illumina Inc., San Diego, CA).
A total of 1,148,852 paired-end reads were obtained, representing approximately 100
coverage of the whole genome. De novo assembly was performed using SPAdes 2.3 (7),
which generated 363 contigs. Contigs with length less than 2,000 bp were discarded.
The remaining contigs were used for a multidraft-based analysis using genome se-
quences of 13 Pseudomonas strains retrieved from the NCBI database (P. aeruginosa
PAO1, P. alkylphenolia KL28, P. denitrificans ATCC 13867, P. entomophila L48, P. fluore-
scens F113, P. fulva 12-X, P. knackmussii B13, P. mendocina ymp, P. protegens CHA0,
P. putida KT2440, P. resinovorans NBRC, P. stutzeri CGMCC, and P. syringae pv. tomato
DC3000) through MeDuSa scaolder (8). The final version of the draft genome assembly
of Pseudomonas sp. Ep R1 is 6,797,087 bp long and embeds 158 contigs (the longest of
which is 1,954,067 bp long). The G C content is 65.5%, similar to that of other
Pseudomonas genomes sequenced so far. Automated annotation of the Pseudomonas
sp. Ep R1 draft genome sequence using the NCBI Prokaryotic Genome Annotation
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Pipeline detected 6,001 protein-coding genes, 67 RNA-coding genes (7 complete
rRNAs, 56 tRNAs, 4 noncoding RNAs [ncRNAs]), and 173 pseudogenes.
Genes involved in the biosynthesis of secondary metabolites with antimicrobial
activity were searched. The analysis was performed within an antiSMASH shell (9),
which revealed that the Pseudomonas Ep R1 genome harbors 6 clusters involved in the
biosynthesis of streptomycin, stenothricin, pimaricin, type 3 polyketide synthase
(T3PKS), siderophore (desferrioxamine B), and nonribosomal peptide synthetase (NRPS)
(amychelin). Moreover, the genome sequence was analyzed through CARD (10), which
led to the identification of several genes (mexABEJKMNW, omrMN, katG, triC, mfd, and
mdtC) putatively involved in antibiotic resistance, some conferring specific resistance to
fluoroquinolone, mupirocin, beta-lactam, aminocoumarin molecules, and others in-
volved in regulatory or inactivating systems and efflux pumps.
Accession number(s). This whole-genome shotgun project has been deposited in
GenBank under the accession no. MWTQ00000000. The version described in this paper
is the version MWTQ00000000.1.
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6Evolutionary genomics
The availability of completely sequenced genomes have opened a new op-
portunity for engaging in evolutionary studies. Evolutionary genomics, or
molecular evolution as it is sometimes called, refers to the study of how
features or components of a genome change both within and between species
over evolutionary timescales. The interpretation of any changes in the struc-
ture or content of genomes is often made within a comparative phylogenetic
context in order to infer evolutionary processes in organisms. This requires
knowledge of the various biological mechanisms underling peculiar DNA
structures and molecular signals, such as coding and regulatory regions in
the genomes, mutations, transpositions, duplications, deletions and so on.
The underlying noise in the data, hence, can be considered as the result of
the variability of DNA sequences due to population genetic forces. This exact
approach is the one I followed in the study of nitrogen fixation pathway
evolution and on which I wrote an essay partially reported in this section.
Nitrogen fixation, or rather the biological convertion of atmospheric N2 in to
ammonia (NH4+), represents an excellent model to study the evolutionary
interconnections that link different metabolic pathways and functional diver-
gences of paralogous genes. The orgin of the process are still under debate
but, it most likely represented a metabolic innovation playing an important
role in first evolutionary steps, when the prebiotic substitutes of all nitrogen
resources decreased. The growing number of primordial cells that thrived
in the ancestral environment would have caused a progressive reduction
of essential nutrients which, in turn, imposed an increasingly strong selec-
tive pressure. This favored those microorganisms able to synthesize those
essential nutrients by themselves. In such a context, the ancestral pathway
of the metabolic process may have been developed from a small number of
genes encoding multifunctional and nonspecific enzymes capable of reacting
with a variety of chemically related substrates. These primordial enzymes
would have been likely responsible for the interconnection of nitrogen fix-
ation with other metabolic pathways, such as bacterial photosynthesis and
leucine/lysine biosynthesis [1]. After, duplication of genes and operons, gene
recruitment, gene lengthening and intense horizontal transfer would have
modeled the entire metabolic pathway.
Today this process represents the most important input of biologically avail-
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able nitrogen in Earth’s ecosystems, although being a metabolic ability pos-
sessed only by certain microbial species, defined diazotrophs. The last,
occupy very diverse ecological niches, including terrestrial and water envi-
ronments, having several different life-styles: photosynthetic (oxygenic and
anoxygenic), chemolitotrophic, aerobic and anaerobic. Many of them are
free-living organisms while some others are symbionts (endophytes). A simi-
lar heterogeneous arrangement appears particularly interesting, either from
an evolutionary and biogeochemical point of view. In fact, since nitrogen
fixation is an oxygen sensitive process, this trait may be correlated to the kind
of atmosphere present on Earth when the process made the scene. Moreover,
the dissemination of this molecular mechanism also stands for several adap-
tive strategies used by different living systems to bypass a common issue (the
oxygen damage).
Nitrogen fixation is a very complex pathway, with an high energetic cost
and requiring the contribution of many genes to properly functioning. The
key-enzyme of the entire process is called nitrogenase. It is known in three
isoforms, which mainly differ for the cofactor usage. Among the three, the
best studied and the most widely-spread is the Mo-dependent nitrogenase,
whose structural component are encoded by the genes nifH, nifD and nifK (of-
ten close in the genomes of diazotrophs organisms and organized as operon).
The other two isoforms, usually reffered to as alternatives, are called Fe-V
nitrogenase (dependent by Iron-Vanadium cofactor; encoded by vnfH, vnfD,
vnfG and vnfK genes) and Fe-only nitrogenase (encoded by anfH, anfD, anfG
and anfK genes; it does not need a cofactor). These two are omologous
to the Mo-nitrogenase, with the only exception of possessing an additional
subunit (G). Despite their odd metal content, the three kind of nitrogenases
show an high degree of conservation at the aminoacidic level, and they are
structurally, functionally and phylogenetically related [1–3].
As mentioned, the origin of this metabolic capacity is unclear. It has not
yet been clarified whether it was acquired before the appearance of the Last
Universal Common Ancestor (LUCA) and subsequently transferred vertically
or rather, if it appeared posterior to LUCA in the branch of Bacteria or Archea
and then handed down to the different phyletic lines by vertical and/or hori-
zontal gene transfer (HGT) mechanisms. The first hypothesis is consistent
with the geological theories that support a high availability of Mo in the
primordial Earth. However, since the nif genes can be organized into operons
and therefore more easily subject to HGT, their presence in both Archea
and Bacteria, is not considered a clear demonstration of the antiquity of the
metabolic pathway [3, 4]. Moreover, nif genes are those most widely dis-
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tributed in today’s diazotrophic populations but it does not necessarily reflect
the genetic make up of early diazotrophs. The vnf or anf genes could have
originated first, constituting a simpler and less efficient nitrogenase system
from which, by means of gene duplication mechanisms, the nif genes could
have evolved. Thus, by using the genome sequences collected from publicly
available databases I investigated the molecular mechanisms responsible for
the evolution of nif, anf and vnf genes, trying to reconstruct the evolutionary
history of the nitrogen fixation process. In particular I was interested in:
1. nitrogen fixation ancestrality (did it appear before or after LUCA?);
2. which were the molecular mechanisms involved in the origin, evolution
and development of the pathway;
3. which is the oldest nitrogenase system and
4. which is the criteria to in-silico distinguish diazotrophs from non-
diazotrophs.
To answer these questions, the homologous sequences of Nif, Vnf and Anf
protein of the model organism Azotobacter vinelandii were collected from
NCBI repository. The Biderectional Best Hit (BBH) BLAST algorithm adopted
as matching criteria, allowed to reconstruct a first draft table of nitrogen
fixation distribution. By analyzing that, it was proposed a new method to
positively recognize nitrogen fixing organisms from the others. According
to a previous work [2], the minimal set of genes enabling to fix N2 is the
co-presence of NifHDKENB. However, if the alternative forms Vnf and Anf
sequences are taken into account, this principle results too stringent, leaving
outside many known diazotrophs. BBH results designate the genetic core-set
of the process as the ensemble of nifB plus at least one among the homologous
genes nif, vnf, anf HDKEN.
Afterwards, the sequences collected have been aligned and analyzed. Based
on the computed molecular identity score (which represent how much se-
quences are conserved among different organisms), phylogenetic trees have
been inferred. The comparison of the resulting specific phylogeny to the
species reference phylogeny tree allowed the estimation of an evolutionary
model for nitrogen fixation process. Particularly, the inconsistencies identified
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Fig. 6.1: Circular tree of Nif, Vnf and Anf H sequences. The color scheme indicate
different taxonomic group.
Fig. 6.2: Radial tree of Nif, Vnf and Anf DK sequences. The color scheme indi-
cate different taxonomic group. Red: Bch, outgroup; Light green and
light blue: Anf D and K, respectively; Yellow and blue: Vnf D and K,
respectively; Dark green and dark blue: Nif D and K, respectively.
between these two highlight some HGT events that shaped the evolution and
the spread of nitrogen fixation process among different bacterial species. The
phylogenetic trees of H (see Figure 6.1) and DK (see Figure 6.2) sequences
show that Anf sequences are those more closely related to the out-group used
(Bch sequences), this meaning that anf encoded nitrogenase may be the most
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ancient system. Additionally, DK tree trace back in the branch of anf genes
family the event that gave birth to these two parologous genes (see Figure
6.2). According to that scenario, Mo-nitrogenase could be the last assembled
system and it would have been enriched by many genes with regulatory and
structural functions in various taxa. The following pages cover the relevance
of Mo-based nitrogen fixation process (with a blink to biochemical details)
and analyze this pathway distribution in present Bacteria and Archea and
how it evolved. The general pipeline used to perform such kind of analysis is
described in the second part.
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Abstract Nitrogen fixation is the most important input of biologically available 
nitrogen in Earth’s ecosystems and is a metabolic ability possessed only by some 
Prokaryotes. To date four classes of nitrogenase enzymes have been characterized. 
Three nitrogenases are homologous enzymes with similar protein subunit compo-
sition and metal cofactor structure; these are the Mo-nitrogenase, V-nitrogenase, 
and Fe-only nitrogenase. How these three systems evolved and which of them first 
appeared on Earth is still under debate. The best studied system is the Fe-Mo-co 
based although several comparative analyses have been performed in past years.
In Chap. 4 only the class of pterin-based (Mo-co) molybdenum enzymes was dis-
cussed. However, there is an enzyme that uses a different form of Mo-cofactor 
(Fig. 5.1), the aforementioned nitrogenase, which catalyses the conversion of 
atmospheric nitrogen into ammonia, a process known as biological nitrogen fixa-
tion. Before entering nitrogenase’s biochemical structure and the relative meta-
bolic pathway, an overview of nitrogen fixation process will be provided.
5.1  Nitrogen Fixation in General
Nitrogen fixation is the most important input of biologically available nitro-
gen in Earth’s ecosystems and is a metabolic ability possessed only by some 
Bacteria (Green Sulphur Bacteria, Firmicutes, Actinomycetes, Cyanobacteria 
and Proteobacteria) and Archaea, where it is mainly present in methano-
gens (Dixon and Kahn 2004). A recent analysis predicted that nearly 15 % of 
prokaryotic species with sequenced genomes are either known or potential 
diazotrophs (i.e. microbes able to fix nitrogen), a fraction much larger than 
commonly accepted (Dos Santos et al. 2012). Nitrogen fixation is a complex 
process with a high energetic cost and requiring the activity of several genes. 
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To date four classes of nitrogenase enzymes have been characterized. Three 
nitrogenases are homologous enzymes with similar protein subunit composi-
tion and metal cofactor structure; these are the Mo-nitrogenase, V-nitrogenase, 
and Fe-only nitrogenase. The majority of present-day biological N2 reduc-
tion is catalyzed by the Mo-dependent nitrogenase (encoded by nif genes), 
although V- and Fe-nitrogenase (encoded by vnf and anf genes, respectively) 
are important biological sources of fixed nitrogen in environments where Mo is 
present in limited amount. In fact the Mo-nitrogenase, which contains the iron-
molybdenum cofactor or Fe-Mo-co, is the most commonly distributed nitroge-
nase; it is also the most efficient enzyme in the conversion of N2 into NH4+. 
Alternative nitrogenases can be synthetized by diazotrophs, i.e. V-nitrogenase 
and/or Fe-only nitrogenase enzymes, which contain the FeV-co or Fe-co met-
alloclusters at their active sites, respectively. Regulation of alternative nitroge-
nases expression is dependent on the availability of molybdenum, vanadium or 
iron in the medium (Pau 2004). The three enzymes are oxygen-sensitive and 
they are irreparably damaged and deactivated by it. They show a high degree 
of conservation of structure, function and amino acid sequence across wide 
phylogenetic ranges. Interestingly, there are no reported diazotrophs lack-
ing a Mo-nitrogenase and carrying uniquely an alternative nitrogenase. How 
these three systems evolved and which of them first appeared on Earth is still 
under debate. Several comparative analyses have been performed in past years 
although, to date, the best studied system is the Fe-Mo-co based.
The last type of nitrogenase is a Mo-nitrogenase phylogenetically unrelated to 
the other three classes and it has only been found in the bacterium Streptomyces 
thermoautotrophicus. This Mo-nitrogenase exhibits completely different biochem-
ical features that consist of different protein composition, insensitivity to O2, low 
Mg·ATP requirement, and a Mo-molybdopterin cytosine dinucleotide or Mo-MCD 
in the active site (Ribbe et al. 1997).
Fig. 5.1  Revised FeMo-cofactor structure derived from the most recent, high-resolution macro-
molecular structure determination. Reproduced from Lee and Holm (2003). With kind permis-
sion of © Proceedings of the National Academy of Sciences
luana.presta@unifi.it
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5.2  Biochemical Aspects
The overall reaction catalyzed by nitrogenase is usually depicted as follows:
This reaction not only represents the key entry point of reduced nitrogen into the 
global nitrogen cycle, but also embodies the formidable chemistry of breaking the 
triple bond of N2 under ambient conditions (Hu and Ribbe 2011).
The FeMo-co nitrogenase (Fig. 5.2) is composed by two proteins, the iron (Fe) 
protein (encoded by nifH) and the molybdenum-iron (MoFe) protein (encoded 
by nifD and nifK). The homodimeric Fe protein is bridged by a single (4Fe–4S) 
cluster between the subunits and contains one ATP binding site within each sub-
unit; whereas the α2β2-tetrameric MoFe protein contains two unique clusters per 
αβ-dimer: the P-cluster (an (8Fe–7S) cluster), which is located at the α/β-subunit 
interface; and the Fe-Mo-co (a (Mo–7Fe–9S–X–homocitrate) cluster, where X 
is considered to be C, N or O), which is positioned within the α-subunit (Kim 
and Rees 1992). The catalysis of nitrogenase involves complex association/
N2 + 8H
+
+ 16MgATP + 8e− → 2NH3 +H2 + 16MgADP
+ 16Pi (inorganic phosphate).
Fig. 5.2  X-ray crystal structure of half of the ADP·AlF4−-stabilized Fe protein/MoFe protein 
complex (a) and the relative positions of components in the complex that are involved in the 
electron flow during catalysis (b). The identical subunits of Fe protein are shown in yellow and 
orange, and the α- and β-subunits of MoFe protein are shown in light and dark blue, respectively. 
The atoms of the components within the Fe protein/MoFe protein complex are colored as fol-
lows: Fe purple; S yellow; O red; C gray; Mg dark blue; Al yellow; F light blue. Reproduced 
from Hu and Ribbe (2011). With kind permission of © Coordination chemistry reviews
5.2 Biochemical Aspects
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Fig. 5.3  Molybdenum trafficking for nitrogen fixation in the bacterium Azotobacter vinelandii. 
The figure shows a pathway of molybdenum towards the molybdenum-nitrogenase enzyme 
and the protein components involved in this pathway. Some of these proteins are exclusively 
dedicated to the nitrogenase biogenesis (e.g. NifQ and NifEN); some other have general roles 
in the metabolism of molybdenum (e.g. the ModABC molybdate transport system and the 
molybdenum-dependent transcriptional regulator ModE). Excreted siderophores with capacity to 
bind molybdate anions are also depicted. The modABC structure corresponds to the molybdate 
transport system of Archaeoglobus fulgidus. The ModE, NifH, and NifHDK structures shown are 
from A. vinelandii. Panel e shows a simplified FeMo-co biosynthetic pathway illustrating the two 
putative pathways for molybdenum incorporation into the Mo-nitrogenase cofactor. Reproduced 
from Hernandez et al. (2009). With kind permission of © Biochemistry
luana.presta@unifi.it
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dissociation steps between the Fe protein and the MoFe protein, and the sequen-
tial, inter-protein transfer of electrons from the (4Fe–4S) cluster of the Fe pro-
tein, through the P-cluster, to the FeMoco of the MoFe protein, where substrate is 
reduced (Hu and Ribbe 2011).
The high level of complexity of nitrogenase’s metallo clusters results in a 
(very) complex pathway for the assembly of nitrogenase and the insertion of the 
FeMo-co in the protein active site. The molybdenum trafficking for nitrogen fixa-
tion in the bacterium A. vinelandii is shown in Fig. 5.3.
In the free-living diazotroph Klebsiella pneumoniae at least 20 genes are 
involved in nitrogen fixation process (nif genes, Fig. 5.4) (Fani et al. 2000). In fact, 
apart from the catalytic components, additional gene’s products are required to 
produce a fully functional enzyme. Indeed, several genes have been identified as 
Fig. 5.4  a Organization of nif genes in Klebsiella pneumonia and b schematic representation of 
the nitrogen fixation process. Reproduced from Emiliani et al. (2010)
5.2 Biochemical Aspects
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being involved in this process (Fani et al. 2000 and references therein) although 
the number of proteins involved in the activation of nitrogenase seems to be spe-
cies-specific and it varies according to the physiology of the organism and its envi-
ronmental niche (Hamilton et al. 2011; Yan et al. 2010). In particular, FeMo-co 
biosynthesis requires, at least, the participation of nifS, nifU, nifB, nifE, nifN, nifV, 
nifH, nifD and nifK gene products. Based on genetic evidence, FeMo-co assem-
bly is likely initiated by the actions of NifS and NifU (encoded by nifS and nifU) 
that generate small building blocks for FeMo-co assembly. NifS is a pyridoxal 
phosphate-dependent cysteine desulphurase, which forms a protein-bound cysteine 
persulphide that is subsequently donated to NifU for the sequential formation of 
small (2Fe–2S) and (4Fe–4S) clusters (Hu and Ribbe 2011). These small Fe–S 
fragments are then transferred to NifB (encoded by nifB) and processed into a 
FeMo-co core (with the help of NifV, Q and X). The last is then transferred to 
NifEN (encoded by nifE and nifN) and undergoes additional rearrangements 
before it is delivered to its target binding site in the MoFe protein through a pro-
tein-protein interaction (Hu and Ribbe 2011, Fig. 5.5).
5.3  How Did Nitrogen Fixation Evolve? Comparative 
Genomes Analyses Approach
The phylogenetic distribution of nif genes (i.e. the set of genes homologous to 
each of the 20 nif genes of another well-studied model organism, Klebsiella pneu-
moniae) in 842 completely sequenced prokaryotes (52 Archaea and 790 bacteria), 
revealed the presence of a common core of nitrogen fixation-related genes in a 
subset of 124 organisms (Emiliani et al. 2010). This core of genes is composed 
by only six nif genes (nifHDKENB), involved in nitrogenase, nitrogenase reduc-
tase and Fe–Mo Cofactor biosynthesis. Instead, all remaining nif genes display a 
Fig. 5.5  Biosynthesis of FeMoco. NifS and NifU mobilize Fe and S for the sequential for-
mation of [Fe2S2] and [Fe4S4] clusters, which are used as building blocks for the formation of 
a large Fe/S core on NifB. This Fe/S core is further processed into a molybdenum (Mo)- and 
 homocitrate (HC)-free precursor, which can be converted to a mature FeMoco on NifEN upon Fe 
protein-mediated insertion of Mo and HC. Once the FeMoco is assembled on NifEN, it is deliv-
ered to its destined location in the MoFe protein. The permanent metal centers of the proteins are 
colored gray ([Fe2S2] cluster diamond; [Fe4S4] cluster cube; P-cluster oval), and the transient 
cluster intermediates are colored yellow. Reproduced from Schwarz et al. (2009). With kind per-
mission of © Nature
luana.presta@unifi.it
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patchy phylogenetic distribution, thus revealing a complex evolutionary history of 
genes involved in the pathway. The finding of the same common core of genes 
has recently been confirmed by Dos Santos et al. (2012), who also proposed it as 
a novel in silico tool for the identification of additional diazotrophs in analyses 
performed in completely sequenced microbial genomes. Moreover, the finding 
of a common core of essential genes involved in the pathway might suggest that 
nitrogen fixation is an ancestral metabolic trait. Even if not proved, it is quite pos-
sible that only nifHDKENB genes were present in the genome of the LUCA (Last 
Universal Common Ancestor) community.
According to this idea, the nifHDKENB might represent a “universal core” for 
nitrogen fixation, whereas the other genes might have been differentially acquired 
during evolution in the different phylogenetic lineages. In fact, if nitrogen fixation 
had required other enzymes, their role might have been performed by others with 
low substrate specificity, in agreement with the Jensen hypothesis on the origin 
and evolution of metabolic pathways (Jensen 1976).
This idea is supported by analyses on the presence of nif genes homologs in the 
microbial domain revealing that most of the nif genes have in-paralogs (i.e. para-
logs involved in the same pathway) and/or out-paralogs (i.e. paralogs involved in 
different pathways) as pointed out in Emiliani et al. (2010) (Fig. 5.6). The analysis 
did not retrieve any known paralogs for nifW (nifO), nifT (fixU), nifQ and nifZ, 
which are also missing from a large fraction of diazotrophs genomes. Eight nif 
genes (nifAFHJLMSU) are related, at a different extent, to proteins involved in 
other metabolic pathways (out-paralogs). NifS is related to a number of paral-
ogs mainly involved in amino acid and carbon metabolisms. NifJ, a multidomain 
pyruvate:ferredoxin (flavodoxin) oxidoreductase, exhibited a large number of par-
alogs. Several proteins involved in Fe–Mo cofactor biosynthesis have paralogs in 
other cofactor biosyntheses.
Fig. 5.6  In- and Out-paralogs network of nif genes. Nodes represent protein, links represent 
similarity values. Reproduced from Emiliani et al. (2010)
5.3 How Did Nitrogen Fixation Evolve? …
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Eight Nif proteins share a significant degree of sequence similarity with pro-
teins involved in other metabolic routes, and also with other nif genes products; 
this group can be further divided into two different clusters, the first of which 
includes nifDKEN, and the second being composed by nifBXY and nifV. NifB, 
NifX, and NifY share a common domain of about 90 aminoacids; moreover, nifB 
has an additional domain belonging to the S-adenosylmethionine (SAM) family, 
found in proteins that catalyze diverse reactions, including unusual methylations, 
isomerisation, sulphur insertion, ring formation, anaerobic oxidation and proteins’ 
radical formation. Evidence exists that these proteins generate a radical species 
by reductive cleavage of SAM through an unusual Fe–S centre. The nifV and nifB 
genes are not directly linked although a sort of connection can be found in multid-
omain proteins sharing homology with NifV and NifB.
The evolutionary history of nifDKEN cluster has been investigate more in depth 
and more details are available to explain how it evolved (Fani et al. 2000).
Indeed, the two gene pairs nifD-nifK and nifE-nifN form a paralogous gene family, 
which code for nitrogenase and the tetrameric complex NifN2E2, respectively. Both 
nifD-nifK and nifE-nifN likely arose through duplications of an ancestral gene by a 
two-step model in which an ancestor gene underwent an in-tandem duplication event, 
giving rise to a bicistronic operon; this, in turn, duplicated, leading to the ancestors of 
the present-day nifDK and nifEN operons (Fani et al. 2000).
However, the role of these primordial enzymes is still under debate and it might 
have depended on the composition of the early atmosphere (Fig. 5.7). Accordingly, 
Fig. 5.7  Two possible scenarios depicted for the original function performed by the nifDKEN 
genes and their ancestor(s) gene(s). Reproduced from Fani et al. (2000). With kind permission of 
© Journal of Molecular Evolution
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it can be accounted for by two alternative scenarios: (i) if we assume that O2 was 
absent from the primordial atmosphere, an essential prerequisite for the appear-
ance of (an ancestral) nitrogenase (since it is inactivated by free oxygen Fay 
1992), then the appearance of nitrogenase would have represented a necessary 
event for the first cells, living in a planet whose atmosphere was neutral, contain-
ing dinitrogen, but not ammonia (first scenario). In fact, if the primitive micro-
organisms for their overall metabolism required ammonia, then its absence must 
have imposed a selective pressure favouring those cells that had evolved a system 
to synthesise ammonia from atmospheric dinitrogen.
Therefore, according to this scenario, the function of the ancestral enzyme 
might have been that of a slow, inefficient and with low substrate specificity 
“nitrogenase” thus being able to react with a wide range of compounds with a tri-
ple bond (Fani et al. 2000).
An alternative scenario would speculate an early reducing, free-ammonia rich 
atmosphere (Fig. 5.7). In those conditions, the evolution of a nitrogen fixation sys-
tem would not have been a prerequisite because of the abundance of abiotically 
produced ammonia. Hence, why a nitrogenase in those days? The answer to this 
question relies in the catalytic properties of nitrogenase. In fact the enzyme is able 
to reduce also other molecules such as acetylene, hydrogen azide, hydrogen cya-
nide, or nitrous oxide, all of which contain a triple bond. Therefore, according to 
this second scenario (Fig. 5.7) the primitive enzyme encoded by the ancestor gene, 
would have been a detoxyase, an enzyme involved in detoxifying cyanides and 
other chemicals present in the primitive reducing atmosphere (Silver and Postgate 
1973). This scenario implies that combined nitrogen progressive exhaustion would 
have imposed the refinement of the enzyme specificity. The last, very likely, 
should have modified and adapted to another triple-bond substrate, dinitrogen, and 
given to this change was selected and retained by some bacterial and archaeal lin-
eages to enable survival in nitrogen-deficient environments. Finally, the decreas-
ing of free ammonia and cyanides in the atmosphere triggered the evolution of 
the detoxyase toward nitrogenase, that might have been a common feature of all 
microbial life until photosynthesising cyanobacteria largely increased the oxygen 
concentration and burned cyanides.
Intriguingly, comparative genomes analyses also showed that genes coding for 
nitrogenase (nifDK) and nitrogenase reductase (nifH) are evolutionarily related to 
genes involved in bacteriochlorophyll biosynthesis (see below). Chlorophyll (Chl) 
and bacteriochlorophyll (Bchl) are the photochemically active reaction centre pig-
ments for most of the extant photosynthetic organisms. During the synthesis of 
both Chl and Bchl, reduction of the tetrapyrrole ring system leads to the conversion 
of protochlorophyllide (Pchlide) into a chlorin. A second reduction, unique to the 
synthesis of Bchl, converts the chlorin into a bacteriochlorin. Two mechanisms for 
reducing the double bond in the fourth ring of protochlorophyllide are depicted. 
An enzymatic complex acts irrespective of the presence or absence of light and 
is thus termed “light-independent protochlorophyllide reductase”. The second is 
a light-dependent reaction that utilizes the enzyme NADPH-protochlorophyllide 
oxidoreductase (Suzuki et al. 1997). In Rhodobacter capsulatus, the products of 
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three genes are required for each reduction: bchL, bchN, and bchB for the Pchlide 
reductase and bchX, bchY, and bchZ for the chlorin reductase (Burke et al. 1993b). 
Both enzymes are three-subunit complexes. Burke et al. (1993a, b) detected a sig-
nificant degree of sequence similarity between BchlL, BchN, BchB, and BchX, 
BchY and BchZ, respectively, suggesting that the six genes represent two triads 
of paralogs and that the two enzymes are derived from a common three-subunit 
ancestral reductase. It was also found that the so-called “chlorophyll iron protein” 
subunits encoded by bchX, bchL, and chlL share a remarkable sequence similar-
ity with the nitrogenase Fe proteins (Burke et al. 1993a). These findings led Burke 
et al. (1993b) to suggest that genes involved in bacteriochlorophyll biosynthesis 
and nitrogen fixation were related mechanistically, structurally and evolutionarily. 
Similarly to NifH protein, which serves as the unique electron donor for the nitro-
genase complex, the products of bchL and bchX could serve as the unique electron 
donor into their respective catalytic subunits (BchB-BchN and BchY-BchZ). The 
idea of a common ancestry of nifH, bchL and chlL genes (Burke et al. 1993a; Fujita 
et al. 1993) has had an elegant experimental support by Cheng et al. (2005) who 
demonstrated in the photosynthetic eukaryote Chlamydomonas reinhardtii that 
NifH is able to partially complement the function of ChlL in the dark-dependent 
chlorophyll biosynthesis pathway.
Nitrogenases and carboxylases might have represented bacterial pre-adap-
tations, resulting in multigenic traits that were retained because leading to new 
selective advantages in altered environments. In fact, as depletion of abiotically 
produced organic matter occurred in early Earth environment, competition for 
the organic prerequisites for reproduction ensued. As the carboxylation and nitro-
gen-fixing functions were achieved, a new, abundant, and direct source of car-
bon and nitrogen for organic synthesis became available. The ability to take up 
atmospheric carbon and nitrogen would have been of great selective advantage 
(Margulis 1993). It is possible to propose a model (Fig. 5.8) for the origin and 
evolution of nitrogen fixation and bacterial photosynthesis based on multiple and 
successive paralogous duplications of an ancestral operon encoding an ancient 
reductase. The eight genes (nifDKEN and bchYZNB) are members of the same 
paralogous gene family, in that all of them are the descendants of a single ances-
tral gene. The model proposed posits the existence of an ancestral three-cistronic 
operon (Fig. 5.8) coding for an unspecific reductase. One might assume that this 
complex was (eventually) able to perform both carboxylation and nitrogen fixa-
tion. The following evolutionary steps might have been the duplication of the 
ancestral operon followed by an evolutionary divergence that led to the appear-
ance of the ancestor of nifH, nifDE, and nifKN on one side, and bchLX, bchNY and 
bchBZ on the other one. In this way the two reductases narrowed their substrate 
specificity: one channelled toward nitrogen fixation and the other one toward pho-
tosynthesis. However, each of the two multicomplex proteins was able to perform 
at least two different reactions:
1. The ancestor of nifDKEN, was likely able to carry out the reduction of dinitro-
gen to ammonia and the synthesis of Fe–Mo cofactor (Fani et al. 2000).
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2. The ancestor of protochlorophyllide- and chlorin-reductase performed both of 
the reactions that in the extant photosynthetic bacteria are carried out by two 
triads (BchLNB and BchXYZ, respectively).
The complete diversification of the function of the two heteromeric complexes 
was likely achieved thorough duplication of nifDE and nifKN ancestors and by 
the three-cistronic operon’s duplication bch(LX)(NY)(BZ) followed by evolution-
ary divergence (Fig. 5.8). In our opinion, this idea may perfectly fit the Jensen’s 
hypothesis.
Concerning the timing of the above reported evolutionary events (Fani et al. 
2000) the two paralogous duplication events leading to nifDK and nifEN likely 
predated the appearance of the LUCA. Conversely, other authors (Raymond et al. 
2004) have proposed a different scenario, according to which nitrogen fixation per 
se was invented by methanogenic Archaea and subsequently transferred, in at least 
three separate events, into bacterial lineages.
Differently from nitrogen fixation, tetrapyrrole-based photosynthesis occurs 
only in bacteria and bacterially derived chloroplasts, therefore it can be surmised 
that the appearance of photosynthesis should have not predated the divergence of 
Archaea and Bacteria.
Recently, a similar scenario has been proposed (Boyd et al. 2011). According 
to phylogenetic- and structure-based examinations of multiple nitrogenase proteins 
Fig. 5.8  Possible evolutionary model accounting for the evolutionary relationships between nif 
and bch genes. Reproduced from Emiliani et al. (2010)
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these authors proposed a model for the emergence of nitrogenase whereby a gene 
encoding for an ancestral protein complex duplicated. The encoded protein should 
have possessed a cavity similar to that observed in the inferred structure of NflD 
(performing a nitrogenase-like reaction in Ni porphyrin F430 biosynthesis (Staples 
et al. 2007), the duplication led to the evolutionary precursor of BchN and NifD 
(including vanadium and Fe-only containing alternative nitrogenases, i.e. VnfD 
and AnfD). Serendipitously, metals (e.g., Fe) or metal clusters (e.g., 4Fe–4S) 
were bound in the cavity of the ancestor in a non-specific manner, resulting in an 
enzyme complex with altered reactivity, perhaps toward N2 reduction (Boyd et al. 
2011). In response to selective pressure of limited fixed nitrogen on early Earth, 
genes and associated gene’s products were presumably recruited to improve the 
enzyme stepwise through the modification of the metal cofactor (Boyd et al. 2011).
5.4  Computational Studies on Mo-related Activities
In the last decade the availability of a large amount of data obtained from 
sequenced organisms has allowed the investigation of Mo utilization in prokary-
otes and eukaryotes and its evolutionary changes. Comprehensive analyses of the 
occurrence and evolutionary trends of Mo-related traits can be carried out through 
bioinformatics tools by searching similar sequences of Mo uptake systems and 
Mo-dependent enzymes in the genomes of all so far sequenced organisms.
Recently several studies allowed the in silico identification of previously 
unknown features Mo-related such as the novel Mo-co-binding proteins that have 
been reported in both eukaryotes (mARC in pig mitochondria) (Havemeyer et al. 
2006) and bacteria (YiiM and YcbX in Escherichia coli) (Kozmin et al. 2008).
These proteins share a significant degree of sequence homology with the 
C-terminal domain of eukaryotic Mo-co-sulfurase (MOSC) and show catalytic 
activity strictly dependent on Mo-co, suggesting that they may represent a pre-
viously unknown molybdoenzyme family. A study of 2011 by Yan Zhang et al. 
investigated the link between the MOSC motif and several known proteins high-
lighting interesting possible interaction between MO-systems and other pathways.
The MOSC domain is a superfamily of beta-strand-rich domains initially identi-
fied in the Mo-co sulfurase however it has subsequently been found in several other 
proteins from both prokaryotes and eukaryotes (Anantharaman and Aravind 2002). 
The MOSC domain of eukaryotic Mo-co sulfurase is involved in Mo-co binding 
with high affinity and its Mo-co carries a terminal sulfur ligand due to the cata-
lytic activity of pyridoxal-5′-phosphate-dependent NifS-like domain (Wollers et al. 
2008). On the other hand, Mo-co bound to the MOSC domain of mARC showed 
no terminal sulfur ligand. The function of the MOSC_N domain is unknown; how-
ever, it is predicted to adopt a beta barrel fold. Computational analysis allowed the 
distribution of these novel MOSC-containing molybdoproteins. It has been shown 
that all organisms containing MOSC-like proteins are Mo-co-utilizing organisms 
and that, in some organisms, genes for MOSC-like proteins are located close to 
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Mo-co biosynthesis components or molybdoenzymes such as MoaC and formate 
 dehydrogenase. These findings indicate that MOSC-like proteins may be orthologs 
and they may serve as Mo-co chaperone involved in Mo-co transfer or storage. 
Further investigation may allow the complete understanding of interactions between 
Mo utilization and that of other trace elements, such as Fe and S.
The next chapter will focus on different methods and comparative genomics 
techniques through which computational studies can be carried out.
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Abstract It is possible to reconstruct the origin and evolution of metabolic 
 pathways by inferring useful hints from the analyses of metabolic pathways 
existing in contemporary cells. Several bioinformatic tools allow the comparison 
of gene and genomes from organisms belonging to the three cell domains, giving 
rise to comparative genomics. Moreover the storage, the interpretation and the 
integration of several sources of information (gene structure and organization, 
gene regulation, protein-protein interactions) make possible to infer phylogenetic 
relationships among organisms, leading to a new approach referred to as 
phylogenomics. A short description of several tools is reported.
How can the origin ad evolution of metabolic pathways be studied and 
reconstructed? By assuming that useful hints may be inferred from the analysis 
of metabolic pathways existing in contemporary cells, important insights on the 
evolutionary development of microbial metabolic pathways can be obtained by the 
use of bioinformatic tools, allowing the comparison of gene and genomes from 
organisms belonging to the three cell domains (Archaea, Bacteria and Eukarya). 
This approach takes advantage of the availability of the phylogenetic relationships 
among (micro)organisms, and possibly on the existence of different structure 
and organization exhibited by orthologous genes. Beside, the more ancient is a 
pathway, the more information can be retrieved from this comparative analysis. 
Such kind of approach has become feasible since, in recent years, saw a dramatic 
increase in genomics data deriving from organisms belonging to all of the three 
known domains of life. By the way, the use of bioinformatic tools allowed the 
storage and the interpretation of several sources of information (gene structure and 
organization, gene regulation, protein-protein interactions) and, probably more 
importantly, their integration, a fundamental step for the global understanding 
of genomes properties and dynamics. This approach is usually referred to as 
comparative genomics. Combining data gained from comparative genomics with 
evolutionary studies of different species (i.e. phylogenetic inference), results in 
a new kind of approach, referred to as phylogenomics. A typical phylogenomics 
pipeline is illustrated in Fig. 6.1.
Chapter 6
Protocols and Methods for the  
in Silico Reconstruction of the Origin  
and Evolution of Metabolic Pathways
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This way of investigating the evolutionary history of genes introduced several 
advantages; in fact, adopting a genome-scale approach theoretically overcomes 
incongruence derived from molecular phylogenies based on single genes mainly 
because (i) non-orthologous comparison (i.e. the comparison of those genes 
Fig. 6.1  A schematic representation of a typical phylogenetic pipeline
luana.presta@unifi.it
69
erroneously defined as orthologous) is much more misleading when the analysis 
is performed on a single gene, whereas it is probably buffered in a multigene 
analysis and (ii) stochastic error naturally vanishes when more and more genes 
are considered. At the same time it is useful to recur to bioinformatics methods in 
order to detect new genes or proteins or to predict their function.
6.1  Browsing Microbial Genomes
At present, hundreds of microbial genomes have been sequenced, and hundreds 
more are currently in the pipeline. Furthermore, functional genomic studies have 
generated a large and growing body of experimental results for many different 
organisms belonging to the known domains of life. However, this whole body of 
data would reveal almost useless if not stored in a proper manner. To this pur-
pose a growing number of public databases have been developed in recent years, 
usually providing also user-friendly tools for their interrogation. These tools, 
despite not allowing automatized large-scale phylogenomic analyses, often rep-
resent their first preliminary (and useful) step. This is the case for example of 
MicrobesOnLine [http://www.microbesonline.org (Alm et al. 2005; Dehal et al. 
2010)], which embeds both structural and functional data on a large (almost 3000) 
dataset of completely sequenced genomes. These data are retrieved from a wide 
range of other specific databases (including KEGG, GeneOntology, RefSeq).
Interestingly, MicrobesOnLine also allows to interactively explore the neigh-
borhood of any given gene, hence allowing, for example, a first analysis of the 
gene organization of a given metabolic pathway. Similarly, IMG (Chu et al. 
2013) provides users some linked tools to support comparative microbial genes, 
genomes, and metagenomics analysis, including COG, KEGG, Pfam, InterPro, 
and the Gene Ontology. Consequently, thanks also to the graphical user interface 
IMG is particularly suited for nonexperienced bioinformaticians which want to 
perform comparative genome analyses (Checcucci and Mengoni 2015).
The same task can be pursued adopting also operonDB web service 
(http://odb.kuicr.kyoto-u.ac.jp/), (Pertea et al. 2009) aiming at collecting all known 
operons (derived from the literature and from publicly available database) in mul-
tiple species and to offer a system to predict operons by user definitions. Several 
other web sites and software tools have been described that assist in the annotation 
and exploration of comparative genomic data. The Prolinks (Bowers et al. 2004) 
and STRING (Jensen et al. 2009) databases offer convenient tools for browsing 
predicted functional associations among proteins. String, in particular imports pro-
tein association knowledge not only from databases of physical interactions, but 
also from databases of curated biological pathway knowledge. A number resources 
are included in the current release [MINT (Ceol et al. 2009), HPRD (Prasad et al. 
2009), DIP (Xenarios et al. 2002), BioGRID (Stark et al. 2008), KEGG (Kanehisa 
and Goto 2000) and Reactome (Matthews et al. 2009) IntAct (Hermjakob et al. 
2004), EcoCyc (Keseler et al. 2009)]. Furthermore, this set of previously known 
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and well-described interactions is then complemented by interactions that are pre-
dicted computationally, specifically for STRING, using a number of prediction 
algorithms (Jensen et al. 2009).
6.2  Orthologs Identification
Genomics data is a fundamental step for addressing the topic of the evolution of 
metabolic pathways, and strictly depends on a correct identification of orthologous 
proteins shared by different genomes. This field has been greatly developed in recent 
years and, paradoxically, the extant challenge seems not to be the lack of orthology 
predictions, but the right choice within the plethora of methods and databases 
that have been recently implemented (Gabaldon et al. 2009). The identification of 
orthologs between two genomes often relies on the so-called bidirectional best-hit 
(BBH) criterion, a reiteration of the BLAST algorithm (Altschul et al. 1997): two 
proteins, a and b, from genomes A and B respectively, are orthologs if a is the 
best-hit (i.e. the most similar) of b in genome A and vice versa. For three or more 
genomes, groups of orthologous sequences can be constructed by extending the BBH 
relationships with a clustering algorithm. This approach has led to the assembly of 
pre-compiled databases embedding groups of orthologous proteins, such as COG or 
KEGG-related systems (KOBAS and KAAS). Moreover, several other algorithms 
have been developed to fulfill this tasks, including Ncut (Abascal and Valencia 
2002), Rio, (Zmasek and Eddy 2002), Outgroup Conditioned Score (OCS) (Cotter 
et al. 2002) or OrthoParaMap (Cannon and Young 2003). Recent advancements 
showed that clustering techniques applied to matrices storing pair-wise similarities 
perform quite well (Brilli et al. 2008). These algorithms work either on the grouping 
of weakly similar homologs or on the identification of protein domains. The most 
widespread are: (i) orthoMCL (Li et al. 2003), which adopts a Markov Clustering 
algorithm (previously implemented in tribeMCL (Enright et al. 2002), (ii) Ortholuge 
(Fulton et al. 2006) that aims at identifying orthologs by comparing proteins and 
species phylogenetic trees and, lastly, (iii) InParanoid (O’Brien et al. 2005) that relies 
on a similar flowchart. All these orthologs’ identification methods have been recently 
tested on a dataset of proteins from different species previously characterized using 
functional genomics data, such as expression data and protein interaction data 
(Hulsen et al. 2006). Results have shown that InParanoid software seems the best 
orthologs’ identification method in terms of identifying functionally equivalent 
proteins in different species (Hulsen et al. 2006).
6.3  Multiple Sequence Alignments
In a phylogenetic analysis workflow (but also when interested, for example, in 
structure modelling, functional site prediction and sequence database searching) a key 
step (usually following the correct orthologs retrieval procedure) consists in comparing 
those residues with inferred common evolutionary origin or structural/functional 
luana.presta@unifi.it
71
equivalence in the whole sequence dataset. This task is fulfilled through multiple 
sequence alignment (MSA), that is arranging homolog protein sequences into a 
rectangular array with the goal that residues in a given column are homologous 
(derived a single position in an ancestral sequence), superposable (in a rigid local 
structural alignment) or play a common functional role. Although these three criteria 
are essentially equivalent for closely related proteins, sequence, structure and function 
diverge over evolutionary time and different criteria may result in different alignments 
(Edgar and Batzoglou 2006). Many approximate algorithms have been developed for 
multiple sequence alignments, including the commonly used progressive alignment 
technique (Pei 2008). This greedy heuristic assembly algorithm involves estimating 
a guide tree (rooted binary tree) from unaligned sequences and then incorporating 
the sequences into the MSA with a pairwise alignment algorithm while following 
the tree topology. The scoring schemes used by the pairwise alignment algorithm 
are arguably the most influential component of the progressive algorithm. They 
can be divided in two categories, that is matrix- and consistency-based algorithms. 
 Matrix-based algorithms such as ClustalW (Thompson et al. 2002), MUSCLE (Edgar 
2004), and Kalign (Lassmann and Sonnhammer 2005) use a substitution matrix to 
assess the cost of matching two symbols or two profiled columns (Notredame 2007). 
Conversely, consistency-based schemes incorporate a larger share of information 
into the evaluation. This result is achieved by using an approach initially developed 
for T-Coffee (Notredame et al. 2000) and inspired by Dialign overlapping weights 
(Morgenstern et al. 1998; Subramanian et al. 2005). Its principle is to compile a 
collection of pairwise global and local alignments (primary library) and to use this 
collection as a position-specific substitution matrix during a regular progressive 
alignment. The aim is to deliver a final MSA as consistent as possible with the 
alignments contained in the library. Many extant algorithms are based on this approach 
such as PCMA (Pei et al. 2003), ProbCons (adopting a Bayesian framework) (Do 
et al. 2005), MUMMALS (Pei and Grishin 2007). Sequence and structural databases 
are expanding rapidly owing to genome sequencing projects and structural genomics 
initiatives, offering helpful sources to further improve multiple protein sequence 
alignments. Structural additional information, for example known 3-dimensional 
(3D) structures, can be exploited in some multiple alignment methods. In fact, since 
structures are generally more conserved than sequences, structural information is also 
valuable for aligning sequences. Several MS algorithm have started implementing this 
source of information, and they include 3DCoffee (Poirot et al. 2004) and FUGUE 
(Shi et al. 2001). Recently, the Expresso server (Armougom et al. 2006) extended the 
3DCoffee method by automatically identifying highly similar 3D structural templates 
for target sequences and using structural alignments for consistency-based alignments.
6.4  Phylogeny Reconstruction
Understanding microbial evolution is essential for gathering information on the most 
ancient events in the history of Life on our planet (Gribaldo and Brochier 2009) as 
well as on the extant relationships between whole microbial communities. This task 
6.3 Multiple Sequence Alignments
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implies the use of molecular phylogeny techniques that is the study of phylogenies 
and processes of evolution by the analysis of DNA or amino acid sequence data 
(Whelan and Goldman 2001). Although parsimony and distance-based methods 
are widely used, the most statistically robust approach is to consider the problem 
in a likelihood framework and use accurate models of evolution (Brilli et al. 2008). 
It is known (Whelan and Goldman 2001), in fact, that disadvantages of distance 
methods include the inevitable loss of evolutionary information when a sequence 
alignment is converted to pairwise distances, and the inability to deal with models 
containing parameters for which the values are not known a priori. Concerning 
maximum parsimony (MP), this approach selects and outputs the tree (or trees) 
that require the fewest evolutionary changes and is reasonably confident when the 
number of changes per sequence position is relatively small (Steel and Penny 2000). 
However, as more-divergent sequences are to be analyzed, the degree of homoplasy 
(i.e. parallel, convergent, reversed or superimposed changes) increases and MP tree 
reconstruction might be misleading since this method has no adequate means to 
deal with this (Whelan and Goldman 2001). Conversely, Maximum likelihood (ML) 
approaches take the hypothesis (the tree topology) that maximizes the likelihood 
of the data (the sequence alignment) in the light of an evolutionary model. A great 
attraction of this approach is the ability to perform robust statistical hypothesis tests 
and to use modern statistical techniques such as hidden Markov models, Markov 
chain Monte Carlo and Bayesian inference (Ewens and Grant 2005; Shoemaker 
et al. 1999). The ML framework also allows each site of the alignment to evolve with 
different replacement patterns, and with different substitution rates in all branches 
of the tree (Whelan and Goldman 2001) as in real proteins, where slowly evolving 
sites are generally functionally or structurally constrained, while variable sites are 
likely to be less important for protein function. The ML approach (including its 
variants as the Bayesian framework) has been included in a number of different 
packages, such as Phylip (http://evolution.gs.washington.edu/phylip.html) PAUP* 
(http://paup.csit.fsu.edu/) MEGA http://www.megasoftware.net/mega.html, (Tamura 
et al. 2008), PAML [http://abacus.gene.ucl.ac.uk/software/paml.html, (Yang 1997)], 
mrBayes (Huelsenbeck and Ronquist 2001; Ronquist and Huelsenbeck 2003) and 
phyML (Guindon and Gascuel 2003).
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The large amount of genomic data deeply impacted on our understanding
of the biology, diversity and evolution of bacteria. Applications of genome
sequencing analysis techniques and computational approaches to genome
comparison are the topic of the following chapter. Notably, two diverse case
study are presented. Both show how analysis of genetic features through
bioinformatic approaches can pave the way to wet-lab experimental proce-
dures, revealing relevant clues and features deserving further investigations.
In the first work a deep genetic characterization of a biotechnological strain,
Rhodopseudomonas palustris 42OL, is presented. This strain, a facultative
anaerobe, has a wide metabolic versatility which allowed it to spread through-
out a variety of habitats. Thanks to its ability to efficiently produce hydrogen,
R. palustris 42OL has been used in mixed culture for wastewater treatment.
However, since it is able to survive in multiple conditions (it is autotrophic,
heterotrophic, organotrophic, litotrophic, chemotrophic and phototrophic), it
could be particularly suitable for a broad spectrum of biotechnological fields.
For instance, its biomass was evaluated for SCP accumulation and amino acid
composition [1] and used as a bio-sorbent for metal removal from waste-
waters [2, 3]. Additionally it has been used for antibiotic delivery though
liposomes formed with its lipids [4]. Given this long list of addresses and
its versatility it was considered a good candidate for DNA sequencing. The
availability of the brand new genome allowed for functional inquiry, struc-
tural sinteny analysis and phylogenetics studies, as reported in the article
embedded in this chapter. The computational analysis confirmed the genetic
features allowing for hydrogen and poly-beta-hydroxy-butyrate production.
Such genetic marks of metabolic capabilities may help the genetic editing for
large-scale industrial use.
The second case study deals with the genetic and phenotypic characterization
of Rheneimera sp. EpRS3, an endophytic bacterial strain isolated from the
medicinal plant Echinacea purpurea. Today there is an increasing interest
in the microbiota of such plants, either from an ecological and pharmaco-
logical point of view [5]. Medicinal plants, in fact, harbor highly complex
bacterial communities with peculiar genetic features to survive the strong
competition undergoing inside the tissues and in the rhizosphere. Some of
these members may promote plants growth through various mechanisms [6].
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Some other can exploit active ecological roles, producing molecules involved
in plant’s defense mechanisms and structuring the communities of specific
organs. The last, by exhibiting antimicrobial activity, may also be medically
relevant strains. This was the case of Rheneimera sp. EpRS3 [7, 8]. The
outcomes of its genome sequencing project, reported in the second article
of the chapter, highlighted potential, functional clues that guided wet-lab
tests. The investigation of its resistome and secondary metabolite production,
through comparative methods, revealed the presence of genetic traits suitable
for experimental inquiry. The analysis through antiSMASH suite [9], revealed
that the genome harbors 111 genes, split in 8 clusters, associated with the
synthesis of various molecules exhibiting antimicrobial activity. In particular,
Rheinheimera sp EpRS3 has:
1. two different putative bacteriocin clusters (a class of extracellular small
peptides exhibiting bactericidal activity) with a comparable number of
genes (6 and 7, respectively);
2. two clusters associated with the synthesis of lantipeptides, harboring
11 and 12 genes each (lantipeptides are a class of polycyclic peptides
characterized by the presence of the thioether-cross-linked amino acids
meso-lanthionine (Lan) and (2S, 3S, 6R)-3-methyllanthionine);
3. three biosynthetic clusters involved in production of different com-
pounds: resorcinol, non-ribosomal peptides (NRPS), polyketides (PKS).
The presence of PKS synthases and NRPS synthases have a topical relevance
for future biotechnological exploitation of this strain, in that some of the
most successful antibiotics (i.e. vancomycin, avermectin, erythromycin) are
produced by these enzymes.
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Draft genome sequence and overview of
the purple non sulfur bacterium
Rhodopseudomonas palustris 42OL
Alessandra Adessi1,2, Giulia Spini1, Luana Presta3, Alessio Mengoni3, Carlo Viti1, Luciana Giovannetti1,
Renato Fani3 and Roberto De Philippis1,2*
Abstract
Rhodopseudomonas palustris strain 42OL was isolated in 1973 from a sugar refinery waste treatment pond. The
strain has been prevalently used for hydrogen production processes using a wide variety of waste-derived
substrates, and cultured both indoors and outdoors, either freely suspended or immobilized. R. palustris 42OL was
suitable for many other applications and capable of growing in very different culturing conditions, revealing a wide
metabolic versatility. The analysis of the genome sequence allowed to identify the metabolic pathways for
hydrogen and poly-β-hydroxy-butyrate production, and confirmed the ability of using a wide range of organic
acids as substrates.
Keywords: Rhodopseudomonas palustris 42OL, Purple non-sulfur bacteria, Hydrogen production, Wastewater
treatment, PHB accumulation
Introduction
Rhodopseudomonas palustris is a PNSB belonging to the
class Alphaproteobacteria. According to Imhoff et al. [1],
the term PNSB is used to indicate a physiological group
of anoxygenic phototrophic bacteria, affiliated to both
Alphaproteobacteria and Betaproteobacteria, containing
photosynthethic pigments and able to carry out anoxy-
genic photosynthesis.
Strains of R. palustris have been isolated from a variety
of different environments, from eutrophic lagoons to
moist soils, from freshwater ponds to marine coastal
sediments [2–4]. The very wide spread of R. palustris
throughout a variety of habitats is due to its extreme
metabolic versatility, with all modes of metabolism
represented (autotrophic, heterotrophic, organotrophic,
litotrophic, chemotrophic and phototrophic); moreover,
the organism is a facultative anaerobe [5].
All PNSBs are characterized by the ability of carrying
out anoxygenic photosynthesis; in the presence of oxy-
gen, photosynthesis is inhibited and a number of PNSBs
are able to carry out respiration [4]. Under anaerobic
conditions, and subject to light irradiation, PNSBs are
able to fix nitrogen via nitrogenase; hydrogen is pro-
duced as a by-product of nitrogen fixation. Among
PNSBs, R. palustris is considered a model organism for
studying biological hydrogen production, due to its cap-
acity of efficiently producing hydrogen during organic
wastes degradation [6].
R. palustris 42OL has been used previously for hydrogen
production processes under various conditions [7–22],
i.e., with different substrates, and cultured indoors and
outdoors, using freely suspended or immobilized cells.
However, its first application was in mixed culture in
wastewater treatment [23]. Its biomass was evaluated
for SCP accumulation and amino acid composition
[24]. The accumulation of PHB and its connection to
hydrogen production were investigated [8, 11, 25].
More recently, the biomass of R. palustris 42OL was
also used as a biosorbent for metal removal from waste-
waters [26, 27]. Furthermore, the NMR and X-ray
structures of its 7Fe-8S ferredoxin and cytochrome c2
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were studied [28–30]. The latest application of the
strain was for antibiotic delivery though liposomes
formed with its lipids [31].
The long history and the versatility of this particular
strain render it a very good candidate for further in-
vestigating the basis of its ability to acclimate to very
different culturing conditions.
Organism information
Classification and features
R. palustris 42OL was isolated in 1973 from a catch-
basin collecting the effluents of a sugar refinery waste
treatment pond, in Castiglion Fiorentino (AR), Italy. The
enrichment was carried out aimed at selecting waste de-
grading phototrophs. The isolated microorganism has
been stored since 1973 at CSMA Collection (WDCM
number 147) under the collection name CSMA73/42,
growing anaerobically on solid RPN medium [32] with
malate 2 g L-1 as the carbon source and supplemented
with 0.4 g L-1 of yeast extract. The general features of
the isolate are reported in Table 1.
The isolate 42OL was firstly assigned morphologically
to R. palustris. Phylogenetic analysis performed subse-
quently (unpublished results) by comparing 16S rRNA
gene sequences revealed that the isolate might be indeed
affiliated to the species R. palustris. With the present
work, a further phylogenetic analysis was conducted
and, as shown in the phylogenetic tree in Fig. 1, con-
firms its affiliation.
R. palustris 42OL is a Gram-negative rod shaped bac-
terium, of 0.6–1.2 μm (see Fig. 2a). It replicates by polar
budding (Fig. 2b) and new cells present one single flagel-
lum that is lost in the subsequent phases of cell cycle
[33, 34]. Its photosynthetic apparatus is located on la-
mellar ICMs, clearly visible in Fig. 2c, d, as characteristic
of this species [2]. The major carotenoid molecules that
Table 1 Classification and general features of Rhodopseudomonas palustris 42OL, according to MIGS standards [45]
MIGS ID Property Term Evidence codea
Classification Domain Bacteria TAS [46]
Phylum Proteobacteria TAS [47]
Class Alphaproteobacteria TAS [48, 49]
Order Rhizobiales TAS [49, 50]
Family Bradyrhizobiaceae TAS [49, 50]
Genus Rhodopseudomonas TAS [1, 51, 52]
Species Rhodopseudomonas palustris TAS [51, 53, 54]
strain: 42OL (CSMA73/42)
Gram stain Negative NAS
Cell shape Rod IDA
Motility Motile only during first part of cell cycle NAS
Sporulation Non sporulating
Temperature range mesophilic NAS
Optimum temperature 28–30 °C IDA
pH range; Optimum 6.0–8.0; 6.8 TAS [32]
Carbon source VFA, CO2 IDA
MIGS-6 Habitat Sugar refinery waste pond IDA
MIGS-6.3 Salinity Not determined
MIGS-22 Oxygen requirement Facultatively anaerobic IDA
MIGS-15 Biotic relationship Free-living NAS
MIGS-14 Pathogenicity Non-pathogen NAS
MIGS-4 Geographic location Castiglion Fiorentino, AR, Italy IDA
MIGS-5 Sample collection 1973 IDA
MIGS-4.1 Latitude 43° 19' 30.054" IDA
MIGS-4.2 Longitude 11° 53' 18.4518" IDA
MIGS-4.4 Altitude 248 m IDA
aEvidence codes - IDA inferred from direct assay, TAS traceable author statement (i.e., a direct report exists in the literature), NAS non-traceable author statement
(i.e., not directly observed for the living, isolated sample, but based on a generally accepted property for the species, or anecdotal evidence). These evidence
codes are from the Gene Ontology project [55]
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Fig. 1 Maximum Likelihood dendrogram based on 16S rRNA gene; Bar = 1.1 indicates the nucleotides substitution rate. Numbers at the nodes
indicate bootstrap values after 500 random replicates. Numbers after strain name indicate the GI code. Sequences have been selected after BLAST
Explorer [56] search for most similar sequences present in GenBank database. Dendrogram has been constructed by using the Maximum
Likelihood algorithm with default options present in phylogeny.fr web server [56]. Strains TIE-1 and DX-1 have completely sequenced genomes;
ATCC17001 is the type strain and is indicated asT
Fig. 2 Electron micrographs of Rhodopseudomonas palustris 42OL grown on RPN medium; a whole cell, longitudinal section; b cell during polar
budding (white arrow), longitudinal section; c whole cell containing PHB granules. d lamellar ICMs in whole cells, transversal section; PHB,
poly-β-hydroxybutyrate granules; ICM, intra-cytoplasmic membranes; P, polyphosphate granules; CW, cell wall
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are present in the photosynthetic apparatus of this strain
are spirilloxanthin, rhodopin, rhodovibrin, anhydrorho-
dovibrin and lycopene (our unpublished results).
The first characterization of R. palustris 42OL was in
terms of protein accumulation and amino acid com-
position on different carbon and nitrogen sources.
Malate and ethanol were tested as carbon sources,
both under nitrogen fixing (N2 sparged) and non-
fixing (NH4
+ supplied) conditions. A significantly lower
amount of protein was produced in presence of etha-
nol, while the nitrogen source did not have any effect.
However, both nitrogen and carbon sources signifi-
cantly influenced the amino acid composition of the
protein biomass [24].
The carbon metabolism of the strain was investigated
in terms of substrates that could be used for growth and
hydrogen production. Short chain fatty acids such as
acetate, pyruvate, lactate, malate and succinate were
found to be photodissimilated by the strain with sub-
strate conversion efficiency of 40, 52, 61, 56, and 67 %,
respectively [35]. Butyrate was found to be suitable for
growth and hydrogen production but with the signifi-
cantly lower substrate-to-hydrogen conversion efficiency
of 9 % (unpublished data).
Vincenzini et al. [36] characterized nitrogenase activity
of R. palustris 42OL in terms of hydrogen production
and acetylene reduction with different atmosphere
composition and at different pH values. The optimal con-
ditions for hydrogen production were under Argon gas as
the atmosphere, for early logarithmic stage cells, at
pH 6.8. The authors also demonstrated the presence of a
hydrogenase enzyme, recycling the hydrogen produced
during late logarithmic and light-limited stage.
Evidences of its suitability for the treatment of wastes
combined with hydrogen production were reported [35],
using wastewaters deriving from a sugar refinery and a
paper mill. The same strain was shown to grow and pro-
duce hydrogen on different substrates such as vegetable
wastes [15], olive mill wastewaters [12, 13] and dark fer-
mentation saline effluents [14].
PHB is synthetized as a reservoir for reducing equiva-
lents by the strain, in this way competing with hydrogen
production [25], especially when grown on acetate [25],
or when subject to phosphorus starvation [11]; in this
condition, R. palustris 42OL could accumulate up to
18 % w/w of PHB on cell dry weight. R. palustris 42OL
accumulates PHB in large amorphous granules, as shown
in Fig. 2. Glycogen is synthetized as well as carbon
and energy reserve [25].
Another relevant characteristic of this strain is the
possibility of cultivation outdoors, under light/dark
cycles both for biomass [37, 38] and hydrogen pro-
duction [10, 11, 22], with an impressive capability of
the photosystem to take advantage of the high light
conditions that take place during the central hours of
the day [21].
Genome sequencing information
Genome project history
The organism was selected for genome sequencing on
the basis of its metabolic versatility and biotechnological
relevance, as witnessed by its long history and by the
diversity of applications. Project information is available
from the Genomes OnLine Database [39], under the GOLD
study ID Gs0114708. The WGS sequence is deposited in
GenBank (LCZM00000000).
Growth conditions and genomic DNA preparation
R. palustris 42OL (CSMA73/42) was maintained anaer-
obically on solid RPN medium [32] with malate 2 g L-1
as the carbon source and supplemented with 0.4 g L-1 of
yeast extract. For the extraction of genomic DNA a sin-
gle colony of cells grown on agar plate was harvested
and cultured anaerobically on the same liquid medium
in 20 mL sealed glass tubes, at room temperature with a
light irradiance of 80 μmol of photons m-2 s-1. Cultures
were then transferred into 100 ml round bottles and the
headspace was exchanged with Argon gas for anaerobio-
sis. Cells were harvested at an OD660 = 0.5, in mid-
logarithmic phase, pelleted and stored at −20 °C. DNA
was isolated from the cells using a CTAB bacterial gen-
omic DNA isolation method, and checked on agarose
gel. The genomic DNA purity was assessed by spectro-
photometric measurements [40].
Genome sequencing and assembly
The draft genome sequence was generated using the
Illumina technology. A Nextera XT DNA library was
constructed and sequenced using Illumina MiSeq plat-
form which generated 23,625,870 reads. After trimming,
a total of 7,574,912 paired end reads were obtained and
assembled into 308 high quality contigs (larger than
5419 bp each) using Abyss 1.0.0 software present on the
Galaxy Orione server [41]. A summary of the project in-
formation is shown in Table 2.
Genome annotation
Genes were identified using the prokaryotic genome anno-
tation software Prokka 1.4.0 [42] (Galaxy Orione server
[40]). For gene finding and translation, Prokka makes use
of the program Prodigal [43]. Homology searching
(BLAST, hmmscan) was then performed using the trans-
lated protein sequences as queries against a set of public
databases (CDD, PFAM, TIGRFAM) as well as custom da-
tabases that come with Prokka. Additional gene prediction
analysis and functional annotation were performed within
the CBS Bioinformatics Tools platform developed by the
Technical University of Denmark (Table 3).
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Genome properties
The genome of R. palustris 42OL resulted to be
5,128,858 bp in length with a GC content of about 65.74 %
(Table 3). It was predicted to contain 4767 genes, 4715 of
which coded for proteins and 52 for RNA (tRNA and
rRNA). The majority of the predicted genes (68.74 %) could
be assigned to one of of 25 functional COG categories
whilst the 8.42 % of the remaining genes were annotated as
hypothetical and 38.9 % as unknown function proteins. The
distribution of genes into COGs functional categories is
presented in Table 4.
Insights from the genome sequence
The genome of R. palustris 42OL contained, as ex-
pected, genes related to nitrogen fixation (nif H, D, K, E,
N, B, U, X, Q, W, Z), genes involved in carbon fixation
(RubisCO), the complete tricarboxylic acid cycle, the
glyoxylate shunt, a Embden-Meyerhof pathway, and a
pentose phosphate pathway. Genes coding for the syn-
thesis of glycogen and poly-β-hydroxyalkanoates as car-
bon storage polymers were also found, as well as genes
related to the photosynthetic apparatus, similarly to all
the other R. palustris strains so far sequenced.
The genome of R. palustris 42OL was analyzed in
terms of synteny with other strains sequenced. The gen-
ome was found to be highly syntenic with those of other
strains of R. palustris (data not shown). Exclusive reac-
tions were then mapped on KEGG with respect to other
R. palustris strains sequenced so far (BisA53, BisB18,
BisB5, CGA009, Haa2, TIE1) by using DuctApe v 0.17.2
software [44]. Data obtained are reported in Table 5. The
proteome size ranged between 4392 and 5242 protein
Table 2 Project information
MIGS ID Property Term
MIGS 31 Finishing quality High-quality Draft
MIGS-28 Libraries used Paired-end Nextera XT DNA
MIGS 29 Sequencing platforms Illumina MiSeq
MIGS 31.2 Fold coverage 366 ×
MIGS 30 Assemblers Abyss version 1.0.0
(Galaxy/CRS4 Orione server)
MIGS 32 Gene calling method Prokka version 1.4.0
(Galaxy/CRS4 Orione server)
Locus Tag AB661
Genbank ID LCZM00000000
GenBank Date of Release 5 June 2015
GOLD ID Gs0114708
BIOPROJECT PRJNA283573
MIGS 13 Source Material Identifier CSMA73/42
Project relevance Metabolic versatility
(hydrogen production),
Biotechnology
Table 3 Genome statistics*
Attribute Value % of total
Genome size (bp) 5,128,858 100.00
DNA coding (bp) 4,388,835 85.00
DNA G + C (bp) 3,369,731 65.74
DNA scaffolds 1 100.00
Total genes 4767 100.00
Protein coding genes 4715 98.91
RNA genes 52 1.09
Pseudo genes NA NA
Genes in internal clusters NA NA
Genes with function prediction 3277 68.74
Genes assigned to COGs 3660 76.78
Genes with Pfam domains 3312 69.48
Genes with signal peptides 449 9.41
Genes with transmembrane helices 1212 25.42
CRISPR repeats 1 0.09
*NA, not available
Table 4 Number of genes associated with general COG
functional categories
Code Value % age Description
J 170 3.61 Translation, ribosomal structure and biogenesis
A 0 0.00 RNA processing and modification
K 218 4.62 Transcription
L 144 3.05 Replication, recombination and repair
B 1 0.02 Chromatin structure and dynamics
D 25 0.53 Cell cycle control, Cell division, chromosome
partitioning
V 57 1.21 Defense mechanisms
T 192 4.07 Signal transduction mechanisms
M 215 4.56 Cell wall/membrane biogenesis
N 80 1.70 Cell motility
U 37 0.78 Intracellular trafficking and secretion
O 165 3.50 Posttranslational modification, protein
turnover, chaperones
C 267 5.66 Energy production and conversion
G 169 3.58 Carbohydrate transport and metabolism
E 358 7.59 Amino acid transport and metabolism
F 59 1.25 Nucleotide transport and metabolism
H 145 3.08 Coenzyme transport and metabolism
I 239 5.07 Lipid transport and metabolism
P 242 5.13 Inorganic ion transport and metabolism
Q 97 2.06 Secondary metabolites biosynthesis,
transport and catabolism
R 397 8.42 General function prediction only
S 383 8.12 Function unknown
– 1055 22.38 Not in COGs
The total is based on the total number of protein coding genes in the genome
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coding genes, corresponding respectively to strains BisB5
and TIE1. The total number of reactions ranged between
2442 and 3012, respectively for strains BisA53 and
CGA009. Strain Haa2 resulted to have the highest number
of unique reactions.
Conclusions
In this study, we characterized the genome of R. palustris
strain 42OL isolated from a wastewater pond of a sugar
refinery in 1973. Along the last four decades, this
strain has been successfully used in a wide number of
applications, from hydrogen production on wastewaters
(its major application) to PHB production. The present
genome analysis supported those findings.
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Abstract
In recent years, there has been increasing interest in plant microbiota; however, despite medicinal plant relevance, very little is known about
their highly complex endophytic communities. In this work, we report on the genomic and phenotypic characterization of the antimicrobial
compound producer Rheinheimera sp. EpRS3, a bacterial strain isolated from the rhizospheric soil of the medicinal plant Echinacea purpurea. In
particular, EpRS3 is able to inhibit growth of different bacterial pathogens (Bcc, Acinetobacter baumannii, and Klebsiella pneumoniae) which
might be related to the presence of gene clusters involved in the biosynthesis of different types of secondary metabolites. The outcomes pre-
sented in this work highlight the fact that the strain possesses huge biotechnological potential; indeed, it also shows antimicrobial effects upon
well-described multidrug-resistant (MDR) human pathogens, and it affects plant root elongation and morphology, mimicking indole acetic acid
(IAA) action.
© 2016 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
Keywords: Endophytes; Antibiotic resistance; Antibiotic production; Biotechnological applications; Genome analysis
1. Introduction
A diverse range of bacteria, including parasites, commen-
sals and mutualists, can colonize the rhizosphere of plants,
growing around their roots [1] and eventually colonizing plant
internal tissues and surfaces (as endophytes or epiphytes).
Despite medicinal plant relevance, very little is known about
their plant-associated bacteria. In recent years, there has been
increasing interest in medicinal plant microbiota; numerous
efforts have been made to explore both endophytic and rhi-
zospheric diversity [2e9]. Those studies showed that medic-
inal plants harbor highly complex bacterial communities,
whose structure is possibly influenced by the plant organ
colonized and secondary compounds with medicinal proper-
ties (e.g. plant essential oils) [7,8]. In particular, in a recent
work on Echinacea purpurea [7], different antibiotic resis-
tance phenotypes have been observed for rhizospheric and* Corresponding author.
E-mail addresses: renato.fani@unifi.it, renato.fani@virgilio.it (R. Fani).
Research in Microbiology 168 (2017) 293e305
www.elsevier.com/locate/resmic
http://dx.doi.org/10.1016/j.resmic.2016.11.001
0923-2508/© 2016 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
endophytic bacterial communities, suggesting the presence of
a plethora of defense mechanisms and differential production
of antimicrobial compounds by members of these bacterial
communities.
Rheinheimera sp. EpRS3, a Gammaproteobacterium,
belonging to the family of Chromatiales, is one such member.
It was isolated from a sample of rhizospheric soil of E. pur-
purea [7,8], a medicinal plant with documented antimicrobial
activity [6]. Rheinheimera sp. EpRS3 showed resistance to
several antibiotic compounds and was able to inhibit growth of
various bacteria isolated from both E. purpurea rhizospheric
soil and plant tissues [7e9].
Therefore, the aim of this work was to characterize the
Rheinheimera sp. EpRS3 strain from different viewpoints so
as to evaluate its possible biotechnological potential, in terms
of both the ability to affect plant growth and to interfere with
growth of human bacterial pathogens. For this purpose, it was
characterized at a phenotypic level by testing different traits
(especially those related to production of antimicrobials and
those involved in plant growth promotion); moreover, the
genome sequence was determined and analyzed in order to
correlate phenotypic data with the genetic repertoire.
2. Materials and methods
2.1. Bacterial strains, isolation and growth conditions
Rheinheimera sp. EpRS3 was isolated from the medicinal
plant E. purpurea as described by Chiellini et al. [5]. This
strain belongs to a collection of isolates from a pool of five E.
purpurea plants that were grown in a common garden at the
“Giardino delle Erbe”, Casola Valsenio (Italy).
Rheinheimera sp. EpRS3 was grown either in tryptic soy
agar (TSA) or in minimal medium Davis (MMD) (1.0 g l1 of
(NH4)2SO4, 7.0 g l
1 of K2HPO4, 2.0 g l
1 of KH2PO4,
0.5 g l1 of Na3-citrate 2H2O, 0.1 g l
1 of MgSO4$7H2O) and
in minimal medium Venetia (MMV) (1.0 g l1 of
MgSO4$7H2O, 0.7 g l
1 of KCl, 2.0 g l1 of KH2PO4,
3.0 g l1 of Na2HPO4, 1.0 g l
1 of NH4NO3, and 24.0 g l
1 of
NaCl in deionized water) containing 0.4% diesel fuel or 1%
glucose as the sole carbon and energy source. Diesel fuel
(Esso Italiana) was previously filtered through a 0.2 mm-pore-
size filter (Sartorius) for sterilization and particle removal.
Bacterial cultures were incubated at 30 C.
Burkholderia strains were grown in TSA medium at 37 C.
2.2. Response to oxidative stresses and heavy-metals
resistance
Resistance to oxidative stress was tested by evaluating
Rheinheimera sp. EpRS3 growth on TSA medium supple-
mented with hydrogen peroxide, zinc, copper, cadmium or
nickel (heavy metals). The strain was grown for 48 h (or until
satisfactory growth) in each of the supplemented TSA media
at 30 C, and an isolated colony was then suspended in 100 ml
of saline solution (0.85% NaCl). The cell suspension was then
streaked onto TSA plates supplemented with different
concentrations of: hydrogen peroxide (1-5-10-20 mM); zinc
(ZnSO4 5-10-15-25 mM); copper (CuSO4 0.25-0.5-1-2.5-5-
10-15-25 mM); cadmium (Cd(NO3)2 5-10-15-25 mM); nickel
(NiCl2 5-10-15-25 mM). Strain growth was rated as absence of
growth (i.e. sensitivity to exposure) or growth (i.e. tolerance at
the tested oxidative stress). No quantitative assessment of the
amount of growth was evaluated.
2.3. Extracellular enzymatic activity (EEA)
Extracellular amylolytic, proteolytic, phospholipase and
lipase enzyme activities were assessed as follows. Amylolytic
activity was evaluated by streaking Rheinheimera sp. EpRS3
onto 10% TSA medium enriched with 1% starch from potatoes
(Fluka Analytical). After incubation at 30 C for 48 h, 2 ml of
Lugol's iodine solution was added to the plate. A positive re-
action was defined as the observation of a pale yellow zone
around the colony, indicating starch degradation [7].
Proteolytic activity was evaluated in 10% TSA supple-
mented with 1% skim milk powder (Fluka Analytical). After
incubation for 48 h at 30 C, a clear halo around the colony
indicated milk degradation and thus a positive reaction [7].
Phospholipase activity was evaluated in 10% TSA supple-
mented with 2% egg yolk emulsion (Fluka Analytical). The
cleavage of the phosphate ester bonds forms water-insoluble
lipids. After incubation for 48 h at 37 C, enzyme activity
can be observed as a halo of opalescence in the opaque me-
dium around the colony.
The presence of extracellular lipase was evaluated either in
10% TSA enriched with 1% (v/v) tributyrin (Sigma Aldrich)
or in 10% TSA enriched with 1% (v/v) Tween 80 (Thermo
Scientific). After incubation at 37 C for 48 h, a positive re-
action is indicated by a clear halo around the colony in opaque
tributyrin agar medium, and by a precipitate around the colony
in Tween 80 agar medium, respectively. Each experiment was
performed in triplicate.
2.4. Antimicrobial activity assay vs. Burkholderia
cepacia complex, Acinetobacter baumannii and
Klebsiella pneumoniae strains
Antibacterial activity of Rheinheimera sp. EpRS3 (defined
as a “tester strain”) was tested using the cross-streak method as
described by Papaleo et al. [8] against six A. baumannii (two
of which, RUH 875 and RUH 134, are well-described MDR
strains of the respective international clones II and I [9],)
eleven K. pneumoniae and thirty Burkholderia strains, listed in
Table 1 and referred to as “target strains”. Moreover, in sus-
ceptibility testing, some A. baumannii and K. pneumoniae
strains used in this work showed a colistin resistance pheno-
type (see Table 1).
In the assay against Burkholderia strains, the tester strain
was streaked across two different half Petri dishes containing
TSA medium either with or without a central septum sepa-
rating the tester strain from target strains. Such an expedient
has been used to test whether any antimicrobial effect occur-
ring is detected only when molecules can reach the target by
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Table 1
List of bacterial strains belonging to the Burkholderia cepacia complex (Bcc), A. baumannii and K. pneumoniae used in this work. Abbreviations: CF, Cystic
Fibrosis; AI, Animal Infection; E, Environment; C, Clinical.
Position on plate Taxonomy Strain Origin
1 B. ambifaria LMG 19182 E
2 B. anthina LMG 20980 E
3 B. arboris LMG 24066 E
4 B. cenocepacia LMG 16656 CF
5 B. cepacia LMG 1222 E
6 B. contaminans LMG 23361 AI
7 B. diffusa LMG 24065 CF
8 B. dolosa LMG 18943 CF
9 B. lata LMG 22485 E
10 B. latens LMG 24064 CF
11 B. metallica LMG 24068 CF
12 B. multivorans LMG 13010 CF
13 B. pseudomultivorans LMG 26883 CF
14 B. pyrrocinia LMG 14191 E
15 B. seminalis LMG 24067 CF
16 B. stabilis LMG 14294 CF
17 B. ubonensis LMG 20358 E
18 B. vietnamiensis LMG 10929 E
19 B. cenocepacia FCF 12 CF
20 B. cenocepacia FCF 13 CF
21 B. cenocepacia FCF 14 CF
22 B. cenocepacia FCF 15 CF
23 B. cenocepacia FCF 18 CF
24 B. cenocepacia FCF 19 CF
25 B. cenocepacia LMG 16656 CF
26 B. multivorans FCF 5 CF
27 B. multivorans FCF 6 CF
28 B. multivorans FCF7 CF
29 B. multivorans FCF 8 CF
30 B. multivorans FCF 9 CF
Position
on plate
Taxonomy Strain Origin Genotype Phenotype
1 A. baumannii RHU 134 C e e
2 A. baumannii RHU 875 C e e
3 A. baumannii ATCC17978 C e e
4 A. baumannii O8C29 C blaOXA-23/blaOXA-58 Beta-lactams R
5 A. baumannii N5O C blaOXA-24 Beta-lactams R, col-R
6 A. baumannii YMCR363 C blaVIM-2 Beta-lactams R
1 K. pneumoniae BO 1 C blaKPC Resistant to: beta-lactams, fluoroquinolones,
gentamycin; colistin S
2 K. pneumoniae BO 4 C blaKPC Resistant to: beta-lactams, fluoroquinolones,
gentamycin; colistin R
3 K. pneumoniae B1 C blaKPC Resistant to: beta-lactams, fluoroquinolones,
gentamycin; colistin S
4 K. pneumoniae B2 C blaKPC Resistant to: beta-lactams, fluoroquinolones,
gentamycin; colistin R
5 K. pneumoniae ATCC 700603 C e e
6 K. pneumoniae KP397 C blaCTX-M-65/fosA Resistant to: extended-spectrum
cephalosporins, aminoglycosides,
fluoroquinolones,
7 K. pneumoniae KP477 C fosA Resistant to: extended-spectrum
cephalosporins, aminoglycosides,
fluoroquinolones, fosfomycin
8 K. pneumoniae KPC249 C blaKPC/armA Resistant to: beta-lactams, aminoglycosides
9 K. pneumoniae KPC261 C blaKPC/armA Resistant to: beta-lactams, aminoglycosides
10 K. pneumoniae KPC284 C blaKPC/armA Resistant to: beta-lactams, aminoglycosides
11 K. pneumoniae NTUHK2044 C e e
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diffusing into the medium, or if the antimicrobial effect is
carried by a volatile compound that hence can also exert its
effect when the tester and target are separated by a barrier. In
tests to probe antimicrobial activity against A. baumannii and
K. pneumoniae, we used the plates without septum.
All plates were then incubated at 30 C for 48 h. Next,
target strains were streaked perpendicularly to the initial streak
in the empty half of the plate; plates with Burkholderia strains
were incubated at 30 C and 37 C for an additional 48 h,
respectively, while the other strains were incubated at 37 C
for 24 h. The antagonistic effect was indicated by growth in-
hibition of target strains in the confluence area. All experi-
ments were performed in triplicate and in parallel with a
positive control to verify viability of target strains.
2.5. Determination of fosfomycin minimum inhibitory
concentration
The minimum inhibitory concentration (MIC) of fosfomy-
cin was determined by the agar dilution reference method
according to CLSI guidelines [10]. Mueller-Hinton agar
plates, supplemented with 25 mg/ml of glucose-6-phosphate,
were added with the following concentrations of the antibiotic:
0.064 mg/ml, 0.125 mg/ml, 0.256 mg/ml, 0.5 mg/ml, 1 mg/ml,
2 mg/ml, 4 mg/ml, 8 mg/ml, 16 mg/ml, 32 mg/ml, 64 mg/ml,
128 mg/ml, 256 mg/ml and 512 mg/ml. Starting from a 0.5
McFarland suspension of Rheinehimera EpRS3, a 1:10 dilu-
tion in saline solution was prepared and agar plates were
inoculated with 5 ml spots from the diluted McFarland inoc-
ulum. Plates were then incubated at 37 C overnight.
Escherichia coli ATCC 25922 and Pseudomonas aeruginosa
ATCC 27853 strains were used as quality control strains.
2.6. Colorimetric estimation of 3-indole acetic acid
production
Three ml of tryptic soy broth (TSB), Biorad solution 1:10,
supplemented with 1 mg/ml L-tryptophan, were inoculated
with 200 ml of Rheinheimera sp. EpRS3 liquid culture. Ac-
cording to the assay described in [20], after incubation over-
night at 30 C, 50 ml of FeCl3-HClO4 reagent were added to
50 ml of medium. Absorbance was measured after 30 min at
530 mm.
2.7. Plant growth conditions
Nicotiana tabacum cv. Xanthi seeds were surface-sterilized
for 20 min in 5% NaOCl solution, followed by three washes
with sterile distilled water. Sterilized seeds were then trans-
ferred onto Petri dishes containing Lindsmaier and Skoog
medium (LS, Lab Associates BV, the Netherlands) supple-
mented with 1% sucrose and 0.7% plant agar. Plates were
incubated in a growth chamber at 24 ± 1 C, 80% humidity
and in the dark until root differentiation. Seeds with primary
roots were then placed in the light at 1500 lux and with a 16 h
light/8 dark photoperiod regimen. Ten days from germination,
N. tabacum seedlings were used for a vertical agar plate (VAP)
assay [11].
2.8. Dual culture vertical agar plate assay
The endophytic Rheinheimera sp. EpRS3 strain and E. coli
DH5a (used as control) were removed from 80 C storage,
streaked onto plates containing TSA and incubated at 30 C
for 48 h. Single colonies were then inoculated into tryptic soy
broth (TSB) and grown in a shaker at the same temperature
overnight. The bacterial suspensions were then adjusted to
108 cfu/ml (OD600 ¼ 1). Twenty N. tabacum seedlings of the
same age and dimension were grown on 15 cm Petri dishes
containing LS basal medium; 100 ml of each of the OD600
suspension cultures or 100 ml culture filtrates were inoculated
onto a sterilized filter paper disc placed 1 cm below the root
tips of the seedlings, approximately at the center of the line of
plants. Control treatments were made with 100 ml of TSB
culture medium. Plates were incubated vertically in the growth
chamber at 24 ± 1 C and scored for root growth and
morphology after 7 and 14 days from treatments. Root growth
was reported as root length fold increase (mm) measured as
(flil)/il where fl was the length of primary root after 7 or 14
days of culture and il was the initial length of primary roots.
Each experiment was performed in duplicate.
2.9. Statistical analysis
All statistical analyses were performed using the PAST
program, version 3.12 [12]. The analysis of variance between
treated and untreated N. tabacum plants was conducted using
One-way ANOVA (P < 0.05). Mean separations were per-
formed using the method of Tukey. Student's t test was used
for comparing two averages.
2.10. DNA isolation and whole genome sequencing
The Rheinheimera sp. EpRS3 strain was grown at 30 C on
TSB medium; genomic DNA was extracted using the CTAB
method [13]. Authenticity of genomic DNAwas confirmed by
16S rRNA gene sequencing. Whole genome shotgun
sequencing was performed with a 2  300 bp paired-end
approach using the MiSeq sequencing system (Illumina Inc.,
San Diego, CA), which produced a total of 1,245,634 high-
quality reads.
2.11. Phylogenetic affiliation
Eighteen 16S rRNA gene sequences belonging to Rhein-
heimera species (representing all the species available for this
genus) were selected from the Ribosomal DataBase Project
(RDP) (http://rdp.cme.msu.edu/) [14] and from NCBI ftp site.
Moreover, the 16S rRNA gene sequence from Gallaecimonas
pentaromativorans CEE 131 was included as an outgroup in
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phylogenetic analysis. The program Muscle v3.8.31 [15] was
used to align 16S rRNA coding sequences; poorly aligned
positions and divergent regions were deleted using Gblocks
software v.0.91b [16]. The phylogenetic tree was inferred by
using PhyML software v.3.0 [17], which computes genetic
distances using a maximum likelihood method, with a GTR
substitution model, 4 substitution rate categories and an esti-
mated gamma shape parameter.
2.12. Genome assembly and annotation
FastQC software package v. 0.52 [18] was used to evaluate
the quality of the obtained read pairs; poor quality bases were
then removed using StreamingTrim [19]. Assembly was per-
formed using SPAdes 3.5 software [20] with a k-mer length of
21, 33 and 55. The resulting contigs were annotated using the
NCBI Automated Genome Annotation Pipeline.
The whole-genome shotgun project has been deposited at
NCBIWGS database under accession number LNQS00000000;
the version reported in this work was named LNQS01000000.
2.13. Comparative genomics
All Rheinheimera representative genomes sequenced thus
far (i.e. Rheinheimera A13L, Rheinheimera nanhaiensis E407-
8, Rheinheimera perlucida DSM 18276, Rheinheimera baltica
DSM 14885, Rheinheimera texasensis DSM 17496, R. sp.
KL1, Rheinheimera sp. F8, Rheinheimera sp. IITR-13) were
collected from the NCBI ftp site (ftp://ftp.ncbi.nlm.nih.gov/
assembly/) and, alongside the Rheinheimera sp. EpRS3
genome, were analyzed using the dgenome module of the
Ductape suite [21], to identify shared orthologous and strain-
specific genes. Furthermore, the COG database [22] was
consulted to classify them.
2.14. Secondary metabolite search parameters
The stand-alone version of antiSMASH software [23] for
genome-wide identification, annotation and analysis of sec-
ondary metabolite biosynthetic gene clusters was used to scan
the Rheinheimera sp. EpRS3 genome sequence. The homol-
ogy relationship between clusters of the same families were
inferred via First Best Hit (FBH) BLAST analysis [24] using a
threshold e-value of 1e20.
3. Results and discussion
3.1. The genome of Rheinheimera sp. EpRS3
After assembling the reads, a Rheinheimera sp. EpRS3
draft genome embedding 14 contigs with an overall length of
4,396,207 bp was obtained. The EpRS3 genome was annotated
to identify the functional elements and their putative biolog-
ical role, revealing the presence of 3961 genes, 3868 of which
are protein-coding genes, 62 are RNA encoding genes, one is
an ncRNA (non-coding RNA), and 30 are pseudogenes. The
main features of the Rheinheimera sp. EpRS3 genome are
reported in Table 2.
The phylogenetic tree (Fig. 1) inferred from the 16S rRNA
gene sequence of the strain shows strain Rheinheimera sp.
EpRS3 within the other members of the genus Rheinheimera.
In particular, the Rheinheimera sp. EpRS3 strain proved to be
close to R. perlucida DSM 18276 (99% of sequences identity).
Comparative genomics analysis was then performed be-
tween Rheinheimera sp. EpRS3 and Rheinheimera genomes
available in NCBI databases (i.e. Rheinheimera A13L, R.
nanhaiensis E407-8, R. perlucida DSM 18276, R. baltica
DSM 14885, R. texasensis DSM 17496, R. sp. KL1, Rhein-
heimera sp. F8, Rheinheimera sp. IITR-13). Fig. 2 shows the
size of unique, accessory and core genomes possessed by these
organisms as a framework to estimate the genomic diversity of
the dataset. The core genome of the genus Rheinheimera
proved to be relatively small (13.8%, 1413 genes), while the
ensemble of unique and accessory genome fraction of
Rheinheimera was large, 51.2% (5237 genes) and 35.0%
(3587 genes), respectively. Such large dispensable genomes
could be related to the different ecological niches colonized by
members of this genus, including water, soil and plant tissues
[24e26], as seen for other bacterial genera [27]. Additionally,
as shown in Fig. 2, the pangenome is open, a feature very
common when bacteria belonging to the same taxonomic
group live with many partners in very diverse environments,
since gene gain events are common and lead to a heteroge-
neous gene pool among the members of the same genus.
In order to obtain functional characterization of the
Rheinheimera genus, the open-reading frames (ORFs) were
mapped to the COG [22] database; the resulting categories
assigned to each gene are reported in Table 3. The abundance
of core, accessory and unique genes was plotted and is
compared in Fig. 3. As expected, the core genome displayed
predominance in COG categories generally associated with
housekeeping functions, such as categories C (energy pro-
duction and conversion, 719 genes), E (amino acid transport
and metabolism, 1119 genes), T (signal transduction mecha-
nisms, 777 genes) and J (translation ribosomal structure and
biogenesis, 856 genes) (Table 3). However, the core genome
also contains a large number of genes with unknown function.
Conversely, the accessory genome was enriched for the COG
categories M (cell wall/membrane/envelope biogenesis, 960
genes), T (signal transduction mechanisms, 871 genes) and K
(transcription, 897 genes) (Table 3). However, the largest part
Table 2
Rheinheimera sp. EpRS3 genome features.
Attribute Value
Genome size (bp) 4,396,207
DNA GþC (%) 49.3
DNA scaffolds 14
Total genes 3961
Protein coding genes 3868
RNA genes 62
Pseudo genes 31
ncRNAs 1
Genome coverage 82.0
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of both the accessory and unique genome was constituted by
genes without a characterized functional class (X).
3.2. Antibiotics resistance
In a previous work [4], Rheinheimera sp. EpRS3 was
demonstrated to be unable to grow in the presence of tetra-
cycline (MIC 0.5 mg/l), rifampicin (MIC 5 mg/l), chloram-
phenicol (MIC 1 mg/l) or ciprofloxacin (MIC 0.5 mg/l). On
the other hand, it showed resistance to some aminoglycoside
antibiotics, including streptomycin and kanamycin at con-
centrations 10 mg/l and 5 mg/l, respectively. In an effort to
identify the genetic determinants responsible for such resis-
tance profiles, the genome of Rheinheimera sp. EpRS3 was
annotated using the Resistance Gene Identifier (RGI) [28] tool
of the Comprehensive Antibiotic Resistance Database
(CARD). This led to identification of several elements usually
associated with antibiotic resistance (original output obtained
from CARD database inquiry are reported in Supplementary
materials). The majority of these genes encode only minor
components of efflux pump systems (like AcrB (belonging to
the AcrAB/TolC system), MexI (belonging to MexGHI-OpmD
complex), or MdtB and MdtC (that forms a heteromultimer
complex, a subunit of MdtABC-TolC efflux pump)), but others
encode complete RND-types systems (such as the complete set
of genes encoding for the multidrug transporter MexEF-OprN
complex and its transcriptional regulator mexT, an LysR-type
transcriptional activator that positively regulates expression).
Some of these efflux systems might be involved in resistance
to kanamycin and streptomycin [29], which has been observed
in this strain [5]. Additionally, such resistance could be due to
another genetic element found in this investigation, i.e. a gene
homologous to acrD, which is known to encode an amino-
glycoside efflux pump in E. coli [30].
Also, inspection of the Rheinheimera sp. EpRS3 genome
through the CARD database led to identification of unexpected
genetic features that could potentially confer resistance to
other drugs. For example, we found a gene coding for the Cfr
23S ribosomal RNA methyltransferase, which catalyzes
methylation of the 23S rRNA subunit at A2503, suggesting its
potential involvement in resistance to many drugs that target
protein synthesis [36]. Moreover, the Rheinheimera sp. EpRS3
genome harbors genes coding for FosC2 and for MurA, two
enzymes that usually confer resistance to fosfomy-
cin [31,32,39]. Given the latter hint, we investigated the ca-
pacity of Rheinheimera sp. EpRS3 to grow in the presence of
fosfomycin by MIC testing (as described in Section 2). Data
obtained revealed that Rheinheimera sp. EpRS3 was able to
grow up to 16 mg/ml, suggesting that the FosC2 and the MurA
gene products could be involved in poor susceptibility to
fosfomycin. Interestingly, such complex resistance profiles,
joined with its ability to inhibit other strains inhabiting host-
tissues [4], highlights the importance of Rheinheimera sp.
EpRS3 from an ecological perspective.
3.3. Genome mining and inhibition of human pathogen
strains
It has been previously reported that the Rheinheimera sp.
EpRS3 strain is able to produce antibacterial compounds
capable of inhibiting growth of many other bacteria isolated
from the same plant [5] (although the molecules responsible
for such inhibition have not yet been identified). Therefore, to
gain insight into the genetic basis of the observed antimicro-
bial activity spectrum, the genome of Rheinheimera sp. EpRS3
was analyzed using the antiSMASH suite, allowing for iden-
tification and annotation of genes encoding secondary me-
tabolites. As reported in Table 5, this approach revealed that
the Rheinheimera sp. EpRS3 genome harbors a considerable
number of genes with putative inhibitory activity. Indeed, we
found a total of 111 genes split in 8 clusters, associated with
synthesis of different molecules exhibiting antimicrobial
Fig. 1. Phylogenetic tree of the genus Rheinheimera based on 16S RNA sequences.
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activity. In particular, we found two different putative bacte-
riocin clusters (a class of extracellular small peptides exhib-
iting bactericidal activity) with a comparable number of genes
(6 and 7). Two clusters were found to be associated with the
synthesis of lantipeptides (harboring 11 and 12 genes each), a
class of polycyclic peptides characterized by the presence of
the thioether-cross-linked amino acids meso-lanthionine (Lan)
and (2S, 3S, 6R)-3-methyllanthionine (MeLan; [33]). The
latter three biosynthetic clusters are involved in production of
different compound classes (resorcinol, non-ribosomal pep-
tides, polyketides). In particular, the presence of polyketide
synthases (PKSs) and non-ribosomal peptide synthases
(NRPSs) have a topical relevance for future biotechnological
exploitation of this strain, in that some of the most successful
antibiotics (i.e. vancomycin, avermectin, erythromycin) are
produced by these enzymes.
The finding that the Rheinheimera sp. EpRS3 strain was
able to inhibit growth of other bacteria, especially Gram-
negative ones, stimulated us to evaluate its inhibitory effects
against human pathogens. Hence, we tested Rheinheimera sp.
EpRS3 through the cross-streaking method against a panel of
30 (target) strains belonging to the B. cepacia complex (Bcc),
a group of opportunistic pathogens able to cause severe in-
fections in immune-compromised subjects, such as cystic
fibrosis (CF) patients [34]. As shown in Table 1, Bcc strains
were of different origin (environmental, animal infection or
clinical). Data from cross-streaking experiments are shown
in Fig. 4A and Table 4. As reported, the assay revealed that
Rheinheimera sp. EpRS3 is able to interfere with growth of
most target Bcc strains. In particular, we observed that it is
strongly effective against all tested Burkholderia multivorans
and Burkholderia cenocepacia strains. Moreover, since it has
Fig. 2. The Rheinheimera genus PanGenome. 1 A: Pangenome shape. B: number of orthologs genes vs. number of genomes orange and blue represent core genome
genes and pangenome size, respectively. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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been previously demonstrated that growth of Bcc strains is
inhibited by microbial volatile organic compounds (mVOCs)
synthesized by Antarctic bacteria [8], we performed the same
cross-streaking experiments on Petri dishes with a central
septum separating the tester strain from the target strains. Data
obtained revealed that Rheinheimera sp. EpRS3 is still able to
inhibit Bcc strains, though to a lesser extent. The latter finding
suggests that at least some of the molecules exhibiting anti-
microbial activity vs. Bcc strains might be volatile organic
compounds (VOCs). Thus, it is quite possible that the inhib-
itory activity exhibited by the Rheinheimera sp. EpRS3 strain
relies on a combination of both volatile and diffusible com-
pounds, reminiscent of the inhibitory activity that many Ant-
arctic bacteria possess vs. Bcc strains [8]. Chemical profiling
is currently ongoing to characterize such molecules.
In order to check whether the antimicrobial compounds
synthesized by Rheinheimera sp. EpRS3 might also be effec-
tive against other human clinically relevant pathogens, we
performed cross-streaking experiments using a panel of MDR
strains belonging to A. baumannii and K. pneumoniae species
as targets (Table 1). Data obtained are shown in Fig. 4 and
demonstrate that Rheinheimera sp. EpRS3 completely inhibits
A. baumanni N50 and A. baumannii YMCR363 strains (Table
1, Fig. 4B) and partially inhibits K. pneumoniae KPC284, K.
pneumoniae B04, K. pneumoniae B2 (Table 1, Fig. 4C).
Interestingly, some of these strains are resistant to a specific
class of antibiotics, i.e. polymyxins, that are encoded by
NRPSs. More in detail, in K. pneumoniae B04 and B2 strains,
such resistance depends on modifications of the lipopolysac-
charide (LPS), while in K. pneumoniae KPC284 and A.
baumanni N50, the precise mechanism responsible for such a
phenotype is currently unknown. Notably, colistin resistance
in A. baumannii may occur due to mutations in the PmrAB
two-component system or in lpxA, lpxC, and lpxD genes (as in
K. pneumoniae strains); the two systems, respectively, lead to
the modification and loss of LPS (as in K. pneumoniae strains)
[35]. Thus, we can argue that Rheinheimera sp. EpRS3 is
probably strongly effective against the colistin-resistant or-
ganisms tested since, due to their (known or putative) LPS-
associated differences, they may be the only ones in which
the antimicrobial molecules produced by the tester are able to
enter into the target cells. We are completely aware that, at this
stage, this scenario represents a hypothesis that will require
more in-depth investigation. Nevertheless, it could represent
an important resource in the treatment of infections sustained
by MDR pathogens, particularly those resistant to last-line
treatment with colistin.
3.4. Identification of genetic elements in Rheinheimera
sp. EpRS3 associated with its ecological role in
rhizospheric soil
Different bacterial genera are involved in a plethora of bi-
otic activities of the soil ecosystem, such as biocontrol of
microbial communities and/or control of nutrient dynamic
turn-over [39],[40]. Several mechanisms come into play when
dealing with plant growth promotion, both directly and indi-
rectly. Among the most well-known, we can cite indole acetic
acid (IAA) production (that increases the root surface) [36],
nodulation and nitrogen-fixing ability, siderophore production
Table 3
Distribution of Rheinheimera sp EpRS3 genes in COG functional category.
COG functional category Description No. of genes %
J Translation ribosomal structure and biogenesis 175 4.52
A RNA processing and modification 1 0.03
K Transcription 203 5.24
L Replication recombination and repair 133 3.43
B Chromatin structure and dynamics 3 0.08
D Cell cycle control cell division chromosome partitioning 33 0.85
Y Nuclear structure 0 0
V Defense mechanisms 69 1.78
T Signal transduction mechanisms 206 5.32
M Cell wall/membrane/envelope biogenesis 209 5.39
N Cell motility 134 3.46
Z Cytoskeleton 0 0
W Extracellular structures 0 0
U Intracellular trafficking secretion and vesicular transport 43 1.11
O Posttranslational modification protein turnover chaperones 138 3.56
C Energy production and conversion 165 4.26
G Carbohydrate transport and metabolism 163 4.21
E Amino acid transport and metabolism 222 5.73
F Nucleotide transport and metabolism 62 1.6
H Coenzyme transport and metabolism 114 2.94
I Lipid transport and metabolism 97 2.5
P Inorganic ion transport and metabolism 157 4.05
Q Secondary metabolites biosynthesis transport and catabolism 45 1.16
R General function prediction only 335 8.65
S Function unknown 296 7.64
X No functional class found 865 22.5
300 L. Presta et al. / Research in Microbiology 168 (2017) 293e305
and 1-aminocyclopropane-1-carboxylate (ACC) deaminase
activity. Therefore, the Rheinheimera sp. EpRS3 genome was
investigated for the presence of genes involved in such
metabolic abilities. Nodulation-related genes (nod) and several
siderophore encoding genes have been detected. Also, data
obtained revealed the absence of genetic elements related to
ACC deaminase biosynthesis; moreover, the Rheinheimera sp.
EpRS3 genome did not encounter the in silico criteria neces-
sary to be considered a diazotroph (i.e. the co-presence of
nifHDKENB genes in its genetic makeup [37]). On the other
hand, we detected genetic traits responsible for production of
enzymes involved in IAA biosynthesis (i.e. indole-3-
acetaldehyde dehydrogenase (IpyA/TAM), indole-3-pyruvate
decarboxylase (IpyA), tryptophan monooxydase (IAM),
Table 4
Inhibition level of the Rheinheimera sp RS3 (tester) versus a panel of 30 Bcc members (target), 6 A. baumannii and 11 K. pneumoniae. The numbers indicate the
different inhibition level from 0 to 3 as: complete (3), strong (2), weak (1), and absent (0). Abbreviations: E, Environmental; A, Animal Infection; CF, Cystic
Fibrosis, C, Clinical. Plates with and without septum.
Target Tester strain Inhibition level
Position
on plate
Species Strain Without Septum With septum
1 B.ambifaria LMG 19182
Rheinheimera sp. EpRS3
2 2
2 B. anthina LMG 20980 2 2
3 B. arboris LMG 24066 1 0
4 B. cenocepacia LMG 16656 3 3
5 B. cepacia LMG 1222 0 0
6 B. contaminans LMG 23361 1 1
7 B. diffusa LMG 24065 1 0
8 B. dolosa LMG 18943 1 1
9 B. lata LMG 22485 1 1
10 B. latens LMG 24064 2 3
11 B. metallica LMG 24068 0 0
12 B. multivorans LMG 13010 1 1
13 B. pseudomultivorans LMG 26883 0 0
14 B. pyrrocinia LMG 14191 0 0
15 B. seminalis LMG 24067 0 0
16 B. stabilis LMG 14294 1 1
17 B. ubonensis LMG 20358 0 0
18 B. vietnamiensis LMG 10929 1 1
19 B. cenocepacia FCF 12 3 3
20 B. cenocepacia FCF 13 3 3
21 B. cenocepacia FCF 14 3 3
22 B. cenocepacia FCF 15 3 3
23 B. cenocepacia J2315 3 2
24 B. cenocepacia FCF 18 3 2
25 B. cenocepacia FCF 19 3 2
26 B. multivorans FCF 5 3 1
27 B. multivorans FCF 6 3 1
28 B. multivorans FCF 7 3 0
29 B. multivorans FCF 8 3 0
30 B. multivorans FCF 9 3 0
1 A. baumannii RHU 134 Rheinheimera sp. EpRS3 0 e
2 A. baumannii RHU 875 0 e
3 A. baumannii ATCC17978 0 e
4 A. baumannii O8C29 0 e
5 A. baumannii N5O 3 e
6 A. baumannii YMCR363 3 e
1 K. pneumoniae BO 1 Rheinheimera sp. EpRS3 0 e
2 K. pneumoniae BO 4 1 e
3 K. pneumoniae B1 0 e
4 K. pneumoniae B2 1 e
5 K. pneumoniae ATCC 700603 0 e
6 K. pneumoniae KP397 0 e
7 K. pneumoniae KP477 0 e
8 K. pneumoniae KPC249 0 e
9 K. Pneumoniae KPC261 0 e
10 K. pneumoniae KPC284 1 e
11 K. pneumoniae NTUHK2044 0 e
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tryptophanase). Colorimetric assay to estimate production of
IAA was performed as described in Section 2 to confirm in
silico data; tests gave positive results (OD530 ¼ 0.225). On this
track, we decided to investigate whether IAA production by
the Rheinheimera sp. EpRS3 strain could affect plant growth,
as already reported for several endophytic strains in different
plant systems [36,38], or whether, inside the plant rhizosphere,
such ability is not expressed. Hence, we monitored elongation
of primary roots of a test plant, namely N. tabacum cv. Xanthi,
after inoculation with Rheinheimera sp. EpRS3 cells. As
described in Section 2, we used the dual culture vertical agar
plate approach previously used in other systems by other au-
thors [38]. Results on the effect of different concentrations of
indole acetic acid (IAA) on inhibition of the length of primary
roots in N. tabacum seedlings after 7 days of treatment are
shown in Supplementary Material SM1. Data obtained
revealed that different concentrations of IAA induce a sig-
nificant decrease ( p < 0.001), compared to the control in
primary root length of N. tabacum seedlings in a dose-
dependent manner. In particular, inhibition of primary root
length seemed to be strongly affected by the distance of the
inoculated paper disc from the seedlings. In fact, seedlings
grown at a distance of more than 2 cm (>2 cm) from the paper
disc showed a lower decrease in root elongation in contrast to
seedlings placed within 2 cm (<2 cm) of the disc. In detail,
statistical analysis showed p values, respectively, of <0.01 for
treatment of plants with 200 mM IAA and p < 0.05 for plants
subjected to 20 mM IAA (SM1). The same trend was observed
after 14 days of treatment, in this case differences between the
two groups of plants (>2 cm or <2 cm) were not significant
(data not shown). The effect of bacterial inoculations of to-
bacco seedlings with either E. coli, both DH5a (known IAA
overproducer used as control) or Rheinheimera sp. EpRS3
strains, was to inhibit primary root elongation, with E. coli
DH5a having a higher activity than Rheinheimera sp. EpRS3
(see Supplementary Material SM2, SM3). In particular, the
inoculation with DH5a cells or culture filtrate registered a
significant (respectively p < 0.01 and p < 0.001) decrease of
root elongation compared to the control. The same was true
only in the case of culture filtrate ( p < 0.01) of Rheinheimera
sp. EpRS3 strain. For both the strains we have not observed
Fig. 3. Distribution of Rheinheimera genus, core, 1 accessory and unique gene plot according to COG functional category. Abbreviations: A, RNA processing and
modification; B, chromatin structure and dynamics; C, energy production and conversion; D, cell cycle control cell division chromosome partitioning; E, amino
acid transport and metabolism; F, nucleotide transport and metabolism; G, carbohydrate transport and metabolism; H, co-enzyme transport and metabolism; I, lipid
transport and metabolism; J, translation ribosomal structure and biogenesis; K, transcription; L, replication recombination and repair; M, cell wall/membrane/
envelope biogenesis; N, cell motility; O, post-translational modification protein turnover chaperones; P, inorganic ion transport and metabolism; Q, secondary
metabolites biosynthesis transport and catabolism; R, general function prediction only; S, function unknown; T, signal transduction mechanisms; U, intracellular
trafficking secretion and vesicular transport; V, defense mechanisms; W, extracellular structures; X, no functional class found; Y, nuclear structure; Z, cytoskeleton.
Table 5
Gene clusters involved in secondary metabolites biosynthesis in the Rhein-
heimera sp. RS3 genome; the type of secondary metabolite produced and the
number of genes embedded in the clusters are reported.
Biosynthetic cluster Type No. of genes
Cluster 1 Resorcinol 22
Cluster 2 Lantipeptide 12
Cluster 3 Lantipeptide 11
Cluster 4 Hserlactone 9
Cluster 5 Bacteriocin 6
Cluster 6 Nrps 7
Cluster 7 Hserlactone 11
Cluster 8 Bacteriocin 7
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any significant difference between groups of plants classified
as >2 cm or <2 cm (Fig. SM2). Moreover, the treatments of
plants with bacterial suspensions induced changes of primary
root morphology concerning either the increase in root hairs
formations and lateral root induction compared to the negative
control (SM3).
Results concerning both the inhibition of the primary root
elongation and morphological changes of roots of tobacco
seedlings suggested a possible relationship between the IAA
production by Rheinheimera sp. EpRS3 strain and these
growth modifications. Experiments are currently ongoing to
demonstrate a possible role of the strain as plant growth pro-
moting bacteria (PGPB).
3.5. Other phenotypic traits of Rheinheimera sp. EpRS3
Since the ability of some soil bacteria to degrade organic
contaminants is promising for the development of bio-
treatment systems to counteract soil pollution, we analyzed
whether Rheinheimera sp. EpRS3 is able to degrade complex
hydrocarbon molecules or to resist to oxidative stresses, like
those occurring in presence of heavy metals. To this purpose
the Rheinheimera sp. EpRS3 was tested for its ability to grow
on two different minimal media (MMV and MMD), differing
in salt concentration, supplemented with either glucose or
diesel fuel as the sole carbon source. Data obtained revealed
that Rheinheimera sp. EpRS3 was not able to grow on diesel
Fig. 4. Petri dishes of cross-streaking experiments against: A) BCC strains (numbers refer to different organisms from 1 to 10, 11e20, 21e30); B) A. baumannii
strains (numbers refer to different organisms from 1 to 6); C) K. pneumoniae strains (numbers refer to different organisms from 1 to 11).
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fuel as carbon source. The only condition supporting growth
was MMD supplemented with glucose as the sole carbon and
energy source, suggesting the inability to degrade hydrocarbon
compounds. The absence of genes involved n-alkanes degra-
dation (i.e. alk genes) in Rheinheimera sp. EpRS3 genome was
in agreement with the experimental data.
Moreover, since plant root tissues can produce reactive
oxygen species (ROS) in response to different stimuli, we
tested the resistance of the strain to oxidative stress by using
hydrogen peroxide or a heavy metal (i.e. zinc, copper, cad-
mium and nickel), revealing that Rheinheimera sp. EpRS3 is
sensitive to zinc, cadmium, nickel and hydrogen peroxide,
while it exhibits a tolerance to low concentrations of CuCl2
(0.25, 0.5 and 1 mM). The genome analysis results, however,
were in disagreement with this conclusion, in that we found a
number of genes (katA, B, C and sodB) involved in the
response to oxidative stress. Indeed, the disagreement between
experiments and genomic analyses is puzzling and prompts for
further investigation. A possible explanation is that heavy
metals may somehow impair the proper expression of these
genes or the functionality of their products. On the other hand,
we have no data regarding the expression of these genes,
which might even be not functional.
Lastly, we performed experimental assays to test whether
EpRS3 is able to secrete enzymes into the extracellular space
in order to hydrolyze macromolecules into constituents that
can be imported for microbial nutrition. Data obtained suggest
that the Rheinheimera sp. EpRS3 strain possesses extracellular
lipases, phospholipase and proteolytic activities, while no
amylolytic activity towards starch has been detected (data not
shown).
In conclusion, the aim of this work was to characterize
newly isolated rhizospheric strain Rheinheimera sp. EpRS3,
isolated from rhizospheric soil of the medicinal plant E. pur-
purea, to test its ability to influence plant growth and to syn-
thesize antimicrobial compounds that might be effective
against bacterial human pathogens. For this purpose, a set of
phenotypic parameters was tested and data obtained were
correlated with the gene repertoire of the Rheinheimera sp.
EpRS3 genome. Cross-streaking experiments revealed that
Rheinheimera sp. EpRS3 is able to inhibit growth of different
bacterial pathogens (Bcc, A. baumanni, and K. pneumoniae),
most of which exhibit a multi-drug-resistance phenotype. This
ability was very likely due to the presence of gene clusters
involved in different types of secondary metabolites. However,
it cannot be excluded that some of these molecule are VOCs,
as shown by cross-streaking experiments performed with Petri
dishes harboring a central septum. It is particularly intriguing
that the Rheinheimera sp. EpRS3 strain synthesize molecules
able to “bypass” the resistance of K. pneumoniae and A.
baumanni strains to colistin.
Moreover, in silico analysis indicated the presence in the
genome of various components involved in multidrug-efflux
transporter and cation efflux system biosynthesis, alongside
traits usually responsible for specific resistance.
These data underline how endophytic and/or rhizospheric
bacteria may play an important ecological role inside the host
plant; it is possible that both antibiotic resistance and synthesis
of antimicrobial compounds might help in shaping the struc-
ture of bacterial communities living near or inside the plant, as
recently suggested [4].
If this is so, the possibility that such bacterial strains might
also influence the growth of the host plant should be taken
into account. Data obtained in this work (i.e. the presence of a
gene encoding triptophanase, involved in IAA production, as
well as results from IAA production and effects on plant
growth) are in agreement with this idea. Lastly, it is worth
mentioning that these bacteria may directly synthesize or
influence host synthesis of some bioactive molecules identi-
fied in extracts/essential oils of medicinal plants, as recently
suggested by a work performed on rhizospheric and endo-
phytic bacteria isolated from the medicinal plant Lavandula
angustifolia [39].
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8Metabolic modeling
The works presented herein offer practical examples about systems-fashion
uses of the genomic data collected through the technology and works cov-
ered in the previous sections of this thesis. The reconstruction of metabolic
models, based on genome annotation, phenotypic data and omics analysis
integration, allowed for systems analysis of a human- and a plant-pathogenic
strain, respectively Acinetobacter baumannii ATCC 19606 and Pectobacterium
parmentieri SCC3193. Thanks to such in silico methods, functional data may
be derived at the systems level allowing hypothesis drawing and tests.
A. baumannii is an opportunistic, multi-drug resistant, bacterial pathogen
associated with a large number of deadly infections. The therapeutic solu-
tions are very few and strains able to resist also to the last-line antibiotic
treatment (colistin antibiotic) have been reported. New antimicrobial agents
and/or strategies are urgently required to control A. baumannii infections
and to eradicate antibiotic resistant strains from affected patients. However,
the traditional approach to the study of this organism keeps failing these
fundamental goals. To address new possible solutions, a system-level study
of antibiotic-response in A. baumannii is required. In the work attached to
this chapter, computational metabolic modeling offered a relatively quick and
effective method to identify valuable and non-trivial potential drug targets
in A. baumannii. After reconstructing the genome scale metabolic model of
the type strain ATCC 19606, the system-level metabolic consequences of A.
baumannii exposure to colistin were explored through integration of gene
expression data in that condition [1]. The analysis revealed the metabolic
reprogramming occurring in this strain following the establishment of the
stressful condition and offered a glimpse on gene essentiality (EG). The
last being pretty relevant. The identification of EGs, in fact, is one of the
key-steps in a drug discovery pipeline (see Figure 8.1). In the case study,
it was achieved by simulating genome-scale gene knock-out in multiple,
specific conditions. At a first stage different, environmental niches were
simulated by changing the set of available nutrients. Thereafter, increasingly
demanding situations, like antibiotic exposure and mutations, were intro-
duced in the model (using available expression data in similar conditions, for
instance). The different scenario tested were useful to recognize both general
and condition-specific EGs [2]. The formers are required to sustain life un-
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Fig. 8.1: A: The classic drug discovery pipeline. B: The use of mathematical model-
ing may abbreviate the identification of drug targets.
der virtually all growth bottom line; conversely, under specific constraints,
changes of central metabolism may occur, leading either to a variation in
flux distribution throughout the network and to noise in gene essentiality.
For example, testing the system in two different media (one rich and one
minimal), highlighted how nutrients availability affects cell metabolism and,
interestingly, how different environmental pressures influence gene essen-
tiality. Particularly, 67 genes were predicted to be indispensable under both
the tested growth conditions, while 71 are prone to become like that only
when limited nutrients availability force the cell to reprogram its metabolic
behavior. Similar trends have been obtained mapping expression records on
the network (i.e. up-regulation and down-regulation genes ratios) on a nor-
mal and on LPS- version of the model (deficiency of lipopolysaccharides leads
to colistin resistance). Beside each singularity of gene expression patterns
found, one of the significant outcome emerging from the work is that the
genes designated to be EGs are likely to be conserved at the A. baumannii
species level. The general trend observed was that more than 90% of the
genomes scanned (i.e. all the 1099 A. baumannii genomes sequenced to date)
possessed the searched queries (EGs sequences with identity treshold > 30%).
Also, the analysis shows that this tendency is kept almost unchanged even
when imposing values of identity threshold up to 90%. Although these genes
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may not be essential in other strains, this preliminary result is encouraging,
since it expresses the possibility that the target genes indicated for A. bau-
mannii ATCC 19606 are probably common targets in most of A. baumannii
type infections. A second evidence to pinpoint is the one emerging from
the comparison of data obtained through metabolic modeling approach and
wet-lab experiments. This in fact, largely supports the strength of metabolic
modeling performances. The results yielded by the study in fact, stand out
for comprehensiveness, highly predictive power and quick response (in the
order of seconds) while the classic expensive and laborious experimental
gene knock-out assays lack wide coverage and, sometimes, reproducibility.
The second metabolic reconstruction features the assessment of metabolic
adaptation in P. parmentieri SCC3193. The strain causes severe crop diseases
worldwide and has been included among the 10 most important bacterial
plant pathogens based on economic impact [3]. To develop new preventive
strategies against the spread of plant infections and to perform sustainable
agriculture, an understanding of host-microbe interactions is crucial. This
interplay is connected with the complexity of the environment in which bac-
teria persist: soil, rhizosphere or plant tissues. Constraint-based metabolic
modeling provides an engaging way to investigate the adaptation to different
ecological niches and may give insights into the metabolic versatility of plant
pathogenic bacteria. Given that, a metabolic model of the strain was first
reconstructed and extensively manually curated. High-throughput Phenotype
Microarrays data were used to asses model’s performances and accuracy.
After, by means of flux balance analysis, the metabolic adjustment to soil
and rhizosphere were predicted. These two different ecological niches were
chosen as they are relevant for both the bacterium persistence and the plant
colonization.
The simulation of environmental switch modified the flux of about 20% of
the reactions embedded in the network. Moreover, a shift in sugars utiliza-
tion was observed: from pentose phosphate and hexose to amino sugars
metabolism, which are supposed to be more abundant in rhizosphere [4].
This shows an inherent robustness of the metabolic network, which can easily
accommodate for nutrient variability when moving from soil to rhizosphere.
Such robustness may imply that several, still unknown, plant species (to-
gether with their soil and rhizosphere) can be a reservoir for this pathogenic
bacterium. Genome-scale gene deletions provided evidence for the presence
of a compact core of essential genes in P. parmentieri that could explain
why bacteria of this species are able to persist on plant residuals without
interacting with host plant for long periods of time.
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Constraint-based modeling 
identifies new putative targets to 
fight colistin-resistant A. baumannii 
infections
Luana Presta  1, Emanuele Bosi1, Leila Mansouri1, Lenie Dijkshoorn2, Renato Fani1 & Marco 
Fondi1
Acinetobacter baumannii is a clinical threat to human health, causing major infection outbreaks 
worldwide. As new drugs against Gram-negative bacteria do not seem to be forthcoming, and due to 
the microbial capability of acquiring multi-resistance, there is an urgent need for novel therapeutic 
targets. Here we have derived a list of new potential targets by means of metabolic reconstruction and 
modelling of A. baumannii ATCC 19606. By integrating constraint-based modelling with gene expression 
data, we simulated microbial growth in normal and stressful conditions (i.e. following antibiotic 
exposure). This allowed us to describe the metabolic reprogramming that occurs in this bacterium 
when treated with colistin (the currently adopted last-line treatment) and identify a set of genes that 
are primary targets for developing new drugs against A. baumannii, including colistin-resistant strains. 
It can be anticipated that the metabolic model presented herein will represent a solid and reliable 
resource for the future treatment of A. baumannii infections.
Bacteria of the genus Acinetobacter were long considered harmless, environmental organisms, but from the 1960s 
onward, an increasing number of reports have documented the emergence of Acinetobacter strains of this genus 
among severely ill, hospitalized patients. These strains showed unusually high levels of resistance to antibiotics 
that could be used at the time. Also, they gave rise to cross-infections and outbreaks among patients1. Recently, 
resistance to antibiotics in A. baumannii has risen to worrisome proportions (as reviewed in ref. 2), from sus-
ceptible prior to the 1960s, to multidrug-resistant (MDR) (end 1970s), and extended- and pan-drug resistant 
(XDR, PDR) today. Currently, A baumannii is one of the most prominent organisms that are both antibiotic 
resistant and involved in health associated infections, the so-called ESKAPE organisms (that include Enterococcus 
faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and 
Enterobacter spp.3).
One of the last-line treatments for MDR A. baumannii is colistin, a positively charged molecule that, by 
interacting with the lipid A moiety of lipopolysaccharide (LPS), causes disorganization of the outer membrane. 
Unfortunately, colistin resistance in A. baumannii has also been reported, thus highlighting the urgency of finding 
new molecules to face this threat4. Although careful monitoring, antimicrobial stewardship and measures to pre-
vent spread in health care institutions are important for controlling A. baumannii infections, new antimicrobial 
agents and/or strategies are urgently required to eradicate antibiotic resistant strains from affected patients.
To address new possible solutions, a system-level study of antibiotic-response in A. baumannii is required. 
Metabolic network reconstruction and its conversion to a mathematical framework has become a cornerstone 
for studying the systems biology of metabolism5, allowing the examination of the connection between pheno-
type and genotype and driving biological discoveries. In particular, constraint-based tools (such as Flux Balance 
Analysis, FBA) enable the estimation of the rate that metabolites’ flow through a metabolic network and to com-
pute cellular phenotypes for various growth conditions6. Interestingly, by identifying those genes whose dele-
tion is predicted to impair cellular growth, this in silico technique can be used to predict essential genes (EGs) 
at a genome-scale. Following a metabolic modelling approach, several EGs datasets have already been derived 
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for important pathogens such as Helicobacter pylori7, Pseudomonas aeruginosa8, Mycobacterium tuberculosis9, 
and Staphylococcus aureus10. Usually, such predictions are performed simulating growth in an arbitrarily defined 
medium, accounting for the main nutrients used by the microbe and without imposing any additional constraint 
to the model. Indeed, the search space of essential genes predicted can be narrowed by imposing additional 
constraints on the model. One possibility consists of modulating the flux admissible across each reaction on the 
basis of the expression values of the corresponding genes. By doing so, it is possible to generate context-specific 
models that reflect the actual set of reactions employed11. This approach promises to reduce i) the gap between 
the predicted and real cellular metabolic landscapes, and ii) the number of false positives/negatives in EGs pre-
dictions. Additionally, it might reveal hints for the synergistic use of antibiotics and, in particular, to the possible 
additional targets that might arise from the adaptation/response of a microbe’s metabolism to a single antibiotic. 
Indeed, changes in gene expression might redirect the cellular metabolic fluxes in such a way that novel and 
untapped essential reactions may emerge, representing good candidates for a synergic antibiotic. Despite that the 
use of antibiotics in combination is sometimes questionable, this approach can be considered in cases of severe 
infections and it has been shown to be effective in the case of Pseudomonas and Acinetobacter spp.12, 13.
Here, we explored the system-level metabolic consequences of A. baumannii exposure to colistin. We inte-
grated gene expression data during exposure to colistin14 with a newly reconstructed genome scale metabolic 
model, allowing for constraint-based modelling of the type strain ATCC 19606. Our data revealed the metabolic 
reprogramming that occurred in this strain following the establishment of a stressful condition such as the pres-
ence of an antibiotic. Furthermore, the metabolic reconstruction provided here represents an important resource 
for the future understanding of A. baumannii metabolism and for the detection and identification of novel drug 
targets.
Results and Discussion
Genome-scale A. baumannii ATCC 19606 model is consistent with large scale phenotypic 
data. A preliminary draft reconstruction of the A. baumannii ATCC 19606 metabolic model was obtained 
through the Kbase server (http://kbase.us). This was manually curated as described in Methods. Afterwards, 
we used previously published large-scale phenotypic data15 to validate our reconstruction over a large set of 
experimental tests. Manual curation was performed by comparing FBA outcomes with such auxotrophies data 
(determined through Phenotype Microarray (PM) technology). During this process, the capability of our model 
to represent the observed phenotypes was tested.
Growth rates were firstly estimated in silico in simulated Simmons minimal medium (a standard bacterio-
logical medium that contains only essential inorganic salts) under aerobic conditions by iteratively probing each 
C-source used in PM plates. During these simulations, biomass optimization was selected as the model objective 
function (O.F.). Results of the simulations (either “growth” or “no growth”, i.e. the estimated flux value across bio-
mass assembly reaction) were compared with the activity directly measured during an experimental phenotype 
microarray experiment, and discrepancies identified between the in silico and experimental data were manually 
adjusted as possible (such as by filling in missing transport reactions or metabolic gaps).
Following this procedure, we reached an overall agreement of about 84% between the in silico and experimen-
tal data: out of the 67 in silico screened metabolites, 24 were correctly found to be carbon and energy sources for 
A. baumannii ATCC 19606 (true positives) and 32 not (true negatives) while only 10 disagreements remained, 
5 false negatives and 5 false positives. All data are briefly summarized in Fig. 1, and a detailed description of the 
outcomes of the comparison is reported in Supplementary Material S1, Supplementary Table 1.
The current version of the A. baumannii ATCC 19606 genome-scale metabolic model (named iLP844 accord-
ing to the current naming convention16) contains 1628 reactions (162 exchange reactions), 1509 metabolites, 
Figure 1. Comparison between in silico and wet-lab experimental outcomes.
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and 844 genes (~23% of all ORFs present in this organism, see Supplementary Material S2). Importantly, this 
proportion is comparable with the coverage of Escherichia coli K12 model, iAF126017 (27%), A. baylyi ADP1 
model, iAbaylyi18 (22%), and A. baumanni AYE model, AbyMBEL89119 (17%). A COG classification of all the 
genes embedded in the model is provided in Table 1. The final A. baumannii ATCC 19606 model is available 
as Supplementary Material in SBML validated format and embedding cross-references to several databases 
(Supplementary Material S3).
Constraint-based modelling identifies metabolic EGs. As already mentioned, the identification of 
EGs is one of the key-steps in a drug discovery pipeline. Indeed, both general and condition-specific EGs can be 
distinguished20. The formers are required to sustain life under virtually all growth conditions; conversely, under 
specific constraints, changes of central metabolism may occur leading not only to a change in flux distribution 
throughout the network, but also to  changes in gene essentiality and to the appearance of condition-specific 
essential genes. Hence, we systematically evaluated relevant switches in both unconstrained and constrained 
models (different scenarios), by imposing the necessary constraints to the metabolic reconstruction. Accordingly, 
screens for EGs were performed for multiple specific conditions: starting by simply changing the set of available 
nutrients (i.e. simulating different environmental niches) and then by simulating stressful situations such as anti-
biotic exposure and mutations (using available expression data in such conditions).
Nutrient availability influences identified metabolic Egs. As we were interested in modelling the system in a 
gradually constrained manner, we initially simulated an arbitrary rich medium, allowing our model to have vir-
tually all the nutrients needed – as likely happens inside of a host19. To do so, we set the lower bound of exchange 
reactions as described in methods. Then we performed in silico gene deletions for each gene in the model. 
Accordingly, each gene was defined as essential if its elimination destroyed the network’s ability to synthesize at 
least one key biomass molecules (i.e. the model predicts no-growth); otherwise, the gene was considered to be 
dispensable. Gene essentiality analysis was performed through both FBA and MOMA approaches (see Methods), 
COG Functional 
Category Description
N. of 
genes
J Translation, ribosomal structure and biogenesis 28
A RNA processing and modification 0
K Transcription 11
L Replication, recombination and repair 21
B Chromatin structure and dynamics 0
D Cell cycle control, cell division, chromosome partitioning 1
Y Nuclear structure 0
V Defense mechanisms 4
T Signal transduction mechanisms 5
M Cell wall/membrane/envelope biogenesis 60
N Cell motility 0
Z Cytoskeleton 0
W Extracellular structures 0
U Intracellular trafficking, secretion, and vesicular transport 0
O Posttranslational modification, protein turnover, chaperones 20
C Energy production and conversion 120
G Carbohydrate transport and metabolism 61
E Amino acid transport and metabolism 182
F Nucleotide transport and metabolism 57
H Coenzyme transport and metabolism 82
I Lipid transport and metabolism 97
P Inorganic ion transport and metabolism 71
Q Secondary metabolites biosynthesis, transport and catabolism 16
R General function prediction only 32
S Function unknown 12
X No Functional Class Found 15
Table 1. Number of genes in the model per COG categories.
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which both lead to the identification of 67 EGs. Fig. 2A shows the values of the ratio between the predicted 
growth rate of the gene knock-out mutant and the wild type strain (GR ratio, see Methods). The complete list of 
EGs and their functions is reported in Supplementary Material S4.
Next, we repeated EGs prediction by simulating growth in a minimal medium (Simmons medium, as defined 
in Supplementary Material S1, Supplementary Table 2). As shown in Fig. 2B, this approach labelled a total of 
138 genes as indispensable for growth in this condition (see Supplementary Material S4 for the complete list). 
Differences emerging from these two simulations highlight how nutrient availability affects cell metabolism 
and, interestingly, how different environmental pressures influence gene essentiality. Particularly, 67 genes were 
predicted to be essential under both the tested growth conditions, while 71 are likely to become essential only 
when limited nutrient availability force the cell to reprogram its metabolic behaviour (i.e. in Simmons medium, 
Fig. 3A).
Figure 2. GRratio value for each gene deletion in rich (A) and minimal (B) media. Blue and red lines represent 
MOMA and FBA predictions, respectively. Please note that, in order to make the analysis more comprehensive, 
also gap-filling genes (i.e. those virtually coding for gap-filling reactions) were included, leading to a total of 
1043 simulated knock-outs.
Figure 3. (A) A venn diagram proportionally showing EGs predicted only in Simmons medium (pink), EGs 
predicted only in rich medium (green), and EGs predicted by both (blue). (B) A venn diagram proportionally 
showing EGs predicted in silico only by iLP844 (pink), EGs obtained only by wet-lab experiment in ATCC 
17978 (green), and EGs predicted by both methods (blue). (C) A venn diagram proportionally showing 
essential reactions predicted in iLP844 (pink), essential reactions predicted only in A. baumannii AYE model 
(AbyMBEL891) (green), and essential reactions predicted by both (blue). (D) A venn diagram proportionally 
showing EGs predicted only in iLP844 (pink), EGs predicted only by wet-lab experiment in A. baumannii 
ATCC 19606 cell (green), and EGs predicted by both (blue).
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Predicted EGs are consistent with available experimental datasets. A large body of data exists concerning A. bau-
mannii gene essentiality. Here we used such information both to validate our EGs prediction and to understand 
whether the identified EGs sets are particular to A. baumannii ATCC 19606.
First we compared the EGs dataset obtained in the arbitrary rich medium to that obtained with an in vivo 
experiment on A. baumannii ATCC 17978 pathogenesis21. By using LB medium (a well-known bacteriological 
rich medium), Wang et al.21 labelled 481 genes as essentials for that strain. However, not all of them were com-
parable with our predictions since a large fraction was neither metabolic or possessed an orthologous gene in 
A. buamannii ATCC 19606. In both cases these genes are absent in iLP844. For the same reason, not all the 67 
EGs found through our simulation were comparable with the reported experiment. After performing all these 
necessary restrictions, we reached the result shown in Fig. 3B, i.e. 42 genes have been predicted to be essential 
by both approaches (in silico and wet-lab) for the two A. baumannii strains considered (Fig. 3B). A complete 
description of these EGs is provided in Supplementary Material S4 and represents an experimentally validated 
dataset in the context of A. baumannii drug target identification. Nevertheless, the two experiments show large 
discrepancies. The most likely reason for such inconsistency is strains genomic diversity, as previously reported 
for E. coli strains22.
Furthermore, our predictions in arbitrary rich medium were compared to those achieved performing the 
same analysis on the AbyMBEL891 model, an existing model of A. baumannii AYE19. In order to implement 
the simulation, it was necessary to perform a preliminary editing step on the AbyMBEL891 model, as the entire 
set of gene-reaction-rules was missing from the main reconstruction file. This difficulty in running the analysis 
highlights the need for a common protocol to be adopted during metabolic reconstruction and a standard to be 
reached in order to facilitate model re-use and data sharing among research groups. Nevertheless, after including 
the genes in the Abymbel891 model, we carried out single gene deletion analysis on both models, as described 
in the methods. As shown in Fig. 3C, 48 genes were predicted to be essential in both models, whereas 18 and 37 
EGs were specific for A. baumannii ATCC 19606 and AYE, respectively. Information about the gene function are 
reported in Supplementary Material S4.
Comparisons were also carried out between our in silico predictions and wet-lab results in minimal 
(Simmons) medium. Specifically, we compared our EGs set to that obtained by Dorsey et al. through insertional 
mutagenesis experiments with A. baumannii ATCC 1960623, where the metabolic deficiency of insertion deriva-
tives was subsequently confirmed, identifying essentiality of 10 disrupted genes. Repeating the assay in silico, our 
model correctly represented the phenotypes of the A. baumannii mutants, with 8 out of the 10 genes predicted 
as essential by Dorsey and colleagues also shown to be essential in iLP844 (Fig. 3D, Supplementary Material S4). 
Additionally, in 6 out of the 7 cases, A. baumannii ATCC 19606 model growth was correctly restored (as done in 
the corresponding wet-lab experiments) by adding to the minimal medium the metabolite(s) whose production 
was affected by the mutation.
Antibiotic treatment defines condition-specific models. Although a large fraction of the predic-
tions was supported by previous experimental data, a possible source of error, using the methodology described 
above, stems from the observation that not all the reactions of the model will be active during growth in a given 
physiological condition. In particular, changes in gene expression are likely to influence the activity rate of the 
corresponding cellular metabolic reactions, leading to the observation that a given reaction can be considered 
‘turned on’ or ‘off ’ on the basis of the expression levels of the encoding gene(s). Using available computational 
methodologies, it is possible to modulate the flux across each reaction on the basis of the expression values of the 
corresponding genes. This permits to take a picture of the current metabolic state and tightening up the predic-
tive capabilities of the model itself. Accordingly, as the dynamic changes of metabolic reprogramming are likely 
mirrored by changes in gene essentialities, a possible solution for avoiding or reducing false positives is to merge 
transcriptomics data of the tested scenario into the genome-scale model.
Arguably, one of the most interesting physiological conditions of A. baumannii strains is the exposure to 
antibiotics and to colistin in particular14. Importantly, both the (metabolic) consequences and the occurrence of 
targets to be used in a synergic treatment are, currently, almost untapped. In order to study the dynamic changes 
of the metabolic network following antibiotic exposure and to derive a more realistic picture of gene essenti-
ality patterns in a real scenario (antibiotic treatment), we used available transcriptomic data for A. baumannii 
ATCC 19606 in response to colistin treatment14. Up-regulation and down-regulation ratios (and correspond-
ing P-values) of genes were combined with the iLP844 by using MADE (Metabolic Adjustment by Differential 
Expression)24. Briefly, MADE uses statistically significant changes in gene expression measurements to determine 
binary expression states (highly and lowly expressed reactions) i.e. reactions are turned on and off depending on 
the changes in mRNA transcript levels. Thus, by mapping gene expression data into the model, the in silico meta-
bolic predictions are more consistent with the actual physiological state of the cell.
In the experiment by Henry et al.14, A. baumannii was grown in two different media, i.e. with and without 
2 mg/L of colistin, and then sampled at 15 and 60 minutes after exposure. Following the described approach, we 
integrated the available transcriptomic data regarding all the metabolic genes embedded in our in-silico recon-
struction (i.e. about 80 genes). Accordingly, we obtained four distinct models, each representing the predicted 
functional metabolic state of the cell at both 15 and 60 minutes, treated and untreated with colistin. These models 
differ in that some of their reactions are (completely) ‘turned on’ or ‘off ’ according to the measured levels of their 
corresponding genes. Afterwards, optimization of the four models was performed, allowing the analysis of flux 
distribution in the network and the occurring metabolic reshape.
Colistin exposure changes predicted metabolic fluxes in central A. baumannii pathways. In 
order to highlight changes in the overall metabolic behaviour and to identify changes on the metabolic rewiring 
occurring after antibiotic exposure, we compared flux distributions at the two time-points by calculating the flux 
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ratio (RFratio, see Methods) of treated vs. untreated models, for all the reactions. However, FBA only provides one 
of the possible optimal solutions out of many alternative (and feasible) cellular flux distributions. Hence, in order 
to correctly predict metabolic changes following antibiotic exposure we restricted the feasible solution space by 
performing Flux Variability Analysis (FVA)25. This approach allows estimating the minimum and maximum flux 
admissible across each reaction (under the same constraints as in FBA) and hence it can be used to estimate the 
correctness and accuracy of FBA predictions (see Methods).
As shown in Supplementary Material S5, according to FVA, the range of admissible flux is sometimes very 
large (spanning from the minimum −1000 to maximum 1000 mmol/g*h−1 in some cases), revealing the lack of 
accuracy in some of FBA-derived predictions. We here used FVA outcomes (as described in Methods) to filter out 
those reactions whose fluxes display little variation. In other words, each reaction was considered for downstream 
analyses only if both the maximum and minimum FVA predicted fluxes did not differ from the FBA predicted 
flux by more than 20%. Consequently, we were left with 901 reactions at 15 minutes and 970 reactions at 60 min. 
It is worth noting that several intervals of admissible flux ranges were tested and we report in Supplementary 
Materials S1, Supplementary Figure 1 the number of reactions filtered for each set of intervals. After carrying out 
this preliminary step, we observed the effects of the treatment at the metabolic level (for each reaction) by com-
paring the flux values in the untreated vs. treated condition.
Both qualitative and quantitative flux changes were analysed by dividing the reactions into three categories 
(‘steady’, ‘increasing’, and ‘decreasing’, see Fig. 4) according to their trends in the examined experimental condi-
tions. Also, we report a survey of the pathways in which they are involved in and their relative abundance for each 
category. Reactions’ fluxes were considered ‘steady’ if their values did not change in the two conditions, otherwise 
they were defined to be ‘increasing’ or ‘decreasing’ according to the corresponding trend.
As shown in Fig. 4, at both 15 and 60 min time-points there is an increase in flux in most of the reactions. 
Interestingly, such change in flux mainly occurs in three biosynthetic pathways: fatty acid, peptidoglycan, and 
lysine biosynthesis. On the other hand, under the given constraints, there is a change in flux in some catabolic 
pathways (mainly involved in sugars and nucleotide metabolism). In our opinion, such a finding could be related 
to the rearrangement of the external membrane layer, a well-known effect of colistin treatment. If this is true, it is 
possible that the cell reacts to the antibiotic treatment by trying to repair the damage established by colistin while 
at the same time redirecting a certain amount of LPS components to catabolic processes.
Also, we would like to point-out that, although a down-regulation of certain genes involved in fatty acids 
biosynthesis was detected by Henry et al., here our data suggest that it does not necessarily imply a turning-off of 
the pathway. On the contrary, in our simulation fatty acid biosynthesis registers an increase in flux, probably as a 
side-effect of LPS disassembly as stated above.
Figure 4. Abundance plot of reactions affected by colistin treatment at 15 (blue) and 60 (pink) minutes 
arranged according to three categories: ‘steady’, ‘increasing’, ‘decreasing’. Pathways which they belong to are 
reported.
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Colistin exposure changes gene essentiality patterns. According to the new constraints taken into 
account, gene essentiality was re-evaluated by calculating growth ratios (FBA and MOMA) at both 15 and 60 min-
utes after exposure to colistin. As for the analysis involving nutrient availability, shifts in gene essentiality emerged 
following antibiotic stress. The complete sets of the predicted EGs for each condition have been reported in 
Supplementary Material S4. As with the previous case, we can easily recognize genes likely to be essential in both 
conditions (treated and not) and, more interestingly, genes that emerged as essential only after the treatment. 
Specifically, following 15 minutes of colistin exposure, a total of 87 EGs were predicted: 66 were required both in 
presence and absence of colistin, but an additional 21 EGs were marked as condition-specific: 12 related to the 
non-treated model and 9 related to the treated one, reported in Table 2 and in Fig. 5A.
The same outline has been depicted in the second time-point condition (60 minutes): we identified 12 and 5 
condition-specific EGs in the absence and in the presence of the antibiotic, respectively, see Table 2. Moreover, we 
found the same set of 66 EGs mentioned above (see Fig. 5B), suggesting that this represents a functionally relevant 
set of genes for sustaining growth in A. baumannii ATCC 19606. Interestingly, however, some genes switch from 
the ‘essential’ condition to the ‘non-essential’ one, following the exposure to colistin.
Locus Tag Function
15′ without 
colistin
15′ with 
colistin
60′ without 
colistin
60′ with 
colistin
LPS− 
without 
colistin
LPS− with 
colistin
HMPREF0010_00435 phosphopyruvate hydratase yes no yes no no no
HMPREF0010_00813 fructose-bisphosphate aldolase class II Calvin cycle subtype yes no yes no no no
HMPREF0010_00815 phosphoglycerate kinase yes no yes no no no
HMPREF0010_00975 amino acid ABC transporter periplasmic protein yes no yes no no no
HMPREF0010_01733 PAP2 superfamily protein yes no yes no no no
HMPREF0010_01995 23-bisphosphoglycerate-independent phosphoglycerate mutase yes no yes no no no
HMPREF0010_02140 fructose-16-bisphosphatase yes no yes no no no
HMPREF0010_03273 glucose-6-phosphate isomerase yes no yes no no no
HMPREF0010_00382 phosphotransferase system fructose-specific EI/HPr/EIIA component yes no yes no no no
HMPREF0010_03275 UTP-glucose-1-phosphate uridylyltransferase yes no yes no no no
HMPREF0010_01305 alphaalpha-trehalose-phosphate synthase (UDP-forming) yes no yes no no no
HMPREF0010_01353 glutamine-dependent NAD+ synthetase yes no no no no no
HMPREF0010_00342 ornithine carbamoyltransferase no yes no no no yes
HMPREF0010_00949 malonate decarboxylase epsilon subunit no yes no yes no no
HMPREF0010_01149 acetyl-CoA carboxylase biotin carboxylase no yes no no no no
HMPREF0010_01969 argininosuccinate lyase no yes no yes no no
HMPREF0010_02047 carbamoyl-phosphate synthase large subunit no yes no no no yes
HMPREF0010_02048 carbamoyl-phosphate synthase small subunit no yes no no no yes
HMPREF0010_02972 argininosuccinate synthase no yes no no no yes
HMPREF0010_03445 34-dihydroxy-2-butanone 4-phosphate synthase no yes no no no no
HMPREF0010_00048 sugar kinase no yes no no no no
HMPREF0010_02330 glutamine synthetase type I no no yes no no no
HMPREF0010_01216 quinolinate synthetase complex A subunit no no no yes no no
HMPREF0010_02175 thymidylate kinase no no no yes no yes
HMPREF0010_03295 nicotinate-nucleotide diphosphorylase (carboxylating) no no no yes no no
HMPREF0010_01705 ketol-acid reductoisomerase no no no no yes no
HMPREF0010_00392 ornithine-oxo-acid transaminase no no no no no yes
HMPREF0010_00419 N-acetyl-gamma-glutamyl-phosphate reductase no no no no no yes
HMPREF0010_00840 methionine adenosyltransferase no no no no no yes
HMPREF0010_01215 ArgJ protein no no no no no yes
HMPREF0010_01382 acetylglutamate kinase no no no no no yes
HMPREF0010_01506 methionine synthase no no no no no yes
HMPREF0010_01669 3-methyl-2-oxobutanoate hydroxymethyltransferase no no no no no yes
HMPREF0010_01887 2-heptaprenyl-14-naphthoquinone methyltransferase no no no no no yes
HMPREF0010_01969 argininosuccinate lyase no no no no no yes
HMPREF0010_02002 riboflavin synthase alpha subunit no no no no no yes
HMPREF0010_02344 adenosylhomocysteinase no no no no no yes
HMPREF0010_0275979 glutamate racemase no no no no no yes
HMPREF0010_03444 67-dimethyl-8-ribityllumazine synthase no no no no no yes
Table 2. Complete set of condition specific EGs found. “Yes” and “no” refet to gene essentiality in the 
corresponding condition.
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The two new sets of EGs show how changes in gene expression induced by the presence of the antibiotic might 
influence gene essentiality patterns in the strain ATCC 19606 and provide additional, nontrivial targets for drug 
design in such an organism. We also performed additional robustness analyses in order to test whether nutrients 
depletion occurring in treated and untreated samples during the in vivo experiments could impact the set(s) of 
predicted EGs. Specifically, the robustness of the number of predicted EGs in each of these conditions (i.e. treated 
vs. untreated samples) in respect to possible variations in the medium composition was assessed via random 
permutation. We tested up to 1,000 different nutritional compositions as described in detail in Supplementary 
Material S1, Supplementary Figure 2). The results showed that possible changes in the nutritional environment 
had only minor implications for the set of predicted EGs.
Further, with the aim of discriminating whether the products of all the identified hypothetical EGs are A. 
baumannii specific or have orthologs in Homo sapiens, meaning that they would not represent good candidates 
for antibiotic treatment development, the sequences of the identified potential EGs were used to probe the human 
genome. Based on this BLAST26 search (see Methods), we excluded from further studies those genes presenting 
more than 30% sequence identity with their human counterparts. Targeting of such genes is non-ideal since they 
may cause potential side-effects by perturbing critical components in the human body. All BLAST results are 
reported in Supplementary Material S6.
Among all the queries, we identified 46 (out of 73) general EGs and 4 (out of 12) condition-specific EGs 
that do not have any human orthologous. Thus, the 46 EGs represent valuable targets for further develop-
ment of brand new drugs against A. baumannii ATCC 19606 infections. However, it is relevant to remark that, 
while these 46 general EGs could have been detected in several conditions, the other 4 condition-specific EGs 
are the result of specific constraints integrated in the model (gene expressions data). Hence, as already men-
tioned, they are nontrivial detections and they could represent a suitable horizon in the field of colistin-coupled 
treatment. The four genes, named HMPREF0010_00949, HMPREF0010_02972 and HMPREF0010_03445, 
HMPREF0010_01216 respectively encode a malonate decarboxylase (epsilon subunit), an arginine succinate 
synthase, a 3-4-dihydroxy-2-butanone-4-phopsphate synthase and a quinolate synthase. Interestingly, malonate 
decarboxylase epsilon subunit has already been characterized in the closely related organism Pseudomonas 
putida and labelled as an indispensable component of the enzyme for the cyclic decarboxylation ofmalonate27. 
However, to the best of our knowledge, no therapies targeting this protein have been developed to date. The 
product of 3-4-dihydroxy-2-butanone-4-phopsphate synthase is an intermediate in the biosynthesis of ribofla-
vin. The enzyme requires a divalent cation, preferably Mg2+, to be active. The step becomes essential after colistin 
treatment as the antibiotic is predicted to cause an increase in flux through this pathway, probably following 
the shutdown of other parts of the network due to the down regulation of the corresponding genes. The argi-
nine succinate synthase, is an enzyme catalysing the penultimate step in arginine biosynthesis (urea-cycle): the 
ATP-dependent ligation of citrulline to aspartate in order to form arginino-succinate, AMP, and pyrophosphate. 
The last EGs encodes for a bacterial specific enzyme that catalyses the second step in the de novo biosynthesis of 
NAD+ from aspartate.
EGs in colistin resistant A. baumannii. Up to now, we have presented how metabolic reconstruction and 
mathematical modelling can be used to explore the strain’s metabolic response during colistin treatment and how 
it can lead to the identification of novel potential drug targets. Our last attempt is now to illustrate how, starting 
from the same available experimental data, the model can be employed as a ready-to use blueprint in order to test 
new hypothesis.
As it was reported by Moffatt et al.28, the mechanism responsible for colistin resistance is linked to LPS. 
Specifically, mutations in the lpxA, lpxC, and lpxD genes have been reported as the main cause of LPS loss, thus 
abolishing the initial charge-based interaction with the antibiotic. Hence, to simulate an A. baumannii LPS 
(LPS−) deficient and colistin-resistant strain, we removed this component from the biomass formulation in our 
genome-scale model. Then, to determine which genes are central for the cell’s survival in such a condition, we 
used the transcriptomic data of the mutant strain in the presence/absence of colistin at 60 minutes14 and mapped 
the data onto the new LPS− model. After this, we repeated the EGs prediction pipeline described above.
The analysis yielded a total of 55 and 72 EGs in the untreated and treated condition, respectively. Even in this 
case, the two sets share several elements (54 EGs) that remain mandatory for the cell in the two conditions (listed 
in Supplementary Material S4). Additionally, it is possible to observe that 18 genes become essential (reported 
Figure 5. Venn diagrams proportionally showing EGs predicted only in absence of colistin (pink), EGs 
predicted only in presence of colistin (green), and EGs predicted by both (blue), at 15 minutes (A) and 
60 minutes (B).
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in Table 2) only after antibiotic exposure: 9 of them were already found to be EGs in the wild type strain while 
9 represent specific EGs of the mutant. Since the latter are non-trivial EGs (obtained through gene expression 
integration and introduction of an antibiotic resistance promoting mutation into the model) they have been 
re-used as seed for an additional BLAST search against the human genome (see Supplementary Material S6). 
The search led to the identification of 5 genes that do not have orthologs in humans: HMPREF0010_01215 
encoding for glutamate-N-acetyltransferase (member of the ornithine acetyltransferase, OAT, family), 
HMPREF0010_00419, encoding for N-acetyl-gamma-glutamyl-phosphate reductase, HMPREF0010_01382 
encoding for N-acetyl-L-glutamate-kinase, all of which are involved in the arginine biosynthesis pathway, 
HMPREF0010_0275979 that encodes for a glutamate-racemase and HMPREF0010_02344 that encodes for an 
adenosylhomocysteinase. This group of 4 EGs represents a potential achievement obtained from this work as it 
suggests specific targets to be taken into consideration when developing therapies in combination with colistin in 
an LPS- strain.
Predicted EGs are common in A. baumannii. Finally, we checked the distribution of EGs predicted for the strain 
ATCC 19606 within the entire A. baumannii species. The sets of predicted EGs were searched in all of the 1099 A. 
baumannii genomes sequenced to date, as described in the Methods. The overall result is shown in Supplementary 
Material S1, Supplementary Figure 3. The general trend observed was that more than 90% of the genomes ana-
lysed possessed the searched queries (identity >30%). Also, our analysis shows that this tendency is kept almost 
unchanged even when imposing an identity threshold greater than 50%, 70% and 90%. Accordingly, it can be 
stated that the possible target genes are broadly distributed and their sequence is conserved at the A. baumannii 
species level. Although we do not have any information about the EGs at such a wide level, this preliminary result 
is encouraging, since it expresses the possibility that the target genes we indicated for A. baumannii ATCC 19606 
are probably common targets in most of A. baumannii type infections.
Conclusions
In this work, we have reconstructed and validated a genome-scale metabolic model of A. baumannii ATCC 19606. 
The model is comprehensive and accurate, as it covers ~23% of all CDSs in the genome of this microorganism 
and it was shown to have 84% agreement with Phenotype Microarray growth experiments. Based on the model’s 
reliability, we applied constraint-based modelling to derive a global understanding of the behaviour of this met-
abolic system. By integrating gene expression data with constraint-based modelling we described the metabolic 
reprogramming occurring after colistin-exposure in A. baumannii and the changes in the pattern of gene essen-
tiality during this stress condition. All the sets of condition-specific putative target genes that we propose have 
been compared (and partially validated) with the results obtained from experiments found in the literature. Some 
of these genes, although not yet experimentally validated, might represent primary targets for future research 
on the treatment of both the wild type and LPS-mutant (i.e. colistin resistant) strains. Our results have practical 
implications for the identification of new therapeutics as the identified essential genes can be used in drug-design 
pipelines. Moreover, we showed that the sequences of predicted EGs for the type strain ATCC 19606 are shared 
by most of the members of A. baumannii species, encouraging further research to check whether they are valuable 
drug targets for a larger number of strains than currently known. Finally, it can be anticipated that the iLP844 
model illustrated herein represents a reliable and solid platform for further developments and the system-level 
understanding of the physiology of A. baumannii representatives and for the treatment of their infections.
Methods
Draft model reconstruction. We obtained a draft metabolic model of A. baumannii ATCC 19606 based on 
the genome annotation using Kbase automated reconstruction method (https://kbase.us/)29. This reconstruction 
was then thoroughly inspected and refined by integrating data from additional functional databases (MetaNetX30, 
Bigg31, Seed32, KEGG33). Further integration was performed by searching for orthologous genes (genes likely hav-
ing an identical biological function in a different organism) in closely related organisms (Acinetobacter baumanii 
AYE, Acinetobacter baylyi ADP1, and Escherichia coli) through a BBH (Bidirectional Best Hit) approach (inPara-
noid34). Information regarding transport proteins was obtained probing the Transporter Classification Data Base 
(TCDB35) and transportDB36.
In order to predict proper phenotypes, the general biomass producing reaction of Gram negative bacteria 
automatically generated by Kbase was substituted with a more accurate one that takes into account strain’s specific 
components, which was recovered from the previously reported model of the related strain A. baumannii AYE, 
AbyMBEL89119.
Metabolic modelling. The reconstructed model was analysed using CoBRApy-0.4.1 COnstraints-Based 
Reconstruction and Analysis for Python37 and COBRAToolbox-2.038 in MATLAB® R2016a (Mathworks Inc.). 
Gurobi 6.5.0 (www.gurobi.com) and GLPK 4.32 (http://www.gnu.org/software/glpk/) solvers were used for com-
putational simulations presented. A MATLAB® script to obtain all the results shown in this manuscript is pro-
vided as Supplementary Material S7.
Two growth media were considered during the in silico simulations:
Rich medium. Lower bounds of salts uptake reactions were set to −1000 mmol/g*h−1 in order to mimic 
non-limiting conditions. Carbon sources uptake reactions were set to −100 mmol/g*h−1.
Simmons medium. Lower bounds of all uptake reactions accounting for the nutrients present in Simmons 
medium39 (see Supplementary Material S1, Supplementary Table 2), were set to −1000 mmol/g*h−1, to mimic 
non limiting conditions, only the C-source (citrate) was set to −5.
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FVA. FVA analysis allows the determination of the span of possible flux variability (i.e. the maximum and min-
imum values of all the fluxes that satisfy the given constraints) while keeping the same optimal objective value.
This approach has been used in this work in order to impose bounds to FBA flux predictions (fFBA), which are 
notably non-unique. In fact, for any optimal solution found through FBA there may exist alternate flux distribu-
tion patterns yielding the same growth rate. Hence, the space of reliable FBA-flux predictions has been restricted 
by selecting only those that occur in the interval defined as follows:
< ≥ . ∗ ∧ ≤ . ∗with f 0 f 1 2 f f 0 8 f (1)FBA FVA, min FBA FVA, max FBA
> ≥ . ∗ ∧ ≤ . ∗with f 0 f 0 8 f f 1 2 f (2)FBA FVA, min FBA FVA, max FBA
Gene essentiality and flux ratios calculation. Gene essentiality testing was performed by simulating 
deletion of each gene within the metabolic network and hence setting the associated reactions to carrying no 
flux (according to the corresponding Gene-Protein-Reaction (GPR) rule). To predict the growth of the mutant 
strain and determine the set of EGs, we used two different approaches, FBA and MOMA40. The main difference 
between them is that while the first predicts growth yield and metabolic fluxes based on the biological assumption 
of optimal growth, the second does not assume optimality of growth but approximates metabolic phenotype by 
performing distance minimization in flux space. The second approach has been shown to be more accurate in 
predicting lethal phenotypes40. The knocked-out gene was defined as ‘essential’ according to the results obtained 
computing the ratio (GRratio) between the simulated knocked out strain growth rate (µKO) and the one predicted 
for the wild type strain (µWT). Formulated as:
= µ µGR / (3)ratio KO WT
Following this approach, if GRratio = 0, then the knocked out gene is labelled as essential. Conversely, in case 
GRratio = 1, the removal of the gene has no effect on the growth phenotype. Finally, when 0 < GRratio < 1, the 
deleted gene was labelled as fitness-contributing gene, i.e. its removal partially affects the capability of the cell to 
produce biomass.
As MOMA and FBA predictions may lead to different essential gene sets41, 42, 40, we used both approaches to 
compute essential genes in all the conditions tested in this work. Although no major differences were observed, 
results obtained with both methods are presented throughout the manuscript.
In order to evaluate the range of the change in the carried flux of each reaction in the model following colistin 
exposure, we compute the ratio between the predicted flux in the treated vs. the untreated conditions as follows:
= ϕ ϕRF ( / ) (4)ratio Treated Untreated
Values of RFratio equal to one indicate that no changes in the activity of the corresponding reactions were 
observed when simulating growth in the treated vs. the untreated conditions. Conversely, values of RFratio between 
0 and 1 or values greater than 1 will indicate a reduced or increased activity of the corresponding reactions in the 
treated condition, respectively. Finally, negative values of RFratio will indicate those reactions whose directionality 
is predicted to change after the treatment.
Transcriptomics data integration and data visualization. In order to add transcriptional regula-
tory rules to the metabolic model, we imported the model from COBRA Toolbox into TIGER-1.2.0 0 (Toolbox 
for Integrating Genome-scale metabolism, Expression, and Regulation) framework (12). Then, the up- and 
down-regulation ratios of gene expression were mapped into the A. baumannii ATCC 19606 metabolic model 
by using MADE (Metabolic Adjustment by Differential Expression)24. The program uses significant statistical 
changes in gene or gene expression to create functional metabolic models. By adopting an optimization approach 
that applies Boolean rules, MADE connects reactions to the binary expression states of associated genes. The four 
arrays of genes to be switched-off yielded by MADE have been reported in Supplementary Material S8.
EGs BLAST searches in H. sapiens and A. baumannii species. Protein sequences of the correspond-
ing EGs found in A. baumannii ATCC 19606 were probed against the human proteome to test their validity as 
potential drug target in infections with this pathogen, i.e. to exclude any cross-interactions between the drug used 
for the treatment and human proteome elements.
Queries were aligned to the protein sequences of H. sapiens using the default search parameters of the NCBI 
BLASTP online tool (BLOSUM62 matrix and gap costs equal to Existence 11, Extension 1). Results were consid-
ered positive (orthologous sequences found) if their sequence identity score value was equal to/greater than 30.
In addition, the global distribution of EGs was evaluated at the A. baumannii species level by probing them 
against all of sequenced genomes retrieved at NCBI ftp site, i.e. 1099 genomes. Particularly, the focus was centred 
on EGs found in Simmons medium and in rich medium, as well as for those found after 15 and 60 minutes of 
colistin exposure. BLAST search parameters and analysis of the results were performed as described above.
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ABSTRACT
Understanding the plant-microbe interactions are crucial for improving plant productivity and plant protection. The latter aspect
is particularly relevant for sustainable agriculture and for development of new preventive strategies against the spread of plant
diseases. Constraint-based metabolic modeling is providing one of the possible ways to investigate the adaptation to different
ecological niches and may give insight into the metabolic versatility of plant pathogenic bacteria. In this study, we present a
fully curated, through high-throughput phenotype testing with Phenotype MicroarraysTM, a metabolic model of the emerging
plant pathogenic bacterium Pectobacterium parmentieri SCC3193. The produced model includes: 1245 genes (covering
approximately 28% of the all coding sequences in the genome), 2182 reactions, and 2080 metabolites. By means of flux
balance analysis (FBA), we predict the metabolic adaptation to two different ecological niches, relevant for the persistence
and the plant colonization by this bacterium: soil and rhizosphere. We also performed in silico gene deletions to predict the
set of core genes essential for this bacterium to grow in laboratory minimal medium, soil and rhizosphere. The changes of
environmental conditions modified the flux of about 10% of the reactions embedded in the model. Nearly 20% of genes were
designated essential (251 in M9 medium, 250 in soil and 245 in the rhizosphere). Most of these essential genes were shared in
the three environmental conditions. However, ten of these genes resulted fundamental in one or two conditions only, suggesting
the presence of specific genes for metabolic adaptation. We anticipate that our metabolic model will be a valuable element for
defining a set of metabolic targets to control infection and spreading of this plant pathogen and a scaffold to interpret future
-omics datasets for this bacterium.
Introduction
Plant-bacteria interplay have been studied over long periods of time, mainly in terms of pathogenic and beneficial (symbiotic)
interactions. Various details are now known concerning the molecular basis of such interactions1. For example, biological
studies of plant pathogenic bacteria allowed understanding the modulation of bacterial recognition by the plants and revealed
important aspects of plant immune responses2. Furthermore, additional investigations have confirmed that plant pathogenic
bacteria exploit high flexibility in utilization of different kinds of sugar, nitrogen and phosphorus resources while adapting to
the new environment, e.g. bacterial plant pathogen Pseudomonas syringae pv. Tomato specifically employs amino acid and
sugar transporters to gain access to nutrients present in its environment. Subsequently, during infection processes of tomato
plant, P. syringae pv. Tomato uses resources within the host, specifically from apoplast fluid3.
In order to access the nutrients present in the plant tissues, pathogenic bacteria colonize, invade and, later on, establish chronic
infections within host plants. During the infection process, they enter plant tissues either through wounds or natural openings
and occupy the apoplast of tissues or the xylem, where they multiply and spread. Notably, phytopathogenic microorganisms
cause damage and often impair plant growth and reproduction. On the other hand, to defend themselves against microbiological
invasion, plants rely on two kinds of innate immunity, i.e. via pathogen triggered immunity (PTI)4 and effector-triggered
immunity (ETI).
Hence, to achieve a compatible interaction, microorganisms at first need to overcome plant’s defenses that could abort the
infection. Plant pathogenic bacteria, like Pectobacterium parmentieri, combine numerous strategies to accomplish that goal, e.g.
they rely on quorum sensing system, hence the probability of weakening of plant defenses is higher due to high quantity of
bacteria in plant environment5. P. parmentieri is a pectinolytic, bacterium belonging to Pectobacteriaceae family (known as
Soft Rot Pectobacteriaceae, SRP)6. It is a newly established species due to the transfer of all potato-originating isolates of
Pectobacterium wasabiae to P. parmentieri sp. nov. (Ppa) on the basis of in-silico calculated DDH, gANI, and ANI values7.
These Gram(-), rod-shaped bacteria are necrotrophs, that are able to destroy plant tissue components through the activity
of PCWDE such as pectinases, cellulases, and proteases, further secreted via Type I or II secretion system8, 9. Nonetheless,
bacteria belonging to this species can exhibit a different level of activities of above-mentioned enzymes10. Pectinolytic bacteria,
and among them P. parmentieri, require favorable environmental conditions to cause disease symptoms; however, they can
reside inside plant tissues as endophytes for a long time11. Bacteria from the genus Pectobacterium are causative agents of
soft rot in economically important crops such as potato, tomato or maize. Also, they are responsible for the blackleg disease,
so far reported only on potato plants11, 12. It is worth to mention that bacteria from the genus Pectobacterium have been
included among 10 most important bacterial plant pathogens based on their economic impact13 since crop losses caused by
phytopathogenic microorganisms can reach up to 20% of total yield14. There is still limited knowledge regarding cascade of
genes being expressed before and during infection process in P. parmentieri. It was previously reported, that initialization
of infection progress is controlled by quorum sensing in closely related Pectobacterium atrosepticum15. Moreover, massive
production of butanediol during plant infection by bacteria of the genera Dickeya and Pectobacterium was reported16. However,
metabolic pathways important for promoting bacterial multiplication before and during plant infection connected with carbon
and other compounds utilization in P. parmentieri have received little attention so far. Given the complexity of bacterial-host
relationships, they cannot be adequately investigated only by means of classical microbiological and molecular methods; rather,
the coupled use of Phenotype MicroarraysTM, computational, large-scale and systemic frameworks are advisable. Metabolic
modeling is now a promising way to interpret puzzling, heterogeneous bacterial phenotypes17, especially those related to
bacterial-host interaction18. Constraints-based approaches, and in particular Flux Balance Analysis (FBA)19 have been shown
to be accordingly predict growth phenotypes and are claimed to provide a systems biology view on multi-omics data, possibly
allowing to predict physiological changes and evolution of bacterial populations20, 21. Recently, genome-scale metabolic model
(GEM) reconstruction and FBA have been used for deciphering the metabolic adaption of environmental microbes following
ecological parameters variation22, ecological niche shift23, as well as for providing insights into the metabolic adaptation
in human and bacterial plant pathogens24, 25. To the best of our knowledge only in a few cases, FBA has been applied in
understanding the metabolic adaptation of specific plant bacterial pathogens e.g. studies performed on R. solanacearum showed
that trade-off between virulence factor production and bacterial proliferation is controlled by the quorum-sensing-dependent
regulatory protein PhcA26.
The aim of this work is the reconstruction of a highly curated metabolic model of the plant pathogenic bacterium P. parmentieri
SCC3193 and the usage of this model to putatively identify the metabolic pathways relevant for P. parmentieri fitness in two
different ecological niches, soil and rhizosphere. We show that niche switching may lead to a metabolic reassessment in
carbon-related pathways in P. parmentieri SCC3193 and we spot the core-set of essential genes in the two examined conditions.
Moreover, we anticipate that the model itself will represent a valuable element which will pave the way to both, knowledge-base
of strain’s biology and novel, applied technologies, like genetic engineering and synthetic biology experiments.
Results
Reconstruction and validation of P. parmentieri SCC3193 genome-scale metabolic model.
An initial draft model of P. parmentieri SCC3193 was obtained through the KBase server (http://kbase.us) then it has been
reviewed and manually curated as described in the methods. The model was augmented by mean of orthologous gene search in
closely related E. coli strains. Following this approach, we hence expanded our reconstruction by adding 93 genes and 383
reactions from E. coli model27. Most of the added genes encode for transport reactions taking place in the membrane, where
compounds are often modified and then transferred into the cytosol. This led to the necessity to add another compartment in P.
parmentieri model, namely the periplasm, which improved descriptive model capability.
Model validation was carried-out by exploiting different approaches. Firstly, a comparison model’s performance to physiological
data obtained in high throughput experiment with the use of PM Biolog plates was performed. FBA has been employed to test if
the model could accurately predict the ability of P. parmentieri to produce biomass on utilized carbon sources. In particular, we
tested 91 compounds, previously used in PM experiment and embedded in the metabolic network. The model was hence first
gap-filled by iteratively correcting the inconsistencies between in silico predictions and PM outcomes. Where possible, missing
reactions and transporters were added according to indications obtained from functional databases (MetaNetX28, Bigg29,
Seed30, KEGG31 and transportDB32) otherwise, gap-filling genes or reactions have been added and named after the missing
components. Precisely, in twenty-two cases, the initial model’s prediction was refined thanks to experimental validations
(further details on the predictions of metabolites usage before and after this stage are given in Supplementary Data SD5). The
refined model displayed agreement with PM in 83 out of 91 tested carbon substrates. As summarized in Figure 1, sensitivity,
specificity, precision, accuracy, negative predictive value and F-score (calculated as described in33, see materials and methods)
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reached very high scores, suggesting a good reliability of the model. The final P. parmentieri model was termed iLP1245 in
accordance with the nomenclature standard34, and includes 1245 genes (covering 28% of the total number of coding sequences
in the genome, 4449), 2182 reactions, and 2080 metabolites. A description of the model and of the genetic features captured
within are reported in Supplementary Information SI1.The Systems Biology Markup Language (SBML) file of the model was
validated by the online SBML validator tool (http://sbml.org/Facilities/Validator/) and is available online as Supplementary
Information SI3. All the metabolites embedded in the model were annotated by using identifiers.org and MIRIAM35 registry in
order to facilitate model reuse and search strategies, by providing unique, unambiguous, perennial, standard-compliant and
directly resolvable identifiers.
Phenotypic characterization of P. parmentieri SCC3193 and metabolic model deep validation
Phenotypical profiling with the use of Biolog Plates PM1, PM2A, PM3 and PM4 revealed that P. parmentieri SCC3193
is able to utilize all common sugar components of plant cell walls at high levels e.g.: sucrose, tartaric acid, D-cellobiose,
stachyose and most importantly pectin (Poly(1,4-alpha-D-galacturonide)) (SD3). Model’s predictions (SD5) are in agreement
with in vivo obtained results. Precisely, this bacterium was very effectively exploiting D-Glucosamine and its derivatives
(N-Acetyl-D-Glucosamine, N-Acetyl-D-Galactosamine) together with xanthine. Intriguingly, 70.5% of phosphorus and sulfur
sources used in experiment were effectively metabolized by P. parmentieri SCC3193 (SD1).
Cross-check of PM Microarray obtained results was achieved by applying EnVisionTM analyses and measuring bacterial mass
after 24 h of incubation in M9 media supplemented with randomly selected carbon sources: alpha-D-glucose, D-trehalose, and
D-xylose. Data obtained in the nutrients metabolization assay enabled to determine growth curves of P. parmentieri SCC3193
in M9 with three different carbon sources: alpha-D-glucose, D-trehalose, and D-xylose (Figure 2). Concerning bacterial growth
in alpha-D-glucose, we observe rapid logarithmic phase and plateau of bacterial culture (Figure 2). Interestingly, in case of
D-trehalose and D-xylose a longer lag phase occurs followed by an intermediate logarithmic phase. Comparison of EnVisionTM
experiment results to models’ predictions revealed agreement in case of all 3 tested carbon sources (Figure 2).
Differential metabolic adaptation to soil and rhizosphere environment
By analyzing flux changes in response to simulated environmental conditions (e.g. M9, soil, rhizosphere) it is possible to
observe whether any significant metabolic rewiring occurs. Loopless FBA and loopless FVA (see materials and methods) were
used in order to estimate niche-specific metabolic adaptations in soil and rhizosphere. The results obtained through FBA were
cross-checked with FVA (see Supplementary Data SD3 for results). Possible fluxes variation occurring during the transition
from soil to rhizosphere was interpreted as a metabolic shift between the two niches. The magnitude of the variation was
described according to different cutoff, i.e. as a variation greater than 10%, 20%, 30%, 40% and 50% of the initial flux value.
Results indicate that the number of the reactions whose fluxes changed significantly is slightly affected by the stringency of the
cutoff, vouching for robustness of the analysis. Accordingly to the previous report23, we focused only on the results for which
variation is higher than 50% in rhizosphere compared to soil. Finally, the total amount of reactions taken into account was
208, corresponding to 1˜0% of those embedded in the reconstruction. These were further classified as reactions whose flux
increase or decrease and reactions turned on or off during the environmental stress (see Figure 3). Based on that classification,
it appears that several pathways keep being active in both examined conditions, though recruiting a different set of reactions.
The main shift seems to occur in sugars metabolic pathways, tracking a switch from pentose phosphate and hexose to amino
sugars metabolism. Also, some peculiar systems seem to be turned on in concomitance of such niche change, as nitrogen,
butanoate, galactose, and propanoate metabolism, and biosynthetic pathways, including those of steroids and folate, attesting a
specific adaptive response of P. parmentieri SCC3193 to this environmental (nutritional) switch.
In silico genes deletion provides insight into fitness relevance of metabolic modules
Simulation of single genes deletion is a very powerful in silico method, as it not only enables to estimate gene’s knock-out
fatality but also, allows predictions on a genome-scale. We performed such test on iLP1245 with two different approach (see
materials and methods), FBA and MOMA. As shown in Figure 4, both methods labeled the same number of genes as essential,
according to the three media examined, hence from now on we will refer only to FBA outcomes.
Specifically, the number of essential genes found is 251 in M9 medium, 250 in soil and 245 in the rhizosphere. The
locus tag of such genes, alongside with their corresponding encoded protein, are reported in Supplementary information
SI4. The Venn’s diagram in Figure 5 shows the overlap among the three different conditions. Results indicate that, a
huge core of genes is likely to be mandatory in all the in silico tested conditions, while only a small number stand-out as
essential just in one or two out of the three media. Notably, in in silico gene deletions predicted the gene W5S-RS13875
encoding for DNA starvation/stationary phase protection protein (WP-014700482.1) as specifically required during growth
in soil and rhizosphere, the gene W5S-RS15765 encoding for an ammonium transporter (WP-014700821.1) essential in M9
and rhizosphere, while eight genes appear to be specifically essential during growth in soil and M9 but not in rhizosphere.
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Seven of them belong to the thiamine and sulfur metabolism pathway: W5S-RS00965 cystathionine gamma-synthase,
WP-014698476.1), W5S-RS01140 (thiazole synthase ThiG, WP-012822036.1), W5S-RS01145 (sulfur carrier protein ThiS,
WP-014698484.1), W5S-RS01150 (adenylyltransferase ThiF, WP-014698485.1), W5S-RS01155 (thiamine phosphate synthase
ThiE, WP-014698486.1), W5S-RS01160 (phosphomethylpyrimidine synthase ThiC, WP-014698487.1), W5S-RS05940
(hydroxymethylpyrimidine/phosphomethylpyrimidine kinase ThiD, WP-014698998.1), while the last one, W5S-RS18250
(diaminopimelate decarboxylase, WP-043899153.1) is an enzyme involved in secondary metabolite production. Interestingly,
the simulated rhizosphere growth medium contains thiamine which, conversely, is absent in soil and M9. Moreover, three
condition-specific genes have been predicted, one during growth in M9 medium, W5S-RS19605 encoding for class II
fructose-bisphosphate aldolase (WP-014701539.1) and two during growth in the rhizosphere, W5S-RS19610 and W5S-
RS06525, respectively encoding for a phosphoglycerate kinase (WP-005973111.1) and a long-chain fatty acid transporter
(WP-014699104.1).
Discussion
Plant-microbe interactions have been under intensive investigation in recent years, regardless of the nature of the interaction
itself: pathogenic or symbiotic. Severity to understand this interplay is connected with the complexity of the environment in
which bacteria persist: soil, rhizosphere or plant tissues. Metabolic modeling allows predicting and examining biochemical
reactions involved in adaptation to above-mentioned ecological niches as well as predicting the phenotypic outcomes of gene
deletions. In this paper, for the first time we report a high throughput experimental validation on metabolic capability of P.
parmentieri SCC3193, and a highly curated metabolic model of such plant pathogenic bacterium (iLPI245). iLPI245 is highly
reliable, as in silico obtained results overlap in 91% with experimentally obtained data on carbon utilization phenotypes, a
value that perfectly fits with the currently accepted standard for genome-scale metabolic reconstructions36, 37. For example,
a previously described genome-scale metabolic reconstruction of Pectobacterium aroidearum PC1, a monocotyledonous
plant pathogenic bacterium, showed the agreement of 80.4% between in silico simulations and Phenotype MicroarrayTM
(Biolog) experiments25. This difference in accuracy of the models was probably related to the fact, that the metabolic
model of P. aroidearum PC1 was constructed on the template of the latest version of E. coli K12 MG1655 metabolic model
iJO1366, whereas in our case E. coli genome was used only for biomass estimation, and identification of orthologues genes,
in consequence producing a more P. parmentieri-specific model. The iLP1245 model of P. parmentieri SCC3193 was then
used to assess the relative importance of single metabolic pathways and genes in adaptation to growth under laboratory (M9
medium) and in silico simulated field conditions (soil and rhizosphere). Soil and rhizosphere conditions were chosen since they
represent two key environments were P. parmentieri is abundant, and for which the information on chemical composition is
readily available and reliable23. While performing FBA on P. parmentieri SCC3193, we observed a shift in sugars metabolic
pathways while conditions were changed from soil to rhizosphere. Namely, switch from pentose phosphate and hexose to amino
sugars metabolism, which are supposed to be more abundant in rhizosphere38. We can consequently suggest, that adapting
to rhizosphere environment involves utilization of this latter carbon compounds. Interestingly, a down-regulation of genes
expression involved in amino sugars and nucleotide sugar metabolism has been associated with starvation stress response
in P. atrosepticum39. Then, our prediction of metabolic fluxes implies, that rhizosphere represents a rich environment for P.
parmentieri, where these bacteria can thrive in. Moreover, butanoate, propanoate, steroid metabolism and, folate biosynthetic
pathways are turned on while we in silico shift environment from soil to the rhizosphere. These compounds are precursors for
volatiles compounds (VOCs) production or are comprised in VOC metabolic pathways; e. g. butanoate is an ester of butyric
acid, which is among the most frequently secreted compounds16, 40. We can hypothesize that interbacterial communication and
possibly plant-bacteria interaction could be mediated by VOCs, which may then have a role in pathogenesis and later on, in
developing strategies for biocontrol. All those volatiles are strictly connected either with encountering other bacteria growing
in rhizosphere or with virulence of plant pathogenic bacteria16, 40. These data were compared with those obtained from the
plant symbiotic nitrogen-fixing bacterium Sinorhizobium meliloti23. We observed that only 10% of reactions changed flux
(at least by 50%) in P. parmentieri, while the shift from soil to rhizosphere conditions changed the flux of more than 20%
of reactions (including reactions which reversed direction) in S. meliloti, though the number of reactions present in the two
models (iLP1245 and iGD1575) was similar (2182 and 1.825 reactions, respectively). Moreover, in S. meliloti 13% of active
reactions were specific to just one of the environments, while only the 5.3% of active reactions were environment specific in P.
parmentieri. We can hypothesize that the smaller and more compact genome of P. parmentieri compared to S. meliloti (4449 vs.
6204 protein-coding genes for P. parmentieri and S. meliloti, respectively, including a multipartite genome organization in
the latter species) allows a reduced metabolic redundancy in P. parmentieri compared to S. meliloti41 and a more generalist
vs. specialist metabolic network (i.e. most reactions are not changing while environment fluctuates). To test this hypothesis,
we performed MOMA and FBA simulations of gene deletions (see Supplementary Data SD6). Both analyses revealed that
P. parmentieri SCC3193 possesses an essential gene core composed of 241 metabolic genes, for growth in both soil and the
rhizosphere. Here, a set of 8 genes only was found to be essential in soil but not in rhizosphere. This is in large contrast to S.
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meliloti, where 66 genes were found as essential for growth in the same simulated rhizosphere environment23, and supports
the previously proposed hypothesis of a robust and versatile metabolic network of P. parmentieri SCC3193, which may allow
the strain to rapidly accommodate with relevant changes in environmental nutrient sources. Additionally, we can assume that
compact core of essential genes important for P. parmentieri is a reason why bacteria from this species are able to persist
on plant residuals without interacting with host plant (potato) for long periods of time, and as well are cosmopolites in the
environment12. To summarize our findings, we established a functional metabolic model of plant pathogenic bacterium P.
parmentieri SCC3193, showing an inherent robustness of the metabolic network, which can easily accommodate for nutrient
variability when moving from soil to rhizosphere growth conditions. Such robustness may imply that several, still unknown,
plant species (together with their soil and rhizosphere) can be a reservoir for this pathogenic bacterium.
Methods
Metabolic network reconstruction and model refinement
A draft metabolic model was build using the KBase Narrative Interface (www.kbase.com), later it was expanded based on the
comparison of identical functions (orthologs genes) in the closely related strain Escherichia coli K-12 MG1655 (through a
Bidirectional Best Hit approach, inParanoid42), for which a reliable metabolic reconstruction is available27. Further model
refinement was then performed through experimental validation, i.e. by iteratively comparing model’s growth outcomes to the
real strain’s growth during Phenotype Microarrays experiment (OmnilogTM). Additional informations on such validation step is
reported are Supplementary Information SI1.
Metabolic modeling
Metabolic modeling was performed using COBRApy Toolbox version 0.6.129 and the Gurobi 7.0.2 solver (www.gurobi.com).
Scripts enabling to run all the in silico analysis performed in this work are available in Supplementary Information SI2. No
comprehensive description of the macromolecular composition of the P. parmentieri biomass is available in the literature.
However, such data are available for E. coli27, therefore we approximated the P. parmentieri gross biomass composition to
that one of this closely related species. The complete biomass composition is given in Supplementary Information SI1. The
biomass reaction was set as the objective function for growth in all the media used in this work.
Bacterial strains and culture conditions
Bacterial strain used in this study is P. parmentieri reference strain SCC3193 isolated from potato tuber in Finland7, 43. For high-
throughput phenotypic characterization, bacteria were grown on TSA medium at 28 C for 24 h. For EnVisionTM experiment
bacteria were first grown in LB at 28 C for 24 h with constant agitation (120 RPM), later on in M9 for 24 h with constant
agitation (130 RPM).
Experimental high-throughput phenotypic characterization on P. parmentieri SCC3193.
Biolog Plates PM1, PM2A, PM3 and PM4 were utilized for high-throughput phenotypic characterization of P. parmentieri
SCC3193. Overnight bacterial culture was transferred from TSA medium to 5 ml of 0.85% NaCl and bacterial suspension
was adjusted to OD600 equaling 0.1 Later on, 1 ml of bacterial suspension was transferred to 11 ml of Minimal Salts medium
(M9-C: 0.6% Na2HPO4, 0.3% KH2PO4, 0.05% NaCl, NH4Cl, 0.005% Yeast Extract) supplemented with 120 ul of Biolog
A dye. To inoculate wells in PM plates 100 ul of described bacterial suspension was used. The measurement was carried
out in OmniLogTM for 46h. Results were analyzed with DuctApe44. All the results are reported in Supplementary Data
SD1. Nutrients metabolization assay with the use of EnVisionTM plate reader was performed to cross-check high-throughput
phenotypic characterization. M9 media supplemented with 20% of selected carbon sources: alpha-D-glucose, D-xylose, and
D-trehalose were prepared. P. parmentieri SCC3193 was grown in LB medium overnight at 28C with constant agitation (120
RPM). Afterwards, overnight bacterial cultures were centrifuged and washed twice in sterile Ringer Buffer and later OD600 of
inoculum was adjusted to 0.1. To establish growth curves 50 ul of inoculum was transferred to 450 ul of M9 supplemented with
different carbon sources. Bacteria were cultured with agitation set at 120 RPM in 28C in 24-well plate in EnVisionTM plate
reader. Optical density measurement at 600 nm was performed every 30 min.
OmniLogTM data processing and analysis
PM1 and PM2A obtained data analysis was performed with DuctApe44. Activity index (AV) values were calculated following
subtraction of the value obtained for blank well from that of inoculated wells, whereas plots of the growth curves are of the
unblanked data. Bacterial growth with each compound was considered positive if the AV value was ≥ 3. Growth phenotypes
were defined as negative if the AV value was ≤ 2, and following a manual inspection of the unblanked curves. All the results
are reported in Supplementary Data SD2.
5/14
In silico environmental representations
In silico representations of the nutritional composition of the soil, and rhizosphere were derived from a previously published
paper23. The composition of M9, soil, and rhizosphere media is reported in Table 1.
Flux Balance Analysis and Flux Variability Analysis
Flux distribution predictions were assessed by performing FBA in M9, soil and rhizosphere media. Moreover, to avoid in
silico artifacts, such as loops (which looks unreal to happen in vivo), we performed loopless-FBA, which instead identifies the
closest (to the reference) thermodynamically consistent flux state avoiding loops. Moreover, since FBA only predicts one flux
distribution among all possible solutions, we also performed loopless-FVA (Flux Variability Analysis) and filtered out those
reactions whose fluxes were outside the following criteria:
(1)
i f f FBA< 0 f FVA,min1.2∗ f FBA∧ f FVA,max0.8∗ f FBA
(2)
i f f FBA> 0 f FVA,min0.8∗ f FBA∧ f FVA,max1.2∗ f FBA
Loopless FBA and FVA predictions for each reaction can be retrieved in Supplementary data SD3 or by running Supple-
mentary information SI2.
Model’s predictive value estimation
M9 growth medium was simulated in silico, i.e. by constraining the lower bound of import reactions for each of the compounds
present in the medium (as reported in Table 1). When reproducing PM experiment in silico, model’s performances were
considered as true positives (TP) if growth was obtained both in silico and in vivo, true negatives (TN) in case of non-growth
both in silico and in vivo, false positives (FP) if growth was obtained in silico but not in vivo and false negatives (FN) if vice
versa. Reliability of the obtained predictions was then estimated according to the following parameters:
(3)
Sensitivity= TP/(TP+FN)
(4)
Speci f icity= TN/(TN+FP)
(5)
Precision(PPV ) = TP/(TP+FP
(6)
Negativepredictedvalue(NPV ) = TN/(TN+FN)
(7)
Accuracy= (TP+TN)/(TP+TN+FP+FN)
(8)
F− score= 2(precision∗ sensitivity)/(precision+ sensitivity)
Single gene deletion analysis
Using genome-scale metabolic networks (GEMs) genes knockout can be simulated in order to identify those genes whose
removal is likely to impair the organism’s growth. Specifically, it is possible to simulate mutants by deleting each gene included
in the metabolic reconstruction and testing the predicted effects on the microbe’s growth. Through this strategy, it is possible to
calculate the growth ratio (GRratio) between the growth rate of the mutant model (uKO) and the one of the wild-type (uWT) as:
(9)
GRratio= uKO/uWT
This measure can provide hints on the essentiality of the knocked out gene. In particular, in our work the knocked out gene was
considered essential when GRratio< 0.9. Furthermore, when 0.9 < GRratio< 1andGRratio= 1 we considered the knocked
out gene as semi-essential and essential, respectively. Minimization of Metabolic Adjustment (MOMA45) and FBA were the
algorithms chosen to perform such analyses.
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COG analyses
The WebMGA webserver33 was used to provide functional Cluster of Orthologous Genes (COG) annotations (p-value cutoff of
0.001) to each gene in the model. The COG annotation for each gene associated with variable reactions during the transition
between two niches was extracted from the WebMGA server. Biases were determined after standardizing by the number of
genes in each class of variable genes. Statistical significance was determined using Pearson’s Chi-squared tests. The complete
list of COG annotations is available as Supplementary Data SD4.
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9Conclusions
The last two decades delivered the great opportunity to study the biology of
organisms at unprecedented level. Thanks to technological and experimental
progresses, the molecular basis of biological activity have been deeply investi-
gated and finally unraveled in several fields, under the common denominator
of genomics. Comparative approaches and evolutionary techniques have been
developed to examine the genetic relationships and the structural landmarks
among different groups of organisms. The challenge of the -OMICS era is
now to integrate such informations in a functional contest. This challenge,
still ongoing, relies on the possibility
1. to reconstruct the genome sequences from the reads obtained on the
various sequencing platforms;
2. to identify genes inside these sequences and assign functions;
3. to predict organism’s phenotypes (based on functional annotations).
The overall content of this thesis aims to describe the logical progression
between these three tasks. The results herein reported, beside referring to
various fields of genomics, all intend to generate or use genomic data to draw
predictions of functional abilities (at different depth) on the examined sub-
jects. Particularly, this scope can be synthesized by the global genome-scale
metabolic model tools, which combine in a single framework the several
encountered topics. GEMs take the described predictive challenges: they
computationally infer the biological properties of an organism on the simple
basis of its genome sequence and return functional, systems clues. However,
although being a synthesis, they do not represent the conclusive step of
research. Conversely, they embody the starting point of new experimental
loops, where molecular aspects and overall mechanisms finally met, in a
system-wide fashion.
Such novelties possibly represent the future of research progress but still need
a huge tuning in order to improve the method. In particular, one of the main
stumbling-block is the gap existing between genome sequence data (which
are growing at explosive rates) and the experimental-based knowledge about
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genes function (which is collected slowly). Metabolic modeling can assist the
process linking biological functions to ORFs by generating hypotheses and
biological reasoning, but it is not sufficient. The body of experimental data
must be increased to achieve accurate functional annotations. The generation
of new high-throughput experimental platforms to provide these data would
accelerate the process, like the setting-up of sequencing machineries made
the pace of scientific discoveries during the last twenty years.
Still, it looks like the integration of experimental evidences and compu-
tational solutions will be the main key-driver of research progress, gently
molding biology in a quantitative science. -OMICS can provide data for
thousands of cellular components across a variety of scales; GEMs can re-
duce dimensionality across the wide spectrum. However, that achievement
requires to find solutions at technical issues. For example, the integration
of RNA-seq data faces unique challenges like experimental and inherent
biological noise, variation among experimental platforms, detection bias, and
the unclear relationship between gene expression and reaction flux. At the
moment, different tools (GIMME [1], MADE [2], iMAT [3]) deal with these
aspects by applying consistent, although different, mathematical strategies.
In the next years higher resolutions may be offered at the upstream level, the
experimental one.
Abundance and characterization of biomass components is also problematic.
Deep awareness is only possessed for few strains, generally model organisms.
Escherichia coli and Saccaromices cerevisiae are brilliant examples of how
a great knowledge baggage has been exploited by the metabolic modelers
community. Yeast modeling, for instance, is a long, successful history which
brought to the genetic editing of several species in order to be used as cell-
factories for sustainable production of energy and of a plethora of molecules
[4–7]. This kind of biochemical and molecular profiling is really auspicable
also for other species. In the next future improvements of empirical measure-
ments and mathematic applications may both suits the scope.
Also, new devices embodying kinetics laws may be delivered, giving birth
to a 2.0 generation of metabolic models [8]. Availability of transcriptomics,
proteomics and metabolomics data will grow crucial as the combination of
computational and experimental fields will definitely take place. For this,
facilities collecting and sourcing similar informations are mandatory.
Standardization is another knot. Scientific community should benefits of
works achieved all over the globe. However, re-usability of computational
models (and biological data in general) are often challenged by lack of for-
mality. Guidelines describing the need to unambiguously and perennially
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identify model components are arising [9–11]. Information regarding model
origin and development (metadata) are sometimes as relevant as the core
data. Controlling these parameters will allow accurate and efficient research
strategies and models comparison (or format conversion). Addressing all
these issues will drastically impact models and, in a larger perspective, whole
biology.
Despite GEMs are still young, they have already offered relevant insights,
especially in microbial systems biology. Here they also promise to open the
field to evolutionary aspects [12] and community models [13–17]. However,
the greatest expectations are probably placed on to human GEMs and their
possible impact on personalized medicine [17–22]. Modeling of disease
states like cancer, obesity and diabetes already started [23–25]. These appli-
cations will facilitate drug discovery, and possibly, therapeutic solutions will
be tailored to individual needs.
Given these incredible chances, the concluding remark of this dissertation is
to underline the importance to drive genomics and scientific efforts in such
a direction. Computational tools and systems-biology should be completely
integrated in daily research to assist biological (genomic) sciences becoming
predictive. This will fundamentally transform not just biology and the way
we learn but the entire society.
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